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Chapter 1  
Introduction 
1.1 Effects of dietary fat in the small intestine 
Overconsumption of high caloric diet and sedentary lifestyle promote overweight and 
obesity (Balwierz et al. 2009; Cheung & Mao 2012; Desmarchelier et al. 2012; Walley et 
al. 2006; Zhang et al. 2009). From 1980 to 2013, the percentage of adults with body mass 
index (BMI) of 25 kg/m2 or greater increased from 28.8% and 29.8% to 36.9% and 38.0% 
in men and women, respectively (Ng et al. 2014). Obesity is associated with multiple 
comorbidities such as insulin resistance and type 2 diabetes (Khaodhiar et al. 1999). The 
incidence of both obesity and overweight were estimated to cause 3.4 million deaths and 
3.8% of disability-adjusted life-years (i.e., the number of years lost due to premature death, 
poor health or disability) globally in 2010 (Ng et al. 2014; Lim et al. 2012). The cost for 
obesity worldwide amounts to $2 trillion annually (Dobbs et al. 2014). Diet and lifestyle 
are relevant for determining the health status of individuals, but also gut microbiota plays a 
key role in health and disease of human (O’Hara & Shanahan 2006). For example, it 
modulates lipid metabolism by modifying bile acid metabolism (Martin et al. 2007) and 
influences energy balance by promoting energy harvest from the diet and energy storage 
into the host (Bäckhed et al. 2004, 2007). Diet plays an essential role in shaping intestinal 
microbiota and high-fat diet exerts a major influence on it (Hotamisligil 2006; de La Serre 
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et al. 2010). An obese individual is characterized by lower bacterial diversity with 
increased proportion of harmful (Firmicutes) in contrast with health-promoting 
(Bacteroidetes) gut microbiota; this condition is termed as dysbiosis (Bäckhed et al. 2004; 
Clemente et al. 2012; Fleissner et al. 2010; de La Serre et al. 2010; Turnbaugh et al. 2008, 
2009). Such reduced bacterial diversity and the presence of dysbiotic conditions were also 
observed in individuals consuming western style diet (De Filippo et al. 2010; Yatsunenko 
et al. 2012). A typical western diet consists of approximately 40% of calories from fat 
although the recommended range is 20-30% (Institute of Medicine 2005; Niot et al. 2009; 
Werner et al. 2000). Individuals that experience weight loss or follow non-western style 
diets (i.e., rich in fiber content) exhibit an opposite pattern of bacterial diversity if 
compared to obese individuals (Bäckhed et al. 2004; De Filippo et al. 2010; Ley et al. 
2006; Turnbaugh et al. 2008; Yatsunenko et al. 2012). Obesity and related metabolic 
complications cause chronic or low-grade inflammation (Hotamisligil 2006). Chronic 
inflammation is triggered by the increased proportion of lipopolysaccharide containing gut 
microbiota, also known as metabolic endotoxemia (Cani et al. 2007). Increased 
endotoxemia is observed during excessive high-fat intake, which dysregulates 
inflammatory signal and leads to weight gain and diabetes (Cani et al. 2007). Dysregulated 
inflammatory signal is responsible for the high-fat mediated hyperphagia and obesity 
(Hotamisligil 2006; de La Serre et al. 2010).  
The small intestine functions as a mediator between the internal and the external 
environment of the body, and is essential for the digestion and the absorption of fat (Kondo 
et al. 2006; Petit et al. 2007). Mice fed with high-fat diet exhibit prominent up-regulation 
of lipid metabolism related genes in the small intestine and show significant predisposition 
to obesity (Kondo et al. 2006; de Wit et al. 2011). The intestine displays regionalized 
distribution in functionality and its longitudinal axis is divided into three sections (from the 
most proximal to the most distal section): duodenum, jejunum, and ileum. Jejunum 
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consists of maximal absorptive surface and the size of lumen decreases from the duodenum 
to the ileum (DeSesso & Jacobson 2001). When mice are fed with dietary fat gradient (i.e., 
10%, 20%, 30%, or 45% kcal from fat), the small intestine displays a buffer capacity in fat 
handling up to an intake of fat that represents 20% of energy demand (de Wit et al. 2011). 
Beyond such a 20% threshold, a shift towards an obese phenotype is observed (i.e., 
significant increase of body weight). The most striking effect in fat-induced differential 
gene expression is detected when the relative contribution of fat (compared to total energy 
demand) is between 30% and 45% (de Wit et al. 2011).The small intestine displays 
adaptability to the lipid content by enhancing cell proliferation and up-regulating the genes 
involved in its uptake (Niot et al. 2009; Petit et al. 2007). For example, the up-regulation of 
fatty acid transport protein (FAT)-4 promotes the uptake of long-chain fatty-acids across 
intestinal enterocytes (Herrmann et al. 2001). Permeability across intestine occurs either 
through the enterocytes (i.e., transcellular) or via the intraepithelial tight junctions (i.e., 
paracellular; Balzan et al. 2007). Enhanced paracellular permeability is observed during 
excessive high-fat intake, obesity and diabetes (Balzan et al. 2007; Cani et al. 2008; de La 
Serre et al. 2010). This is due to the modulation of gut microbiota during high-fat 
overconsumption. Such modulation modifies bile acid metabolism, thus leading to the 
breach in intestinal permeability by up-regulation of farnesoid X receptor (FXR) and tumor 
necrosis factor (TNF) while repressing the expression of tight junction proteins (zonula 
occludens-ZO-1, occludin, claudin-1, and claudin-3; see Cani et al. 2008; Martin et al. 
2007; Stenman et al. 2012; Suzuki & Hara 2010). Disruption in intestinal permeability 
consequently increases metabolic endotoxemia that triggers inflammation and metabolic 
disorders. Therefore, investigation of the gene expression patterns in the small intestine in 
response to dietary fat intake is of key interest for better understanding the relationships 
between fat mediated modification of intestinal lipid metabolism and susceptibility to 
obesity (Kondo et al. 2006; Petit et al. 2007; de Wit et al. 2011). Figure 1.1 illustrates the 
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complex interplay that characterizes dietary fat overconsumption, gene expression, 
microbiota, and disease onset in the small intestine. 
 
Figure 1.1 Consequences of high-fat overconsumption on small intestine. (a) Excessive consumption of 
high-fat diet with minimal physical activity represents a major contributing factor to the global obesity 
epidemic. High-fat diet exhibits section-specific impacts on the small intestine. The intestinal epithelial cells 
consist of absorptive enterocytes, goblet cells, Paneth cells, enteroendocrine cells and microfold cell. The 
maximum absorption and digestion occurs in the small intestine due to the presence of folds (plicae), 
depressions (crypts) and fingers like projections (villi). The magnified diagram of the structure of intestinal 
barrier in (a) is adapted from (Garrett et al. 2010; Mowat & Agace 2014; Mowat 2003; Peterson & Artis 
2014). (b) In the small intestine of mice, a high-fat diet overexpresses genes involved in the lipid metabolism 
(de Wit et al. 2011). However, these genes exhibit limited change in other metabolic organs such as the liver, 
muscle, and white adipose tissue (Kondo et al. 2006). (c) High-fat overconsumption also impacts the 
microbiota; this promotes the dysbiotic condition during which Firmicutes increase at the cost of 
Bacteroidetes (Bäckhed et al. 2004; Turnbaugh et al. 2008, 2009). Such condition reportedly increases energy 
harvest from the diet by the microbiota and impairs the balance between energy harvest and storage (Bäckhed 
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et al. 2004, 2007). Both modulation of fat metabolism (b) and disruption of microbiota homeostasis (c) are 
characterized by intestinal barrier breach and reduced bacterial diversity (whilst supporting the dysbiotic 
condition). (d) Such condition (i.e., dietary fat mediated breach in intestinal barrier and dysbiosis) triggers 
inflammatory cascade, which promotes extra-intestinal and intestinal disorders (Carding et al. 2015; Fasano 
& Shea-Donohue 2005). 
1.2 Small intestine morphology and physiology 
The small intestine displays spatial differences in morphology and physiology. Its 
absorptive surface is greatly maximized by the presence of folds (plicae), depressions 
(crypts) and fingers like projections (villi; DeSesso & Jacobson 2001). Intestinal epithelial 
cells are lined by a single layer of columnar epithelium (they mainly refer to absorptive 
enterocytes, but also include goblet cells, Paneth cells, enteroendocrine cells and microfold 
cells) while intraepithelial cells are sealed together by tight junctions (Figure 1.1a). The 
intestinal epithelium renews every 4 days in human and 3 days in mice (Kaminsky & 
Zhang 2003; Petit et al. 2007). Among the three sections of the intestinal epithelium (i.e., 
duodenum, jejunum and ileum), jejunum displays the maximal surface area; the height of 
villi decreases from jejunum to the ileum, and lumen size decreases from proximal 
duodenum to distal ileum (DeSesso & Jacobson 2001). The small intestine displays high 
variability in gene-expression and this is due to three factors: (1) cell-type differences; (2) 
changes along the longitudinal axis; (3) differences in developmental stages. George et al. 
(2008) found high expression levels of innate antimicrobials (alpha defensin 5 - Hd5, and 
regenerating islet-derived 3 alpha - Reg3A) exclusively in the ileum-crypt cells. The lipid 
sensing mechanism of the upper intestine suppresses glucose production to maintain 
energy balance and regulate food intake (Wang et al. 2008). Adenosine deaminase (ADA) 
is activated significantly in the duodenal epithelium of mice during the suckling-weaning 
transition (2-3 weeks; Dusing et al. 2000).   
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Among the macronutrients, gastric emptying is faster for carbohydrates and slower for fats. 
The transit time for chyme (a partially digested food from the stomach) in the small 
intestine takes about 3-4 hours. An increase in transit time enhances absorption, especially 
for poorly absorbed substances (except anticholinergic; DeSesso & Jacobson 2001). The 
intestinal morphology shows adaptability to the nutritional status. Along with the decline 
in cell proliferation, fasting leads to gradual atrophy of rat intestinal epithelium (Dunel-Erb 
et al. 2001). Refeeding activates cellular proliferation and dietary lipids are the strongest 
stimulators (Buts et al. 1990). In mice, dietary fat-content mediated intestinal adaptation 
occurs through two complementary events: (1) fatty-diet enhances the height of the villi 
and shows strongest effect on the intestinal trophism (i.e., crypt-to-villus migration, during 
epithelial cell renewal); (2) high-fat diet leads to up-regulation of dietary-fat responsive 
genes that play a significant role in the intestinal fatty acid uptake (i.e., fatty acid transport 
protein 4 - FATP4, fatty acid transport protein - FAT/CD36, intestinal fatty acid binding 
protein - I-FABP, and liver fatty acid binding protein - L-FABP) and lipoprotein secretion 
(i.e., microsomal triglyceride transport protein - MTP, and apolipoprotein - apoA-IV; (Petit 
et al. 2007). For example, FATP4 up-regulation promotes long-chain fatty acid uptake by 
the enterocytes (Herrmann et al. 2001).  
The activity of the small intestine is regulated via a complex interplay of different organs. 
The gut-brain-liver axis, together with the oral cavity, provides cumulative sensory inputs 
to maintain metabolic health. Both rodents and humans have developed intestinal lipid-
sensing mechanisms (through vagal afferent neurons in the intestinal walls) that regulate 
food intake and maintain energy homeostasis (Ding & Lund 2011; de Lartigue et al. 2011). 
In rodents, a raise in lipid concentration in the upper part of small intestine lowers glucose 
production through the intestine-brain-liver neurocircuitry (Wang et al. 2008). Such signal 
mediates satiety via the cholecystokinin (CCK) pathway and its impairment promotes 
hyperphagia (Ding & Lund 2011). High-fat fed rats (i.e., with lard-oil-enriched diet) 
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increase caloric intake rapidly and, after three days, acquire defects in brain’s lipid sensing 
mechanism (defects in glucose production; Pocai et al. 2006; Wang et al. 2008). Wang et 
al. (2008) have proposed that the lipid-sensing mechanism of the intestine provides one of 
the first lines of metabolic defense against nutrient excess by inhibiting food intake and 
maintaining energy balance. Furthermore, reduced satiety during high-fat feeding can be 
due to: (1) oral sensory input (this is because rats on high-fat diet reduce oral fat sensitivity 
with decreased expression of oral CD36 transporter; Newman et al. 2013); (2) malfunction 
in gut nutrient sensors like G protein-coupled receptors (GPCR, expressed in 
enteroendocrine cells; Janssen & Depoortere 2013)(Janssen & Depoortere 2013). On a 
high-fat diet, lipid metabolism related genes are prominently over-expressed in the small 
intestine while a limited change can be detected in the liver, muscle, and white adipose 
tissues (Kondo et al. 2006; see Figure 1.1b). 
1.3 Lipid absorption and digestion in small intestine 
Dietary fat belongs to a variety of lipid classes and each class exhibits unique metabolic 
phases in different cellular environments. The lipid classes are categorized based on the 
chain length or the interaction with water. Based on the chain length (C2 to C24), fatty 
acids have been grouped into four classes: saturated, monounsaturated, n-6 polyunsaturated 
and n-3 polyunsaturated (Nassir & Abumrad 2009). The solubility of lipids in water plays 
a key role in their uptake across membranes and, based on interaction with water, lipids are 
categorized as non-polar (e.g., cholesteryl oleate) and polar (e.g., triacylglycerols; Phan & 
Tso 2001; Schulthess et al. 1994; Werner et al. 2000). In a western diet, almost 40% of the 
calories are contributed by the dietary fat (i.e., about 90-95% triacylglycerols , 4.5% 
phospholipids and sterols; Niot et al. 2009; Werner et al. 2000). Most of the phospholipids 
in intestinal lumen are from the bile, while only a small amount comes from the diet (Phan 
& Tso 2001; Werner et al. 2000). Most of the dietary sterol is cholesterol (animal origin) 
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and only a small amount from plants (mainly beta-sitosterol). Beta-sitosterol is efficiently 
released from the enterocytes into the intestinal lumen, due to intestinal half-transporters 
ATP-binding cassette (ABC) transporters G5 (ABCG5) and G8 (ABCG8; see Berge et al. 
2000). Mammalian cells cannot synthesize a specific group of lipids called essential fatty 
acids, which must be obtained from the diet. The fat-soluble vitamins (A, D, E and K) are 
essential for the normal functioning of cells and organs. The absorption rates are higher for 
vitamins A, D and K compared to vitamin E. It has been suggested that competition 
between these fat-soluble vitamins can exist for what concerns intestinal absorption and 
transport (Phan & Tso 2001; Werner et al. 2000). The intestinal lipid absorption occurs via 
two successive events: intraluminal and intracellular processes (Werner et al. 2000).  
1.3.1 Intraluminal lipid absorption 
Multiple physico-chemical changes involve dietary lipids before the uptake from the 
intestinal lumen to the enterocytes (Werner et al. 2000). Intraluminal lipid absorption 
includes: (1) emulsification and lipolysis; (2) solubilization; (3) uptake of lipolytic 
products by enterocytes (Phan & Tso 2001; Werner et al. 2000).  
(1) Emulsification and lipolysis. Dietary fat digestion begins in the stomach with 
mechanical emulsification and partial triacylglycerols hydrolysis by the acid lipases 
(lingual and gastric lipases; Phan & Tso 2001; Werner et al. 2000). Most of the 
triacylglycerols digestion occurs in the duodenum and the first part of the jejunum by the 
combined action of bile and pancreatic lipase (Borgström 1977; Werner et al. 2000). 
Pancreatic lipase hydrolyzes triacylglycerols into monoglycerides and fatty acids (Nassir et 
al. 2007). When triacylglycerols droplets are covered with bile salts, pancreatic lipase 
requires the cofactor pancreatic co-lipase for adequate triacylglycerols hydrolysis (Werner 
et al. 2000). The digestion of phospholipids occurs mainly in the duodenum by the 
pancreatic phospholipase A2 (PLA2) which yields fatty acids and lyso-
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phosphatidylcholine (Iqbal & Hussain 2009; Werner et al. 2000). Dietary cholesterol is 
mostly available in the form of free sterol, with only 10-15% cholesterol ester. Before 
absorption, cholesterol esters must be hydrolyzed in the duodenum by pancreatic 
cholesterol esterase (ChEt; see Iqbal & Hussain 2009; Phan & Tso 2001; Werner et al. 
2000). Pancreatic ChEt in humans shows wide specificity (it acts on triacylglycerols, 
cholesterol esters and phosphoglycerides) and its activity is considerably amplified by the 
presence of bile salts (Lombardo et al. 1980; Phan & Tso 2001; Werner et al. 2000). 
(2) Solubilization. The luminal content (nutrients and bacteria) of small intestine is 
separated from the intestinal epithelial cells by the unstirred water layer, which is secreted 
by the mucin producing cells (e.g., goblet cells; Turner 2009). In order to pass through the 
unstirred layer, dietary fats need to be solubilized into mixed micelles by the bile acids 
(Wang et al. 2013). Mixed micelles act as transporters by delivering emulsified dietary fat 
to the apical enterocytes for the uptake (Iqbal & Hussain 2009; Schwenk et al. 2010; Wang 
et al. 2013). 
(3) Uptake of lipolytic products by enterocytes. The diffusion of fatty acids across the 
enterocytes was believed to depend on simple passive-diffusion (Iqbal & Hussain 2009; 
Schwenk et al. 2010; Wang et al. 2013). However, fatty acid uptake occurs mainly by 
membrane-associated FABP (Schulthess et al. 1994; Wang et al. 2013). There are three 
main mechanisms for the uptake and transport of fatty acids across the enterocytes (Wang 
et al. 2013). These mechanisms govern fatty-acid uptake and are mediated by membrane-
associated FABP; they refer to: (1) CD36 (also known as fatty acid translocase); (2) 
FATP4; (3) combined action of Niemann-Pick C1 like 1 protein (NPC1L1), ABCG5 and 
ABCG8 (Wang et al. 2013). CD36 is a multifunctional protein homologous to the class B 
scavenger receptor (SR-B1; Niot et al. 2009). It is abundantly expressed at the major site of 
fat absorption, the duodeno-jejunum (Poirier et al. 1996). Rat and human studies show a 
precise localization of CD36 in the apical enterocytes. The magnitude of CD36 expression 
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exhibits a clear positive relationship with dietary-lipid content, with significant up-
regulation in rats fed with high-fat diet (Iqbal & Hussain 2009).CD36 is also up-regulated 
in case of genetic obesity and diabetes mellitus (Greenwalt et al. 1995; Iqbal & Hussain 
2009). CD36-null mice show abnormal lipid processing with the accumulation of lipids in 
the proximal small intestine; thus, CD36 plays a vital role in both secretion and clearance 
of intestinal lipoproteins (Drover et al. 2005). The activity of CD36 is enhanced by the 
plasma membrane-associated FABP (FABPpm) that facilitates medium- and long-chain 
fatty acid uptake across the apical membrane of the enterocytes (Wang et al. 2013). After 
uptake, fatty acids are bound by the cytoplasmic FABP (FABPc) and enter various 
metabolic pathways (e.g., oxidation in mitochondria; Georgiadi & Kersten 2012; Wang et 
al. 2013). FATP4 transports medium- and long-chain fatty acids (Wang et al. 2013). 
FATP4 is more expressed in mature apical enterocytes than in crypts cells (where its 
expression is low or almost negligible); higher expression levels are usually found in 
jejunum than duodenum (Stahl et al. 1999). Its relevance in the in vivo fat absorption 
remains unclear but a role in the triacylglycerols processing is suggested. This is because 
FATP4-null mice show increased accumulation of triacylglycerols in the enterocytes (Shim 
et al. 2009). Intestinal cholesterol can also be maintained by the combined effects of 
NPC1L1 and ABC half-transporters (ABCG5 and ABCG8; Iqbal & Hussain 2009; Wang 
et al. 2013). NPC1L1 facilitates sterol influx at the apical enterocytes, whereas cholesterol 
and plant sterol efflux into the intestinal lumen is actively promoted by ABC half-
transporters (Wang et al. 2013). NPC1L1 deficient mice show reduced cholesterol 
absorption (Altmann et al. 2004). Moreover, the deletion of Cd36 in mice results in up-
regulation of NPC1L1 in the middle and distal sections of small intestine (Nassir et al. 
2007). Cholesterol absorption is minimally affected in Abcg5 and Abcg8 deficient mice 
that show reduced biliary cholesterol secretion and increased absorption of dietary plant 
sterol (Yu et al. 2002). 
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1.3.2 Intracellular lipid absorption 
After crossing the apical enterocytes, dietary lipids are directed into the endoplasmic 
reticulum where they are converted into the bio-inert triacylglycerols. Conversion into 
triacylglycerols is needed since lipolytic products (especially free fatty acids present in 
high concentrations) are toxic to the intestinal cells that are thus exposed to be damaged 
(Mansbach & Nevin 1998). As a countermeasure to toxic damages, FABP aids in the 
transport of absorbed fatty acids (FABP is more available in the villi than in the crypts and 
more expressed in the jejunum than in the ileum; Ockner et al. 1972; Ockner & Manning 
1974). In the proximal section, FABP is expressed in two forms: L-FABP and I-FABP. 
The fate of unbound fatty acids from the intestinal cytosol mainly follows two ways: (1) L-
FABP activates a storage mechanism for the free fatty acids and monoacylglycerol; (2) 
when L-FABP is overwhelmed by excess free fatty acids fluxing into the enterocyte, then 
free fatty acids and monoacylglycerol are rapidly esterified into triacylglycerols (Mansbach 
& Dowell 2000). However, Vassileva et al. demonstrated that I-FABP is not essential for 
the dietary fat absorption but rather maintains energy homeostasis; I-FABP performs such 
function by acting as a lipid-sensing component that alters body weight gain in a gender-
specific manner (Vassileva et al. 2000).  
The absorbed cholesterol is dispatched into the free cholesterol pool inside the enterocytes 
and is mostly transported into the lymphatic system as cholesterol ester, which is esterified 
by the pancreatic ChEt and acyl-CoA cholesterol acyltransferase (ACAT; Clark & Tercyak 
1984). Higher activity of ACAT has been observed in the jejunum compared to the ileum 
(Phan & Tso 2001) and two types of ACAT have been identified: ACAT-1 and ACAT-2. 
The expression of ACAT-2 is more restricted to small intestine and liver. Its role in the 
intestinal cholesterol absorption and esterification is demonstrated, with ACAT-2 knockout 
mice that are resistant to diet-induced hypercholesterolemia (Buhman et al. 2000). In the 
smooth endoplasmic reticulum, newly synthesized triacylglycerols and cholesterol esters 
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are packaged into a lipoprotein particle called chylomicron (Werner et al. 2000). These 
nascent chylomicrons are covered with phospholipids, cholesterol and apolipoproteins 
(apoA-I, apoA-IV and apoB-48). The gradual rise of fat absorption and triacylglycerols 
resynthesis increases the size and number of lipoprotein particles, which are packaged in 
vesicles filled with pre-chylomicrons. After modification of the pre-chylomicrons into 
mature chylomicrons in the Golgi apparatus, these vesicles translocate to the lateral 
enterocytes to be exocytosed into the interstitium and the lymph. Then, they enter the 
thoracic duct via the mesenteric lymph duct and finally reach the systemic circulation 
(Werner et al. 2000). During postprandial period, an increase in circulating chylomicrons 
induces the peak of triglycerides. This peak in plasma triacylglycerol is highest in obese 
and diabetic individuals (Georgiadi & Kersten 2012). Circulating chylomicrons are further 
hydrolyzed by the endothelial lipoprotein lipase (LPL) and then fatty acids are distributed 
to the peripheral tissues (muscles and adipose tissues; Georgiadi & Kersten 2012; Iqbal & 
Hussain 2009; Niot et al. 2009). 
1.4 High-fat diet and microbiome in intestine 
In the human body, most of the interactions between host and microbial cells occur along 
the mucosal surface, and gut is densely populated by commensal and symbiotic bacteria 
(O’Hara & Shanahan 2006; Shen et al. 2013). The ensemble of microbial cells that are 
harbored by the human body constitutes the microbiota and all genes encoded by them are 
the microbiome. In the gut, the microbiome includes 3.3 million non-redundant genes (i.e., 
they represent an amount of genes that is 150 times larger than the human gene 
complement; Clemente et al. 2012; Qin et al. 2010). Metabolism and survival of these two 
coevolved genomes (human and microbiome) are inextricably interwoven, and microbiota 
performs a major role in health and disease of human (Clemente et al. 2012; O’Hara & 
Shanahan 2006). The gut microbiota composition is highly influenced by diet (Fleissner et 
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al. 2010), but its plasticity (i.e., adaptability) in response to diet is also affected by the 
genome of the host (Parks et al. 2013). When the balanced activity of health-promoting and 
deleterious/neutral gut microbiome is disrupted, a condition called dysbiosis emerges 
(Figure 1.1c). This promotes the development of obesity, inflammatory bowel disease, 
diabetes and other metabolic complications (Clemente et al. 2012; Shen et al. 2013). 
The microbiota of a healthy human gut is composed of six main bacterial phyla: 
Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, Fusobacteria and 
Verrucomicrobia (Eckburg et al. 2005; Shen et al. 2013; Zhang et al. 2009). However, 
more than 90% of the total gut microbiota comprises Firmicutes and Bacteroidetes 
(Clemente et al. 2012; Garrett et al. 2010; Shen et al. 2013; Velagapudi et al. 2010).The 
composition (species/strains members and their abundance) of gut microbiota is unique for 
each individual (Lozupone et al. 2012; Shen et al. 2013; Zoetendal et al. 1998). Bacterial 
diversity is lower in obese individuals, with higher abundance of Firmicutes compared to 
Bacteroidetes (Bäckhed et al. 2007; Clemente et al. 2012; Fleissner et al. 2010; de La Serre 
et al. 2010; Turnbaugh et al. 2008, 2009). In presence of weight loss there is an increased 
proportion of Bacteroidetes with a reduction in Firmicutes (Bäckhed et al. 2007; Ley et al. 
2006; Turnbaugh et al. 2008). Dietary habits play an essential role in shaping the gut 
microbiota community. For example, the fecal microbiome of western populations (i.e., 
from US metropolitan areas) shows less bacterial diversity than the one of populations 
from non-western areas, and even the phylogenetic composition varies significantly 
according to the geographical location (when this well approximates different feeding 
behaviors; Yatsunenko et al. 2012). The gut microbial composition of African children 
(consuming fiber rich, non-western diet) is enriched in Bacteroidetes and depleted in 
Firmicutes if compared to European children (consuming western-style diet; De Filippo et 
al. 2010). In general, western style diet is associated with the reduction of bacterial 
diversity in the gut and promotes dysbiotic conditions. 
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1.5 Dietary fat intake and diseases in intestine 
Obesity and other metabolic disorders such as diabetes are characterized by a chronic or 
low-grade inflammation (Hotamisligil 2006). A condition called metabolic endotoxemia, 
during which there is an increased proportion of lipopolysaccharides containing gut 
microbiota, is the causative factor for the associated inflammatory state (Cani et al. 2007). 
Excess high-fat intake increases the proportion of lipopolysaccharides, which trigger body 
weight gain and diabetes by dysregulating the inflammatory signal (Cani et al. 2007). 
Lipopolysaccharides regulate the insulin sensitivity and the onset of diabetes and obesity 
by binding to the CD14-dependent TLR4 complex of the innate cells (Cani et al. 2007; 
Wright et al. 1990). Moreover, TLR4 seems to be the molecular link among nutrition, 
lipids and inflammation such that its deletion partially protects mice from high-fat diet-
induced insulin resistance (Shi et al. 2006).Gut microbiota has influence over both sides of 
the energy balance (i.e., energy harvest from the diet and energy storage into the host) and 
high-fat diet induced microbiota composition exhibited enhanced energy harvest from the 
diet (Bäckhed et al. 2004, 2007). Mice fed with high-fat diet show increased intestinal 
permeability with the down-regulation of the epithelial tight junction proteins ZO-1 and 
occludin, a condition that leads to liver inflammatory damages by increasing 
lipopolysaccharides levels in the portal blood (Brun et al. 2007; Cani et al. 2008). Gut 
microbiota is involved in this mechanism and its relevance is corroborated by the fact that 
when mice fed with high-fat diet are treated with antibiotic they display normal intestinal 
integrity and down-regulation of several inflammatory markers such as plasminogen 
activator inhibitor-1 (PAI-1), Interleukin 1 family (IL-1), and tumor necrosis factor alpha 
(TNF-α; Cani et al. 2008). The intestinal barrier disruption (a process that is triggered by 
environmental factors such as dietary or microbial antigens) can stimulate the immune 
response in extra-intestinal organs such as liver, pancreas, kidney, the skeletal system and 
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the brain (Fasano & Shea-Donohue 2005). Moreover, dysbiotic gut microbiota has 
consequences on both (1) extra-intestinal disorders (e.g., obesity, cardiovascular diseases, 
metabolic syndrome, asthma, and allergy) and (2) intestinal disorders (e.g., inflammatory 
bowel diseases like Crohn’s disease, irritable bowel syndrome and coeliac disease (Carding 
et al. 2015; see Figure 1.1d). Many disorders display regionalized distribution along the 
longitudinal axis of small intestine. Microarray transcriptomic data analysis has revealed 
that, during dietary fat-induced development of obesity and insulin resistance, the most 
pronounced effects are in the middle small intestine (with most of the differentially 
expressed genes that are related to lipid metabolism; de Wit et al. 2008). Among the 
intestinal inflammatory disorders, Crohn’s disease tends to be restricted to distal small 
intestine and colon, while coeliac disease is more characteristic of duodenum and upper 
small intestine (Knights et al. 2013; Meresse et al. 2012). Crohn’s disease displays aberrant 
inflammatory response to commensal bacteria whereas coeliac disease is triggered by 
dietary gluten (Knights et al. 2013; Meresse et al. 2012).In patients with ileal Crohn’s 
disease, the function of Paneth cells is compromised and results in a decrease of 
antimicrobial peptide production (i.e., NOD2, ATG16L1 and immunity-related GTPase 
family M protein 1 - IRGM-1; see Knights et al. 2013; Mowat & Agace 2014; Peterson & 
Artis 2014; Vaishnava et al. 2008). In patients with coeliac disease, dietary gluten 
enhances intestinal permeability by MyD88 dependent up-regulation of zonulin, which is 
followed by antigen-specific adaptive immune response (Fasano et al. 2000; Fasano & 
Shea-Donohue 2005; Thomas et al. 2006). The complex relationship involving different 
environmental factors such as diet and microbiota can alter the balance between immunity 
and tolerance thus playing an important role for the onset of metabolic and intestinal 
disorders. Dysbiotic conditions can be improved by treating the patients with antibiotic, 
prebiotic (increased consumption of dietary fiber) and probiotics (dietary supplements 
containing beneficial bacteria; see Cani et al. 2008; Everard et al. 2011; Serino et al. 2009). 
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Prebiotic treatment enhanced the production of GLP-1 and GLP-2 from the 
enteroendocrine L cells, which play a vital role in the regulation of gut barrier function and 
glucose homeostasis (Delzenne & Cani 2011). Oligofructose increased the abundance of 
Akkermansia muciniphila, which reversed metabolic disorders induced by high-fat diet 
(such as metabolic endotoxemia and insulin resistance; Everard et al. 2013). Malt 
counteracted the fat mediated increase in the mRNA expression of tight junction proteins 
and TLR in the small intestine and distal colon (Zhong et al. 2015). 
1.6 Nonlinear transcriptomic response to dietary fat intake 
Dietary fatty acids act as signaling molecules and influence metabolic processes by 
stimulation/inhibition of DNA transcription (Georgiadi & Kersten 2012). The 
transcriptional regulation of genes associated with the fatty acid metabolism has a pivotal 
role in modulating the long-term regulatory mechanism that controls lipid homeostasis. 
This control is executed by means of transcription factors such as sterol regulatory element 
binding protein (SREBP), PPAR and other nuclear receptors (Desvergne et al. 2006). 
In molecular nutrition, most studies investigate linear gene expression changes in response 
to treatments or dietary interventions (Dawson et al. 2005). However, it has been shown 
that many biological interactions between genes and environment (e.g., diet) reportedly 
occurs in a nonlinear fashion (Chen et al. 2001; Nicholson et al. 2004; Pácha 2000). In the 
small-intestine, long-chain fatty acids and vitamins undergo concentration-dependent, 
nonlinear transport across the enterocytes (and such process can even be saturated; see 
Chen et al. 2001; Pácha 2000). Also,, the relevance of nonlinear responses is considered by 
the dual intervention point model (Speakman et al. 2011). Such model identifies upper and 
lower limits at which maximal physiological regulations take place (whereas minimal or no 
regulations occur within the range of these two limits) and has been proposed to explain 
the regulation of body weight (and fatness). The upper limit to body fat accumulation in 
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mice suggests the presence of genetic mechanisms that are activated when a certain limit is 
attained (Bäckhed et al. 2004; Parks et al. 2013). However, in presence of continual 
feeding there are some mice strains that display a disrupted set-point mechanism (i.e., fat 
accumulation is not constrained and continues throughout the whole feeding period; Parks 
et al. 2013). These studies suggest that the genetic mechanism regulating fat mass gain 
reacts to the continual feeding with both saturated (logarithm) and unsaturated 
(exponential) responses. Therefore, the exclusive focus on linear response patterns can 
represent a limit for the understanding of different biological processes that link food 
intake to gene expression. An alternative approach that seems particularly suitable for 
studying gene expression in the small-intestine is to model transcriptomic response to 
varying concentrations of dietary fat intake using linear and nonlinear fitting, by 
considering fat intake as the independent variable and gene expression intensity as the 
dependent one. Nonlinear response types can be used to assess the presence of dose-
dependent thresholds (e.g., upper limits to gene expression that can be modelled with the 
logarithmic function). The presence of upper limit thresholds can be related to excessive 
fat intake and used to quantify small intestine metabolic capacity.  
1.7 Thesis objective 
This thesis investigates whether various gene expression response types (i.e., linear and 
nonlinear) characterize the longitudinal axis of the small intestine as a function of dietary 
fat doses (i.e., dietary fat intake represents the independent variable and gene expression is 
the dependent variable). Gene expression is analyzed as a continuous function of fat intake. 
The aim is categorizing the changes in the response types of differentially expressed genes 
(i.e., linear response; nonlinear response: logarithmic, exponential, quadratic and cubic) 
along the small intestine axis. The motivation behind the adoption of these models lies in 
the idea that excessive fat intake can result in the saturation of some absorptive and 
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digestive processes. In particular, the linear and exponential responses are associated to 
processes that are not constrained by any saturation (with the latter referring to an increase 
of the biological efficiency in presence of high-fat concentration), while the logarithmic 
response implies a limited capacity of the small intestine to withstand excessive fat intake. 
This idea is further corroborated by the presence of physiological and anatomical 
differences from the proximal to the distal section of the small intestine (DeSesso & 
Jacobson 2001). Such differences are reflected by changes in gene expression and can be 
related to the following biological mechanisms: 
(1) Lipid absorption. Clear differences can be observed for what concerns the absorption 
capabilities of small intestine, with the middle part known to be particularly active (de Wit 
et al. 2008). These differences suggest that the efficiency of the most responsive part (i.e., 
the middle small intestine, in case of absorptive processes) can be saturated by excessive 
amounts of fat (i.e., logarithmic response). 
(2) Lipid transportation. A high-fat diet leads to excess of cholesterol and phospholipids. 
In the small intestine, this excess concomitantly increases the demand for bile acids that 
are essential for chylomicron assembly and for a proper fat digestion and absorption. The 
chylomicron is required for lipid transportation and is accompanied by changes in the 
transcriptomic levels of genes related to its formation (Desmarchelier et al. 2012). 
Therefore, modelling gene expression as continuous function of dietary fat intake is 
relevant to understand whether chylomicron formation can be saturated by excessive fat 
intake (i.e., logarithmic response) or can promptly respond to it (i.e., either with a linear or 
exponential response). 
(3) Buffer capacity. The development of an obese phenotype occurs beyond the buffer 
capacity of the small intestine in fat handling (i.e., such buffer capacity has been observed 
until 20% kcal from fat; see de Wit et al. 2011). Prominent fat-induced differential gene 
expression was triggered when fat intake exceeded 30% of energy consumption. This 
   
 Thesis overview 
 
32 
 
behavior could be due to the fact that fat absorption and transportation are particularly 
responsive to increasing levels of fat intake (i.e., exponential response), without being 
associated to comparable changes for what concerns digestive mechanisms (i.e., saturation 
patterns with logarithmic response). 
1.8 Thesis overview 
The thesis is organized into five Chapters. Chapter 1 introduces the morphology and 
physiology of small intestine, and explains how gene expression responses are modulated 
by dietary fat intake along its axis. It mainly discusses the reasons and motivations behind 
the approach utilized for the analysis of two different microarray datasets that measure 
gene expression along the longitudinal axis of small intestine in C57BL/6J mice. This 
Chapter also explains why the nonlinear modelling of intestinal transcriptomic response to 
dietary fat intake is particularly relevant for understanding the consequences of high-fat 
intake. 
Chapter 2 describes the methods used for the analysis of the microarray datasets. Two 
different gene expression datasets were analyzed and are detailed separately in Chapters 3 
and 4. Both datasets measured the genome-wide regulation of mRNA abundance in 
response to dietary lipid and the samples were collected from the intestinal mucosa of 
C57BL/6J mice.  
Chapter 3 reports the results of the analysis performed on the dietary fat responsive gene 
expression in three sections of the small intestine of C57BL/6J mice. Intestinal 
transcriptomic data were collected after four weeks of dietary intervention during which 
mice were fed with different levels of fat (i.e., 10%, 20%, 30% and 45% kcal from fat). 
Due to the regionalized physiology (i.e., differences in absorption and digestive capability 
in each of the three sections) and the availability of higher amount of fat in the proximal 
section, linear and nonlinear (i.e., logarithmic, exponential, quadratic or cubic) 
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transcriptomic responses to dietary fat intake were tested along the longitudinal axis of the 
small intestine. The objective was investigating the presence of: (1) gene-specific response 
types for which a particular gene exhibits the same response type regardless of the 
intestinal section; (2) section-specific response types, meaning that a particular gene 
displays unique response types in different intestine sections. We found that: (1) the middle 
section was the most responsive to dietary fat intake; (2) the relative importance of 
logarithmic and exponential response was highest in the proximal and distal section, 
respectively; (3) the majority of the genes were linearly responsive to the fat intake; (4) 
there was gene-specific, linear response of inflammation related processes in the whole 
intestine, while the processes related to cholesterol transport and efflux were regulated 
with exponential response in the middle section. 
Chapter 4 is about the analysis of transcriptomic data collected from ten sections of the 
small intestine of C57BL/6J mice. These mice were fed with three kinds of diet (i.e., high-
fat, low-fat or chow) and the dietary intervention lasted 2 weeks. The consumption of 
dietary fat is essential as it represents a metabolic fuel and plays a key role in the structure 
of cell membranes. However, when fat is consumed in excess the intestine can adapt to it 
and increase its absorption (i.e., by increasing the secretion of bile acid for fat digestion). 
Therefore, three main kinds of transcriptomic response (i.e., linear, logarithmic or 
quadratic) to dietary fat intake were tested along the longitudinal axis of the small 
intestine. The main findings were: (1) high-fat intake over-expresses processes related to 
lipid metabolism and transport, while down-regulating carbohydrate metabolism; (2) 
middle and distal sections are sensitive to fat whereas the proximal section is responsive 
irrespective of the diet; (3) transport and metabolic processes were more representative of 
saturated logarithmic and linear response, respectively.  
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Chapter 5 provides the conclusions of thesis and describes how our new approach can give 
new clues to understand the relationships between fat mediated modification of intestinal 
lipid metabolism and predisposition to obesity.
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Chapter 2  
Materials and methods 
2.1 Transcriptome microarray 
This section briefly introduces the fundamentals of genomic expression and the Affymetrix 
GeneChip technology. The main aim is to describe the transcriptomic datasets that were 
used to investigate the patterns of gene expression response types (i.e., linear and 
nonlinear: logarithmic, exponential, quadratic or cubic) as a function of dietary fat gradient 
along the longitudinal axis of the murine small intestine. 
2.1.1 Affymetrix GeneChip technology 
Gene expression quantification is mainly performed using Affymetrix GeneChip 
oligonucleotide microarray and cDNA microarray. The datasets analyzed in this thesis 
were produced using Affymetrix GeneChip microarrays. These GeneChip arrays were 
manufactured using spatially patterned, light-directed combinatorial chemical synthesis 
(Lipshutz et al. 1999). Each array contains up to hundreds of thousands different 
oligonucleotide probes, which are complementary to the target transcripts. Sets of probe 
pairs called probesets interrogate particular transcripts. A probe pair consists of a set of 
two features called perfect match (PM) and mismatch (MM) where the former shows 
perfect complementarity to the target sequence (cRNA prepared from mRNA) whereas a 
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single base in the middle of the later shows a mismatch (i.e., the MM probe differs from 
the PM by a change in the central nucleotide). The benefit for having MM probes and 
probesets is that they reduce the effects of non-specific hybridization/binding and 
background signal (Murphy 2002). The intensity of the hybridization between the target 
sample and the probe array is computed for each probe cell (location for each probe). The 
image of this probe array is stored as .DAT file. The pixel values per probe cell are 
calculated and used to produce another (.CEL) file containing the probe intensity. This 
thesis is based on the analysis of data stored in .CEL files.
2.1.2  Microarray data 
This thesis investigates the genome wide effects of dietary lipids in the small-intestine 
using two distinct microarray transcriptomic datasets. The data were collected from the 
intestinal mucosa of male C57BL/6J mice. Two experiments were carried out; they were 
based on two types of dietary intervention. For the first dataset, different doses of dietary 
fat (i.e., 10%, 20%, 30% or 45% kcal from fat) were supplied. For the second dataset, three 
kinds of diets (i.e., high-fat, low-fat or chow) were used.  
In the first case study, transcriptomic data refer to three sections of the small intestine (i.e., 
proximal, middle and distal). Mice aged 12 weeks were initially fed with a control diet 
containing 10% energy intake from fat for 4 weeks. The dietary intervention was carried 
out for another 4 weeks during which mice were fed with diet containing 10%, 20%, 30% 
or 45% kcal from fat. Table 2.1 details the composition of the diet. Mice were sacrificed at 
the end of the intervention. In total, we analyzed 120 samples that represent ten biological 
replicates for each dietary group in each of the three intestinal sections. The GeneChip 
arrays used for the analysis were European Nutrigenomics Organization (NuGO) 
customized Affymetrix arrays (nugomm1a520177mmentrezg); each array contained 
16,269 probesets. The microarray data are available at GEO (accession number 
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GSE26300) and are MIAME (Minimum Information About a Microarray Experiment) 
complaint. Chapter 3 presents the results obtained by analyzing this dataset. 
 
 10E% fat 20E% fat 30E% fat 45E% fat 
 gm% kcal% gm% kcal% gm% kcal% gm% kcal% 
Protein 19 20 20 20 22 20 24 20 
Carbohydrate 67 69 60 60 53 50 40 35 
Fat 4 10 9 20 14 30 24 45 
Other 10 1 11 1 11 1 12 1 
Total 100 100 100 100 100 100 100 100 
kcal/gm 3.8  4.1  4.3  4.7  
         
Ingredient gm kcal gm kcal gm kcal gm kcal 
Casein, lactic 200 800 200 800 200 800 200 800 
L-Cystine 3 12 3 12 3 12 3 12 
         
Corn Starch 427.2 1709 325.8 1303 224.3 897 72.8 291 
Maltodextrin 100 400 100 400 100 400 100 400 
Sucrose 172.8 691 172.8 691 172.8 691 172.8 691 
         
Cellulose, BW200 50 0 50 0 50 0 50 0 
         
Soybean Oil 25 225 25 225 25 225 25 225 
Palm oil 20 180 65.2 586 110.2 992 177.5 1598 
         
Mineral Mix S10026* 10 0 10 0 10 0 10 0 
DiCalcium Phosphate 13 0 13 0 13 0 13 0 
Calcium Carbonate 5.5 0 5.5 0 5.5 0 5.5 0 
Potassium Citrate, 1 
H2O 
16.5 0 16.5 0 16.5 0 16.5 0 
         
Vitamin Mix V10001* 10 40 10 40 10 40 10 40 
Choline Bitartrate 2 0 2 0 2 0 2 0 
         
Total 1055 4057 999 4057 942 4057 858 4057 
 
Table 2.1: Diet composition of the intervention used for the case study discussed in Chapter 3. Main 
ingredients are in bold (e.g., palm oil is the main source of saturated fats whereas corn starch is the main 
source of carbohydrates). 
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In the second case study, transcriptomic data were collected from ten sections of the small 
intestine of male C57BL/6J mice. The microarray platform used for this study was 
customized Affymetrix mogene11stmmentrezg arrays. Mice received diets containing 
high-fat (HF), low-fat (LF) or chow. The detailed composition of diet is summarized in 
Table 2.2. Each diet group contained four biological replicates in the ten sections of the 
small intestine. Altogether we analyzed 120 arrays and each array consisted of 21,266 
probesets. Chapter 4 presents the results of this analysis. 
 
 Chow LF HF 
Protein % 24 20 20 
Fat% 
C16:0 
C18:0 
C18:1 
C18:2 
6 
1.2 
0 
2.2 
2.6 
10 
2.8 
0.4 
3.2 
3.6 
45 
18.7 
1.8 
17.4 
7.1 
CHO% 
Sugar 
Starch 
Fiber 
Nitrogen-free extract 
64 
 
 
4 
60 
70 
27 
42 
1 
 
35 
27 
7 
1 
 
Ash % 6   
Total 100 100 100 
 
Table 2.2: Dietary intervention used for the case study presented in Chapter 4. Three types of diet were 
used: chow, low-fat (LF) and high-fat (HF). 
2.2 Background correction and quality assessment 
Objective of microarray technology is to quantify the specific hybridization between the 
target and the probe sequence. However, the measured probe intensities can be confounded 
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by variations from sources such as technical (non-specific hybridization or optical noise) or 
manual handling. Therefore, it is necessary to perform preprocessing before obtaining 
significant biological information. Data preprocessing and quality assessment was 
performed using the interactive environment provided by the affyPLM package (Bolstad 
2004). This package is an updated version of the affy package and is part of BioConductor 
software project (Gentleman et al. 2004) that is based primarily on the R Statistical 
Environment (R Core Team 2015).The fitPLM function of the affyPLM package was used 
to fit probe level linear model to Affymetrix data. This function fits robust Probe Level 
Linear Models to each probeset and converts Affymetrix GeneChip probe level data 
(AffyBatch) into a PLMset (Probe Level Linear Models fitted to Affymetrix GeneChip 
probe level data). The standard series of steps adopted for the preprocessing of raw data 
are: (1) background adjustment and normalization (to reduce variability within or between 
arrays), and (2) summarization (a probeset consists of multiple probes and summarization 
combines these intensities to an expression value). In GeneChip arrays, multiple probes in 
a probeset represent a given transcript and intensity values are summarized into an 
expression value. 
2.2.1 Background adjustment 
Affymetrix introduced MM probe sequences in order to reduce non-specific binding. The 
default background noise correction involves subtracting MM from PM intensity. 
However, Irizarry et al. found that this strategy can lead to over-estimation of the 
expression variance (Irizarry et al. 2003). Therefore, they proposed a new procedure called 
robust multi-array average (RMA) that corrects the PM intensities whilst neglecting MM. 
This preprocessing algorithm (RMA) is widely used for Affymetrix microarrays. It 
includes background correction and also performs quantile normalization and 
summarization (McCall et al. 2010). Background correction for the dataset presented in 
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Chapter 4 was implemented using RMA (i.e., it is based on global background 
adjustment). Using the normalization and the summarization methods of RMA, Wu et al. 
(2012) proposed another background adjustment algorithm called GCRMA. GCRMA 
adjusts the intensities via estimators derived from a statistical model that relies on probe 
sequence information. The dataset analyzed in Chapter 3 was preprocessed using GCRMA. 
Both RMA and GCRMA produce output data with expression values measured in log 2 
base scales. The affyPLM package provides multiple quality assessment tools such as 
Relative Log Expression (RLE) and Normalized Unscaled Standard Error (NUSE) plots. 
The Relative Log Expression tool computes RLE values for each probeset in each array by 
comparing the expression value of a probeset against the median expression value of the 
probeset across all arrays (Brettschneider et al. 2008). This approach assumes that, in a 
given array, only a few genes are differentially expressed and therefore RLE values are 
centered near 0. The Normalized Unscaled Standard Error considers the differences in 
variability; the standard error estimates for each gene in the PLMset are normalized such 
that the median standard error for a probeset across all arrays equals 1 (Brettschneider et al. 
2008). The quality of the datasets of Chapter 3 was assessed using RLE and NUSE plots. 
2.2.2 Variability adjustment and quality assessment 
Variations in expression between multiple arrays are categorized into interesting variations 
and obscuring variations. Interesting variations are contributed by biological differences 
(e.g., differences between disease and normal tissues), while obscuring variations depend 
on other factors that are of no biological interest but exist in almost all microarray data 
(i.e., they can be due to sample preparation, hybridization condition and scanner 
differences; see Bolstad et al. 2003). Therefore, in order to compare measurements 
between multiple arrays it is necessary to normalize the obscuring variations, which would 
otherwise lead to misleading results (Irizarry et al. 2003). Normalization of arrays can be 
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performed with several methods. There are methods which use information from all arrays; 
these methods are called complete data methods and include cyclic loess, contrast based 
method and quantile normalization. Other approaches use baseline arrays such as scaling 
and non-linear methods (Bolstad et al. 2003). Bolstad et al. (2003) compared the 
performance of these normalization methods for Affymetrix GeneChip. The comparison 
showed that the quantile method performs better than the others in terms of speed, variance 
and bias criteria (Bolstad et al. 2003). Quantile normalization transforms the probe 
intensities of arrays to have the same distribution. This approach can impose problems to 
the signals in the tail. However, empirical evidence does not suggest any drawback with 
this normalization method in practice (Bolstad et al. 2003; Irizarry et al. 2003). Therefore, 
the usage of this method is preferred over the other methods. This normalization method 
was applied to the datasets analyzed in in Chapters 3 and 4. Additionally, another 
normalization technique called UPC (Universal exPression Code) was applied to the 
dataset presented in Chapter 4. This method uses linear models to correct technological and 
experimental biases by modelling the genomic base composition and the length of target 
regions (Piccolo et al. 2013). It assumes that genes of same molecular characteristics 
constitute same background expression levels and estimates the transcriptional activation 
level using the mixture model (a specific model used by the function). The mixture model 
is applied separately for each sample. Furthermore, for the dataset presented in Chapter 4 
genes with low variability across samples (usually considered not expressed in cells) are 
filtered using genefilter library (Bourgon et al. 2010; Gentleman et al. 2012). In general, 
unexpressed genes are detected as the ones that display low variability across all samples. 
These genes are filtered and excluded from the study for differential expression to increase 
the power of the analysis. 
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2.3 Regression models 
Linear regression model was applied to describe the relationship between the 
dependent/response variable (i.e., gene expression) and the independent/predictor variable 
(i.e., dietary intervention). The linear relation could also be expressed as: 
𝑦௜ =  𝛽଴ +  𝛽ଵ𝑥௜ +  𝜀௜ 
Or 
𝐺𝑒𝑛𝑒 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑟𝑒𝑠𝑝𝑜𝑛𝑠𝑒௜ =  𝛽଴ +  𝛽ଵ𝐷𝑖𝑒𝑡𝑎𝑟𝑦 𝑖𝑛𝑡𝑒𝑟𝑣𝑒𝑛𝑡𝑖𝑜𝑛௜ + 𝜀௜ 
Where 𝑦௜: The predicted value of the response variable 
 𝛽଴: The intercept or response value when the predictor variable equals zero 
 𝛽ଵ: The slope that quantifies the relation between the predictor variable and the 
response variable 
 𝑥௜: The independent or predictor variable    
 𝜀௜: The residual error 
 
However, in addition to linear response patterns we also investigated different nonlinear 
functions. This is because nonlinear processes might be particularly useful to describe fat 
absorption and digestion in the small intestine (i.e., by modelling how gene expression 
changes as a function of dietary fat intake when moving along the longitudinal axis of 
small intestine). Therefore, by combining linear and nonlinear analysis different aspects 
might be investigated: (1) which is the predominant relationship linking gene expression to 
dietary fat intake (i.e., linear vs. nonlinear patterns)? (2) Are different biological processes 
associated to specific response types? (3) How does gene expression change along the 
longitudinal axis of the small intestine (i.e., gene-specific vs. section-specific responses)? 
Gene-specific responses are constantly associated to some genes, irrespective of the section 
where the differential expression occurs. Section-specific responses depend on the section 
where the genes are differentially expressed (e.g., the same gene can respond either in 
linear or nonlinear way, and the type of functional response depends on the section where 
the gene is differentially expressed) and not on the identity of the gene. Linear and 
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nonlinear gene expression in response to dietary fat intake was modelled in the R 
Statistical Environment (R Core Team 2015) by using the syntax summarized in Table 2.3. 
 
Response Model R syntax 
Linear 𝑦௜ =  𝛽଴ + 𝛽ଵ𝑥௜ lm(y~x) 
Logarithmic 𝑦௜ =  𝛽଴ + 𝛽ଵlog (𝑥௜) lm(y~log(x)) 
Exponential 𝑦௜ =  𝛽଴ + 𝛽ଵexp (𝑥௜) lm(y~exp(x)) 
Quadratic  𝑦௜ =  𝛽଴ + 𝛽ଵx + 𝛽ଶ𝑥ଶ lm(y~poly(x,2)) 
Cubic 𝑦௜ =  𝛽଴ + 𝛽ଵx + 𝛽ଶ𝑥ଶ + 𝛽ଷ𝑥ଷ lm(y~poly(x, 3)) 
 
Table 2.3 R syntax for testing linear and nonlinear responses. Biological interpretations of these models 
is that the consumption of excessive fat may result in the saturation (i.e., logarithmic) of some biological 
processes (i.e., absorption or digestion). However, some processes that are not constrained by any saturation 
may be measured by linear and exponential responses, which describe increased efficiency in presence of 
highest fat concentration. Quadratic and cubic functions measure processes that follow hyperbolic and 
oscillating responses, respectively. 
2.4 Analysis of differentially expressed genes 
In this thesis, the relationship linking gene expression to dietary fat intake along the 
longitudinal axis of the small intestine was investigated. The transcriptomic data presented 
in Chapter 3 was fitted with linear and nonlinear (logarithmic, exponential, quadratic and 
cubic) responses by using dietary fat doses (10%, 20%, 30% and 45% of energy intake) as 
a continuous predictor of gene expression (i.e., gene expression levels were analyzed as a 
continuous function of fat intake). Gene expression intensity and fat doses were considered 
as the dependent and independent variable, respectively. Linear regression was performed 
on the pre-processed data (i.e., log 2 transformed gene expression); data were pre-
processed using the limma library (Smyth 2005). The nonlinear responses were tested by 
modelling expression as a function of logarithmic, exponential quadratic and cubic 
transformed fat intake. Multiple test correction of p-values were performed using 
Benjamini and Hochberg’s method (Benjamini & Hochberg 1995) and the significance 
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threshold for the adjusted p-values was at 0.1. When a gene was significant in more than 
one response type, the one with the lowest adjusted p-value was selected. In Chapter 4, the 
transcriptomic data was fitted with linear and nonlinear (logarithmic and quadratic) 
responses as a function of the interaction between diet and intestinal sections (i.e., both diet 
and intestinal section are the independent variables; gene expression is the dependent 
variable). This analysis investigated the transcriptomic response to distinct diets (i.e., high-
fat, low-fat, or chow) along the small intestinal axis. The reasons behind the fitting of 
logarithmic and quadratic responses are: (1) when the amount of fat reaching the intestine 
is highest, the metabolic processes may display saturated (i.e., logarithmic) response; (2) 
the digestion process and the microbiota effects are expected to be highest in the most 
proximal and distal sections, respectively; as such these activities could be effectively 
modelled with a quadratic response that describes the highest expression in the proximal 
and distal sections (and lowest in the middle). Diet was represented as ordered categorical 
values (i.e., chow < low-fat diet < high-fat diet) to illustrate the increasing energy content 
of fat. The intestinal sections were considered as continuous numerical values (i.e., values 
from 1 to 10 refer to the longitudinal axis of the small intestine, moving from most 
proximal to the most distal section). The limma library was used to perform linear 
regression on the pre-processed data (i.e., log 2 transformed gene expression; see Smyth 
2005). For the nonlinear responses, gene expression was modelled as a function of the 
interaction between diet, and logarithmic or quadratic transformed intestinal sections. Lists 
of dietary fat responsive (differentially expressed) genes were obtained by making 
comparisons between samples (i.e., high-fat diet vs. low-fat diet; low-fat diet vs. chow). 
The p-values were adjusted for multiple test correction using Benjamini and Hochberg’s 
method (1995) and the adjusted p-value threshold of 0.1 was considered. In the case that 
both linear and nonlinear responses were significant then the one with the lowest adjusted 
p-value was selected. Various nonlinear functions were associated to specific processes 
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and have different biological explanations: (1) the logarithmic response reports the 
presence of saturation mechanisms; (2) the exponential response corresponds to extremely 
efficient processes in the presence of high-fat intake; (3) the quadratic response refers to 
enzyme kinetics; (4) the cubic response is expected to be associated to circadian rhythms 
with oscillating trends. The limma library computes moderated t-statistics for each probe 
(and for each contrast). It differs from the ordinary t-statistics because: (1) the standard 
errors across genes are moderated to a common value by using the simple Bayesian model 
(i.e., the standard error measured from the estimated log-fold changes are moderated 
towards a common value by borrowing information across genes); (2) the degrees of 
freedom are increased to be consistent with the smoothened standard errors (Smyth 2005). 
2.5 Correlation network analysis 
The correlation patterns of the diet responsive differentially expressed genes were analyzed 
by constructing a co-expression network (i.e., each node represents the gene expression 
profile and the pairwise correlation between expressions are used to generate the edges 
between genes) using the WGCNA library (Langfelder & Horvath 2008). The hierarchical 
clustering method implemented in the WGCNA library was used to identify clusters of 
highly interconnected genes (in graph theory, these clusters are also called modules) in the 
dataset analyzed in Chapter 4 (Kaufman & Rousseeuw 1990; Langfelder & Horvath 2008). 
The topological overlap measure of the expression data was inferred from the adjacency 
matrix (i.e., calculated from the co-expression similarity by using the principle of scale-
free topology) and this was used to define the interconnectedness of clusters. In order to 
avoid identifying clusters with similar expression profiles, the co-expression similarities of 
all clusters were further evaluated by grouping the correlated clusters on the basis of their 
eigengene profiles (i.e., the most characteristic gene expression profile is considered as the 
representative of the module - it is the first principal component of the module; see 
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Langfelder & Horvath 2008). Most biologically interesting clusters (i.e., clusters that 
showed significant correlation with the ten intestinal sections) were obtained by finding the 
most significant association between the eigengene profiles of each cluster with the ten 
intestinal sections (Langfelder & Horvath 2008). 
2.6 Functional annotation of the differentially expressed genes 
The functional annotation of the differentially expressed genes found with both datasets 
(i.e., in Chapters 3 and 4) were performed with two different libraries in R. The over-
represented Gene Ontology Biological Processes (GOBP) relative to each section (and for 
each response type) in the first dataset (i.e., Chapter 3) were investigated using the 
hypergeometric test. This test was performed using HTSanalyzeR library, which tests for 
the overlap between hits and gene sets (such as Gene Ontology, MSigDB, and KEGG; see 
Wang et al. 2011). The p-values were adjusted using Benjamini and Hochberg’s method 
and the significance threshold was 0.1 (Benjamini & Hochberg 1995). Each significant 
cluster identified with correlation network analysis (i.e., the second dataset; see Chapter 4) 
was tested for enriched GOBP terms using the gage library (Luo et al. 2009). Three kinds 
of GOBP enrichment tests were performed for each cluster: (1) by ignoring the dietary 
effect, the processes that were enriched along the longitudinal axis of the small intestine 
were obtained; (2) high-fat diet responsive processes were investigated by considering 
high-fat diet samples as the target and the low-fat diet samples as the reference; (3) low-fat 
diet responsive processes were investigated by taking low-fat diet samples as the target and 
chow diet samples as the reference. For each analysis, three kinds of outputs were obtained 
based on the regulatory direction of the GOBP: (1) up-regulated processes; (2) down-
regulated processes; (3) processes which include gene regulation in both directions, such as 
canonical signaling pathways (Luo et al. 2009). The Benjamini and Hochberg’s method 
was used to obtain adjusted p-values and the significance threshold was at 0.1. For each 
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cluster, the enriched GOBP terms were grouped based upon GO similarities (i.e., by 
considering information content measure of GO terms within a specific ontology - 
biological process in our case) as implemented in GOSim library (Fröhlich et al. 2007). 
The information content values for each GO term are precomputed. These values are based 
on the number of times a specific GO and its gene products or neighboring (i.e., direct or 
indirect) offspring are annotated into the GO. In order to test the nonlinear responses in 
each network cluster the over-represented GO terms that refer to metabolic and transport 
processes were selected for further analysis. Also, the clusters that showed the highest 
significance to diet-responsive GOBP and that displayed the highest correlation with the 
ten intestinal sections (i.e., as computed using WGCNA library) were considered for the 
subsequent analysis (i.e., to find the predominant transcriptomic responses for each 
enriched process and examine which intestinal segments are most responsive to diet). Each 
of these clusters was characterized by the GO term with the highest information content 
value. This selection was made by identifying more specific GOBP terms (e.g., lipid 
metabolic process prevails over general terms like metabolic process).  
2.7 Biological process trend analysis 
In order to check if specific response types (i.e., linear, logarithmic, exponential, quadratic 
or cubic) are representative of certain biological processes or change their relative 
importance along the small intestine axis, GOBP trends were analyzed from the most 
proximal to the most distal section (results of such analysis are presented in the Chapter 3). 
In the Chapter 3 we aimed at finding: (1) the GOBP terms that were composed of genes 
that preserved their response type in all intestine sections (i.e., proximal: linear – middle: 
linear – distal: linear); (2) the GOBP terms that included genes that changed the shape of 
their response type along the different small intestine sections (e.g., proximal: linear – 
middle: logarithmic; middle: logarithmic – distal: linear; middle: linear – distal: 
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exponential). Two additional analyses were performed in Chapter 4 to identify dietary 
mediated predominant response types in each of the ten sections. First, the most 
characteristic (gene-level) response pattern of each GOBP per cluster was considered as 
the dominant one (i.e., the linear or nonlinear response type for which the highest gene 
count was recorded). Second, for each gene the intestinal sections with the highest 
frequency of high/low expression values were considered to be most responsive to diet.  
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Chapter 3  
Nonlinear transcriptomic response 
to dietary fat intake in the small 
intestine of C57BL/6J mice1 
3.1 Background 
Overconsumption of food that are rich in saturated fats leads to excessive energy intake 
and is strongly linked to metabolic disorders such as obesity, diabetes, cardiovascular 
diseases and some forms of cancer (Balwierz et al. 2009; Cheung & Mao 2012; 
Desmarchelier et al. 2012; Walley et al. 2006; Zhang et al. 2009). As the primary source of 
dietary fat uptake, the small intestine plays a key role in governing nutritional health 
(Kaminsky & Zhang 2003; Kondo et al. 2006; Petit et al. 2007; Thomson et al. 1986; de 
Wit et al. 2008). The intestinal absorptive capacity is enhanced by numerous fingers like 
projections of the mucosal membrane called villi, and there exist regionalized anatomic 
and physiological differences from proximal duodenum to distal ileum (Figure 1.1). The 
middle section has longer villi in comparison with the proximal and distal sections. It 
covers nearly half of the intestinal length and is characterized by the highest absorptive 
                                                 
1 Chapter 3 includes the findings of the following manuscript: Nyima, T. et al., Nonlinear transcriptomic 
response to dietary fat intake in the small intestine of C57BL/6J mice. Under revision in BMC Genomics. 
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capacity. The distal section contains shorter villi and less absorptive capacity 
(Desmarchelier et al. 2012; Goncalves et al. 2015).  
The small intestine acts as a gatekeeper between the diet and the body and can directly 
metabolize or block the uptake. Recent studies have demonstrated a strong intestinal 
transcriptomic response to dietary fat intake. Kondo et al. (2006) found high fat-induced 
up-regulation of lipid metabolism-related genes (e.g., Mod1, Cyp4a10, Acot1 and Acot2) in 
the small intestine of C57BL/6J mice, with negligible effects observed in the liver, muscle 
and white adipose tissue. Fat intake triggers the down-regulation of ABC half-transporters 
(Abcg5 and Abcg8) in liver and intestine thus leading to increased levels of sterols in 
diabetic rats (Bloks et al. 2004). Biological processes like inflammatory response and cell 
cycle were highly up-regulated in the small intestine of C57BL/6J mice during dietary fat 
induced development of obesity and insulin resistance (de Wit et al. 2008). The absorption 
capacity of intestine displays adaptability in response to dietary fat composition such as 
enhanced intestinal cell proliferation, synchronization of fatty acid uptake and lipoprotein 
secretion, and altered transport processes (Petit et al. 2007; Thomson et al. 1986).Section-
wise studies focused on gene-specific responses: (I) Simon et al. (2011) found increased 
distal gut hormone response to a high fat diet in apoA-IV knockout mice; (II) Nassir et al. 
(2007) observed sharp decreasing gradient in CD36 levels from proximal to distal 
intestine. de Wit et al. (2011) showed prominent effect of dietary-fat doses on gene 
expression, mainly in the proximal and middle sections. They concluded that differentially 
expressed genes correlated with the development of obesity, and the main shift towards an 
obese phenotype was observed when an amount of energy included between 20% and 30% 
was derived from fat. Previous research studies investigated the consequences of fat intake 
on transcriptomic response of intestine by individual, pairwise comparisons between 
control (i.e., baseline) diets and treatments (e.g., high fat vs. low fat; see Kondo et al. 2006; 
Westergaard & Dietschy 1974; de Wit et al. 2008). Their goal was detecting a significant 
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difference between control and treatments, rather than quantifying the strength of the 
response as a function of different levels of fat intake. Our work is a re-analysis of the data 
produced by (de Wit et al. 2011). We propose a novel approach to study whether linear or 
nonlinear response types characterize gene expression in the small intestine (i.e., dietary fat 
intake represents the independent variable and gene expression level is the dependent 
variable). We investigate dose-dependent transcriptomic response to dietary fat along the 
horizontal axis (proximal, middle and distal sections) of the small intestine of C57BL/6J 
mice. Mice were fed with 10%, 20%, 30% or 45% of energy (E%) derived from fat for 
four weeks (n = 10 mice/diet) and corresponding gene expression levels served to fit dose-
dependent responses. Due to the unique morphological and functional characteristics of 
each intestinal section (Desmarchelier et al. 2012; Hollander & Truscott 1976; Shaw-Smith 
& Walters 1997; Thomson et al. 1986; Westergaard & Dietschy 1974; Westergaard & 
Dietschy 1976), we expect to observe variations in transcriptomic response from proximal 
to distal section (Figure 1.1a). Our focus is mainly upon evaluating possible nonlinear 
relationships between gene expression and dietary fat percentage in the three sections. We 
aim at categorizing changes in the response types of differentially expressed genes (i.e., 
linear response; nonlinear responses: logarithmic, exponential, quadratic or cubic) among 
each of the three sections of the small intestine (Figure 3.1). The main advantage of 
studying continuous transcriptomic responses as a function of dietary fat intake is related 
to the chance of combining the information of different treatments into a unique picture. 
This helps in better understanding how the response to highest levels of fat intake is 
attained. Thus, we can investigate whether biological processes are overloaded by highest 
levels of fat content (i.e., logarithmic response type) or modulated in order to cope with 
them (i.e., exponential response type). The presence of a constant, linear response type 
along the whole small intestine can indicate spatial-independent mechanisms (i.e., this 
applies to processes that respond in a gene-specific manner, independently of the intestine 
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section where they occur). For example, such an approach can be used to illustrate whether 
an obese phenotype (I) corresponds to a 'tipping point' of the system (i.e., exponential 
response vs. linear and logarithmic responses) or (II) is limited by the metabolic capacity 
of the system (i.e., logarithmic response vs. linear and exponential responses). Moreover, 
distinguishing among the shape of the response types in differentially expressed genes adds 
a further qualitative level to the description of the biological processes (i.e., in addition to 
the magnitude and direction of the regulation). The broadest goal of our study was 
investigating whether the response types are gene-specific (i.e., a given gene always 
exhibits the same response type, regardless of intestinal section) or intestinal section-
specific (i.e., for the same gene, the response type displays unique patterns in the three 
intestine sections).  
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Figure 3.1: Comparison between classical and novel approach for identifying differentially expressed 
genes. We use as a reference the case study of mice fed with four levels of fat representing 10%, 20%, 30% 
and 45% of total energy intake; gene expression is measured in three sections of small intestine: (a) in the 
classical approach, the total number of differentially expressed genes is determined by comparing the control 
diet (10 E%) with treatments (20 E%, 30 E% and 45 E%); (b) in the novel approach, all expression levels of 
each gene (in the three sections) are considered to fit linear or nonlinear (i.e., logarithmic and exponential, in 
this case) response types. Three hypothetical patterns are described in (b): (I) gene type A preserves a linear 
response in the three sections of small intestine; (II) gene type B displays saturation (i.e., logarithmic 
response) in the proximal and middle sections; (III) gene type C shows exponential responses in most 
downstream sections (i.e., middle and distal parts of small intestine). Transcriptomic response of gene type A 
is gene-specific while the patterns observed for gene type B and C are section-specific.
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3.2 Materials and methods 
3.2.1 Ethics statement 
The institutional and national guidelines for the care and use of animals were followed. 
The experiment was approved by the Local Committee for Care and Use of Laboratory 
Animals at Wageningen University. 
3.2.2 Dietary intervention 
At twelve weeks of age, mice were fed for an initial period of four weeks with a control 
diet containing 10% of energy intake from fat. The main reason for this relatively long run-
in period was that we wanted to be sure that the effects of chow diet were highly 
diluted/not present when starting the dietary intervention. In addition, since we wanted to 
investigate the effect of diet-induced obesity in adults, we choose to start the experiment 
when the mice were 16 weeks old (mice aged 12 weeks are considered young adults that 
are still growing). After the initial period, mice were divided into four groups that received 
10%, 20%, 30% or 45% kcal from fat (see Table 2.1 for dietary composition). The dietary 
intervention lasted four weeks and then mice were killed by cervical dislocation after five 
hours fasting and anesthesia with 1.5% isoflurane. The isoflurane was evaporated in a 
vaporizer using a mixture consisting of 70% nitrous oxide and 30% oxygen. Ten biological 
replicates were carried out for each diet group in the three sections of the small intestine 
(i.e., altogether we analyzed 120 samples). 
3.2.3 Microarray data 
We analyzed microarray transcriptomic data from the intestinal mucosa of male C57BL/6J 
mice. The small intestine was divided in three equal parts: proximal, middle and distal 
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sections. These three parts were chosen because of practical reasons; when dissecting the 
small intestine one has to process the tissue quickly to avoid RNA degradation. The 1st 
part (i.e., proximal section) consists of the duodenum plus proximal jejunum, the 2nd part 
(i.e., middle section) corresponds to jejunum, and the 3rd part (i.e., distal section) includes 
the distal jejunum and ileum. Detailed protocols on dietary intervention and RNA 
extraction are described by de Wit et al (de Wit et al. 2011). The microarray platform used 
for this study is nugomm1a520177mmentrezg, a custom Affymetrix mouse array 
containing 16,269 probesets. The NuGO arrays are custom designed Affymetrix GeneChip 
arrays, designed by the European Nutrigenomics Organisation (NuGO) and manufactured 
by Affymetrix. These arrays contain in part common probe sets that are also present on 
standard Affymetrix arrays and in part newly designed probe sets (GEO platform 
GPL7440). The microarray data used for our analyses are MIAME compliant, available at 
GEO (accession number GSE26300). Data pre-processing and quality assessment, 
statistical analysis to identify differentially expressed genes and pathway analysis have 
been carried out in the R Statistical Environment (R Core Team 2015). 
3.2.4 Data pre-processing and quality assessment 
We used the affyPLM (PLM = Probe Level Model) library for data preprocessing and 
quality assessment. We applied the fitPLM function that fits iterative reweighted least 
square M-estimation regression to the probe intensity (Bolstad 2004). Background 
intensities (optical noise and non-specific binding) were adjusted with the GCRMA library 
(Wu et al. 2007). Such adjustment is obtained via estimators derived from a statistical 
model that uses probe sequence information. The GCRMA library has been shown to 
perform particularly well in adjusting background intensity in Affymetrix Genechips (Kroll 
et al. 2008). After background adjustment, technical variability between arrays was 
adjusted by quantile normalization (Bolstad 2001). The quality of the PLMset object was 
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assessed by plotting Relative Log Expression (RLE) and Normalized Unscaled Standard 
Error (NUSE; Brettschneider et al. 2008). Genes with low variability across samples are 
usually considered as not expressed. This is motivated by the observation that, in general, 
unexpressed genes are detected most reliably through low variability of their features 
across samples. Non-specific filtering of the genes was made with the genefilter library 
(Bourgon et al. 2010; Gentleman et al. 2012). The pOverA R function was used for 
variance-based filtering; genes with unlogged intensity above five, in at least five arrays, 
were chosen for the subsequent analysis. Genes without Entrez Gene ID and Affymetrix 
quality control probe-sets were excluded. After data pre-processing and quality assessment 
we selected 14,952 genes in the proximal section, 14,933 in the middle and 14,925 in the 
distal.  
3.2.5 Statistical analysis to identify differentially expressed genes 
We investigated the statistical relationship between gene expression and dietary fat intake. 
We fitted linear and nonlinear (i.e., logarithmic, exponential, quadratic and cubic) 
responses describing gene expression levels (dependent variable) as a function of dietary 
fat intake (independent variable). We considered nonlinear responses that reflect: (I) 
blunted differential expression at higher fat intake, which may indicate overloading of the 
relevant biological process (logarithmic curve); (II) progressively stronger differential 
expression with increasing fat intake (exponential curve); (III) parabola-like differential 
expression (quadratic function); (IV) oscillating trends (cubic function). The array data 
were log2 transformed (GCRMA normalized data). All responses (i.e., linear and 
nonlinear) were tested by modelling log2 transformed expression as a function of fat intake 
(i.e., with fat providing 10, 20, 30 or 45 E%). When comparing the diets of 40 mice (n = 10 
mice per diet group), there was no significant difference with respect to total food intake in 
grams per day (see Table 3.1). However, caloric intake increased with increasing fat 
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percentage (and a linear relationship existed between the % of kcal from fat intake and the 
actual grams of fat intake - i.e., soybean oil and palm oil). Fat intake (the independent 
variable) is considered as continuous predictor of log2 transformed gene expression. We 
used the limma library (Smyth 2005) to perform linear regression on GCRMA normalized 
data (i.e., log2 transformed gene expression), and tested nonlinear responses by modeling 
expression as a function of logarithmic-, exponential-, quadratic- and cubic-transformed fat 
intake. To identify differentially expressed genes we performed multiple testing correction 
using Benjamini and Hochberg's false discovery rate (1995; FDR, with 0.1 significance 
threshold). It should be noticed that many studies regularly adopt an adjusted p-value 
threshold of 0.1 for identifying differentially expressed genes (e.g., Daves et al. 2011; 
Stevens et al. 2013). In the case that both linear and nonlinear responses were significant 
for a given gene, we selected the one with the lowest p-value. The robustness of our 
analysis was then tested by comparing the results obtained with two criteria of model 
selection (i.e., using p-values and Akaike’s information criterion - AIC). 
 
Feed intake in grams per day (mean and SEM, n = 10) 
10E% fat 20E% fat 30E% fat 45E% fat 
MEAN SEM MEAN SEM MEAN SEM MEAN SEM 
3.396 0.060 3.279 0.072 3.404 0.034 3.196 0.073 
 
Caloric content feed (kcal/gm) 
3.8 4.1 4.3 4.7 
 
Caloric intake (kcal per mouse per day); mean (n = 10) 
12.905 13.443 14.635 15.020 
 
Table 3.1 Food and caloric intake in week 4. Data refer to the week the mice were killed. We summarized the mean 
and standard error of the mean (SEM), based on n = 10 per diet group. The caloric intake consistently increased from 10 
to 45% diets, but the absolute amounts of food intake varied in a non-significant way. 
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3.2.6 Functional analysis 
We investigated whether fat-responsive genes were enriched within distinct biological 
processes (defined as Gene Ontology Biological Process - GOBP), and tested whether each 
intestinal section displayed unique transcriptomic response to fat intake. We performed 
hypergeometric tests to functionally characterize groups of differentially expressed genes. 
We investigated over-represented Gene Ontology Biological Process (GOBP) in each 
section (adjusted p-value < 0.1; such threshold is commonly used for gene set enrichment 
analysis - e.g., Harris et al. 2009; Raymond et al. 2010) using the library HTSanalyzeR 
(Wang et al. 2011). To understand whether specific response patterns (i.e., linear, 
logarithmic, exponential, quadratic or cubic) characterize certain biological processes, or 
change according to the intestinal sections, we assessed trends of GOBP terms passing 
from the proximal to the distal region. We studied GOBP terms that preserved the same 
response pattern in different intestinal sections (e.g., proximal: linear - middle: linear - 
distal: linear), and analyzed those changing response pattern between the sections (e.g., 
proximal: linear - middle: logarithmic; middle: logarithmic - distal: linear; middle: linear - 
distal: exponential). A flowchart of the overall analysis is shown in Figure 3.2. 
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Figure 3.2 Schematic representation of workflow adopted for the analysis of microarray data. We 
identified linear and nonlinear response patterns for significantly over-represented GOBP terms. Trends for 
the response patterns specific to each term were examined from proximal to distal section.  
3.3 Results 
3.3.1 Linear and nonlinear gene expression  
The count of genes that respond in a significant way (either linear or nonlinear) to fat 
intake varies between the three sections (Table 3.2).  
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Response 
(Gene 
expression 
vs. Fat 
intake) 
Proximal Middle Distal 
Gene 
(count) 
Relative 
% 
GOBP 
(count) 
Gene 
(count) 
Relative 
% 
GOBP 
(count) 
Gene 
(count) 
Relative 
% 
GOBP 
(count) 
 
Linear 
 
 
1053 
 
53.29 25 1410 56.65 27 185 59.11 26 
Logarithmic 
 
678 
 
34.31 
 
1 
 
458 
 
18.40 
 
22 
 
26 
 
8.31 
 
- 
 
Exponential 
 
139 
 
7.03 
 
- 
 
499 
 
20.05 
 
9 
 
84 
 
26.84 
 
8 
 
Quadratic 
 
61 
 
3.09 
 
- 
 
87 
 
3.50 
 
7 
 
9 
 
2.88 
 
- 
 
Cubic 
 
45 
 
2.28 
 
- 
 
35 
 
1.41 
 
2 
 
9 
 
2.88 
 
- 
 
 
Table 3.2: Count of genes that respond in a significant, dose-dependent way to fat intake. Results were 
extracted using the limma library and are specific to each section of small intestine; adjusted p-value < 0.1. 
Genes are classified based on the mathematical function used to fit their expression in response to fat intake 
(linear, logarithmic, exponential, quadratic or cubic). For each section, we summarize the relative percentage 
of genes characterized by the five response types (%) and the number of significant GO terms (Biological 
Processes - GOBP) found with hypergeometric test (adjusted p-value < 0. 1). Only GOBP terms with, at 
least, six differentially expressed genes (in the whole small intestine) have been taken into account. 
 
The highest number of genes showing linear, exponential or quadratic transcriptomic 
response to fat intake was found in the middle section, but the highest number of genes 
displaying either logarithmic or cubic patterns of expression in response to fat intake was 
in the proximal section. The lowest number of differentially expressed genes, for all five 
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response types, was observed in the distal section. The proportion of differentially 
expressed genes exhibiting a significant linear relationship with the dietary fat intake was 
always above 53%. In the proximal and distal sections, the relative importance of 
logarithmic and exponential response, respectively, was the highest. Both quadratic and 
cubic response types are of marginal importance in all intestine sections (hereafter, given 
the fact that quadratic and cubic responses are associated with around 5% of differentially 
expressed genes, the focus will be on linear, logarithmic and exponential patterns only). 
The number of genes displaying a logarithmic response to fat intake dropped from the 
proximal to the distal section (the percentage decreases from 34.31% in the proximal to 
8.31% in the distal section). The opposite trend is found for the exponential response: the 
percentage increases from 7.03% in the proximal to 26.84% in the distal section. Thus, 
although the highest number of genes responding in an exponential way to fat intake was 
in the middle section, an increasing relative importance of this response is observed from 
the proximal to the distal part of the small intestine (Figure 3.3). In the three sections, if we 
consider the changes in gene expression that were significantly associated with varying 
levels of fat intake we observed a prevalence of up-regulated genes (Figure 3.4). These 
results were not affected by the model selection criteria chosen for the analysis (the trends 
of differentially expressed genes identified using AIC are summarized in the Table 3.3. 
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Figure 3.3: Percentages of differentially expressed genes that respond in a linear, logarithmic and 
exponential way to fat intake. Histograms are grouped according to response type, while different colors 
are associated to three small intestine sections. Linear response is highly represented in all sections, while the 
relative importance of logarithmic (exponential) response decreases (increases) from the proximal to the 
distal part of small intestine. 
 
 
Figure 3.4: Differentially expressed genes that are up- or down-regulated in response to increasing fat 
intake. Results were obtained using the limma library, modeling gene expression as a function of raw fat 
intake data (i.e., linear model), logarithm-, exponential-, quadratic- or cubic-transformed fat intake values; 
adjusted p-value < 0.1. In each plot, y-axis represents the gene count and x-axis corresponds to response 
types (linear, logarithmic, exponential, quadratic and cubic).  
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3.3.2 Functional annotation 
In the previous section, we classified the genes according to their category of response to 
fat intake (i.e., using linear, logarithmic, exponential, quadratic and cubic response types). 
We found two main classes: (I) genes that preserve linear responses along the whole 
longitudinal axis of small intestine; and (II) genes that alter the shape of their 
Response 
(Gene 
expression 
vs. Fat 
intake) 
Proximal Middle Distal 
Gene 
(count) 
Relative 
% 
GOBP 
(count) 
Gene 
(count) 
Relative 
% 
GOBP 
(count) 
Gene 
(count) 
Relative 
% 
GOBP 
(count) 
Linear 1219 48.18 6 1439 50.03 16 366 50.76 3 
Logarithmic 719 28.42 7 443 15.40 11 45 6.24 - 
Exponential 148 5.85 2 461 16.03 17 121 16.78 6 
Quadratic 212 8.38 - 326 11.34 - 85 11.79 - 
Cubic 232 9.17 1 207 7.20 - 104 14.42 4 
 
Table 3.3 Count of genes that responded in a significant, dose-dependent way to fat intake (model 
selection based on AIC). We identified the significant responses in three sections of small intestine (limma 
library, adjusted p-value < 0.1). Differential gene expression was modelled as either a linear or nonlinear 
(i.e., logarithmic, exponential, quadratic or cubic) function of dietary fat intake. For each section, we reported 
the percentage of genes per response type (%) and the number of significant GO terms (Biological Processes 
- GOBP; hypergeometric test, adjusted p-value < 0. 1). Only GOBP terms with, at least, six differentially 
expressed genes (in the whole small intestine) have been taken into account. Outcomes obtained by using 
AIC for model selection were coherent with the model selection based on the lowest p-value (see Table 3.2). 
In particular, with AIC we found: (I) the prevalence of linear-responding genes in all intestine sections; (II) 
the decreasing relative importance of the logarithmic response when moving from the proximal to the distal 
section (while the opposite pattern holds for the exponential response); (III) the marginal relevance of other 
response types (i.e., quadratic and cubic functions). 
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transcriptomic response, depending on intestinal section. Due to the progressive absorption 
that occurs in the small intestine the amount of fat decreases from the proximal to the distal 
section. This pattern correlates well with the decrease of the relative importance of 
overload/logarithmic response, and with the increase in relative importance of exponential 
response. The broadest objective of our study was to characterize the biological processes 
that are associated with: (I) genes that maintain linear response types (gene-specific 
processes), and (II) genes that change their transcriptomic response as a function of fat 
availability (section-specific processes). To this aim we applied hypergeometric test to 
investigate the presence of GOBP terms that are significantly enriched with fat-responsive 
genes. We analyzed lists of genes associated with different response patterns to fat intake 
(i.e., linear, logarithmic or exponential). First, we considered full lists of genes, including 
both up- and down-regulated ones. Second, we performed gene set enrichment analysis by 
taking into account the direction of change (i.e., using either up- or down-regulated genes 
only). We found terms that are over-represented in more sections and, in some cases, they 
are characterized by changes in the response type along the longitudinal axis of small 
intestine (section-specific processes). This served to understand whether GOBP terms in 
different sections preserve their response type (e.g., APR, acute-phase response exhibited a 
linear response type in all three sections, including both up- and down-regulated genes, and 
can be classified as a gene-specific process: thus, fat intake triggered the same response 
pattern, independently of intestinal sections; Tables 3.4 – 3.6) or showed some changes 
(e.g., cholesterol homeostasis was characterized by linear response in the proximal section 
and changed to logarithmic in the middle; mostly up-regulated genes, Tables 3.4 – 3.6). 
The complete list of genes associated with specific processes (i.e., we do not include 
details on three generic GOBP terms: metabolic process - GO:0008152; oxidation-
reduction process - GO:0055114; transport - GO:0006810) that displayed unique patterns 
along different sections of the small intestine is summarized in Table 3.6 (details on up- 
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and down-regulated genes are available). The Tables 3.7 – 3.10 list GOBP terms and genes 
with characteristic response types along the small intestine; they refer to strictly up- and 
down-regulated processes, respectively. We identified distinctive patterns for 
inflammation-related pathways (i.e., acute-phase response and negative regulation of 
caspase activity) and cholesterol-related processes (i.e., cholesterol transport, cholesterol 
homeostasis and cholesterol efflux).  
(I) Acute-phase response (GO:0006953): genes belonging to this GOBP term showed a 
constantly linear response in all three sections of small intestine, with mixed direction of 
regulation (i.e., both up- and down-regulated genes; see Table 3.6). The only gene 
differentially expressed in all three sections was Serpina1b (up-regulated). 
(II) Negative regulation of caspase activity (GO:0043154): caspase activity plays an 
essential role in apoptosis and inflammation. This is a section-specific process: from 
middle to distal section we observed a change from linear to exponential expression (Table 
3.4). The genes Birc5 (up-regulated) and Igbp1 (down-regulated) were significantly 
responsive in the middle and the distal sections. Prdx3 and Gpx1 were differentially 
expressed and up-regulated in the middle section only. 
 (III) Cholesterol transport (GO:0030301): the response of differentially expressed 
genes related to this GOBP term changed from linear to exponential when passing from the 
proximal to the middle section (Table 3.4). The gene Abca1 was down-regulated in both 
proximal and middle small intestine. Cd36 showed up-regulation proximally, while all 
differentially expressed genes that showed an exponential response in the middle section 
were down-regulated (e.g., Abcg1 and Scarb1). 
(IV) Cholesterol homeostasis (GO:0042632): up-regulated genes involved in this process 
exhibited overload in the middle section only (i.e., they were linearly significant 
proximally and in the distal section, but displayed logarithmic response in the middle; 
Tables 3.7 – 3.8). Most of the genes involved in cholesterol homeostasis were up-regulated 
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(Tables 3.6 – 3.8). For example, the gene Pla2g10 was up-regulated in both proximal and 
middle section, and the same positive regulation was displayed by Apoa4 when moving 
from the middle to the distal part of small intestine (Table 3.8). These findings may 
illustrate how excessive fat intake can have detrimental consequences (i.e., logarithmic 
response with an upper limit to gene expression) in processes involved in the maintenance 
of the cholesterol steady state in cells, especially in the middle section. 
(V) Cholesterol efflux (GO:0033344): this GOBP term shares many genes with 
cholesterol transport and homeostasis, but exhibits a less sharply defined behavior. Up-
regulated genes showed logarithmic and linear response in the middle and distal sections, 
respectively (e.g., Apoa4). Down-regulated genes displayed linear and exponential 
response in proximal and middle parts, respectively (e.g., Abca1). The overload of the 
process that regulates steady state of cholesterol within cells (i.e., cholesterol homeostasis) 
represents a bottleneck, and the negative, exponential response found for cholesterol 
transport should be considered in relation to it (with the sharp down-regulation that is 
triggered by the highest level of fat intake only; i.e., 45E%). It seems that the directed 
movement of cholesterol into or between cells is impaired when cholesterol level reaches 
its carrying capacity. 
In summary, by completing the analysis of transcriptomic response patterns (i.e., linear and 
nonlinear response types) with functional annotation we highlighted three main 
mechanisms of action in the small intestine: (I) acute-phase response (an inflammatory-
related process) is not section-specific and exhibits a linear regulation along the whole 
small intestine; (II) lipid absorption and transportation are particularly active in the middle 
section, but the coupling with other overloaded functions can limit the processing capacity 
(see the logarithmic, up-regulation of cholesterol homeostasis and associated exponential, 
down-regulation of cholesterol transport); (III) in the distal section, an exponential 
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response characterizes the interplay between up- and down-regulated genes involved in the 
negative regulation of caspase activity, likely having a role in apoptosis and inflammation. 
Section 
and 
Responses 
GO ID GOBP 
Proximal Middle Distal 
Set 
Size 
Hi
ts 
Adjusted 
p-value 
Set 
Size 
Hi
ts 
Adjusted 
p-value 
Set 
Size 
Hi
ts 
Adjusted 
p-value 
Prox – Mid 
– Dist 
(all linear) 
GO:00
06953 acute-phase response 22 5 0.09 22 6 0.08 21 3 0.03 
Prox – Mid 
(lm - lm) 
GO:00
06629 
lipid metabolic 
process 184 33 <0.01 183 46 <0.01    
GO:00
06631 
fatty acid metabolic 
process 68 19 <0.01 67 28 <0.01    
GO:00
06635 
fatty acid beta-
oxidation 21 9 <0.01 21 11 <0.01    
GO:00
06637 
acyl-CoA metabolic 
process 19 7 <0.01 19 6 0.04    
GO:00
07040 lysosome organization 18 5 0.03 18 6 0.04    
GO:00
15031 protein transport 386 45 0.01 387 60 <0.01    
GO:00
22900 
electron transport 
chain 69 14 <0.01 69 18 <0.01    
GO:00
55085 
transmembrane 
transport 390 42 0.07 391 57 0.02    
Prox – Mid 
(lm - log) 
GO:00
42632 
cholesterol 
homeostasis 33 11 <0.01 33 4 0.10    
Prox – Mid 
(lm - exp) 
GO:00
30301 cholesterol transport 15 7 <0.01 15 4 0.03    
Mid – Dist 
(lm - lm) 
GO:00
06520 
cellular amino acid 
metabolic process    16 5 0.07 16 2 0.05 
GO:00
16042 lipid catabolic process    69 14 0.05 69 5 0.03 
GO:00
51262 protein tetramerization    17 5 0.09 17 2 0.05 
Mid – Dist 
(lm - exp) 
GO:00
43154 
negative regulation of 
caspase activity    36 10 0.02 36 2 0.06 
Mid – Dist 
(log - lm) 
GO:00
06644 
phospholipid 
metabolic process    17 4 0.01 17 2 0.05 
GO:00
06749 
glutathione metabolic 
process    24 4 0.04 24 2 0.08 
GO:00
45859 
regulation of protein 
kinase activity    16 4 0.01 16 2 0.05 
 
Table 3.4: Over-represented Gene Ontology Biological Process (GOBP) terms that can be found in 
various intestinal sections. We summarize total number of genes corresponding to a given GO term in the 
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microarray gene expression (gene set size, labelled as Set Size), count of genes extracted with our analysis 
(observed hits, labelled as Hits) and adjusted p-values (values have been rounded-up to two decimal points; 
adjusted p-value < 0.1). Intestine sections: Prox = proximal; Mid = middle; Dist = distal. Response types: lm 
= linear; log = logarithm; exp = exponential. GOBP terms showing quadratic and cubic response types have 
been excluded as they can be found in the middle section only (i.e., there are no spatial trends along the small 
intestine axis; see Table 3.2). 
 
Section and 
responses Gene set name Gene set term 
Set 
size 
Observed 
hits 
Adjusted 
p-value 
Proximal 
(Linear) 
GO:0006631 fatty acid metabolic process 68 19 <0.01 
GO:0006629 lipid metabolic process 184 33 <0.01 
GO:0006635 fatty acid beta-oxidation 21 9 <0.01 
GO:0042632 cholesterol homeostasis 33 11 <0.01 
GO:0030301 cholesterol transport 15 7 <0.01 
GO:0033344 cholesterol efflux 17 7 <0.01 
GO:0006695 cholesterol biosynthetic process 18 7 <0.01 
GO:0006637 acyl-CoA metabolic process 19 7 <0.01 
GO:0006694 steroid biosynthetic process 42 11 <0.01 
GO:0016126 sterol biosynthetic process 16 6 <0.01 
GO:0022900 electron transport chain 69 14 <0.01 
GO:0016192 vesicle-mediated transport 134 21 0.01 
GO:0010718 positive regulation of epithelial to mesenchymal transition 15 5 0.01 
GO:0015031 protein transport 386 45 0.01 
GO:0042157 lipoprotein metabolic process 15 5 0.01 
GO:0008203 cholesterol metabolic process 50 10 0.02 
GO:0034968 histone lysine methylation 22 6 0.02 
GO:0071300 cellular response to retinoic acid 17 5 0.02 
GO:0007040 lysosome organization 18 5 0.03 
GO:0055085 transmembrane transport 390 42 0.07 
GO:0006665 sphingolipid metabolic process 15 4 0.08 
GO:0006953 acute-phase response 22 5 0.09 
Proximal 
(Logarithm) GO:0006917 induction of apoptosis 131 16 0.06 
Middle 
(Linear) 
GO:0006631 fatty acid metabolic process 67 28 <0.01 
GO:0006629 lipid metabolic process 183 46 <0.01 
GO:0006635 fatty acid beta-oxidation 21 11 <0.01 
GO:0005975 carbohydrate metabolic process 141 32 <0.01 
GO:0022900 electron transport chain 69 18 <0.01 
GO:0015031 protein transport 387 60 <0.01 
GO:0042542 response to hydrogen peroxide 18 7 0.01 
GO:0009058 biosynthetic process 39 11 0.01 
GO:0043154 negative regulation of caspase activity 36 10 0.02 
GO:0055085 transmembrane transport 391 57 0.02 
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GO:0050796 regulation of insulin secretion 21 7 0.02 
GO:0006006 glucose metabolic process 38 10 0.03 
GO:0007040 lysosome organization 18 6 0.04 
GO:0045471 response to ethanol 29 8 0.04 
GO:0006637 acyl-CoA metabolic process 19 6 0.04 
GO:0045444 fat cell differentiation 24 7 0.04 
GO:0016042 lipid catabolic process 69 14 0.05 
GO:0032091 negative regulation of protein binding 15 5 0.05 
GO:0043161 proteasomal ubiquitin-dependent protein catabolic process 32 8 0.07 
GO:0006520 cellular amino acid metabolic process 16 5 0.07 
GO:0034612 response to tumor necrosis factor 16 5 0.07 
GO:0001890 placenta development 22 6 0.08 
GO:0006953 acute-phase response 22 6 0.08 
GO:0051262 protein tetramerization 17 5 0.09 
Middle 
(Logarithm) 
GO:0071230 cellular response to amino acid stimulus 22 7 <0.01 
GO:0007160 cell-matrix adhesion 40 8 <0.01 
GO:0051259 protein oligomerization 22 6 <0.01 
GO:0007155 cell adhesion 341 25 <0.01 
GO:0006644 phospholipid metabolic process 17 4 0.01 
GO:0018149 peptide cross-linking 17 4 0.01 
GO:0045859 regulation of protein kinase activity 16 4 0.01 
GO:0034446 substrate adhesion-dependent cell spreading 18 4 0.01 
GO:0043065 positive regulation of apoptosis 165 14 0.01 
GO:0007229 integrin-mediated signaling pathway 55 7 0.02 
GO:0006749 glutathione metabolic process 24 4 0.04 
GO:0001937 negative regulation of endothelial cell proliferation 16 3 0.06 
GO:0030574 collagen catabolic process 16 3 0.06 
GO:0009411 response to UV 29 4 0.07 
GO:0043627 response to estrogen stimulus 29 4 0.07 
GO:0045766 positive regulation of angiogenesis 57 6 0.07 
GO:0030334 regulation of cell migration 30 4 0.08 
GO:0030168 platelet activation 19 3 0.09 
GO:0007179 transforming growth factor beta receptor signaling pathway 47 5 0.10 
GO:0042632 cholesterol homeostasis 33 4 0.10 
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation 47 5 0.10 
GO:0051897 positive regulation of protein kinase B signaling cascade 33 4 0.10 
Middle 
(Exponential) 
GO:0007243 intracellular protein kinase cascade 56 8 0.03 
GO:0030301 cholesterol transport 15 4 0.03 
GO:0006468 protein phosphorylation 426 27 0.08 
GO:0007049 cell cycle 411 26 0.08 
GO:0009615 response to virus 59 7 0.08 
GO:0031532 actin cytoskeleton reorganization 22 4 0.08 
GO:0006919 activation of caspase activity 50 6 0.09 
GO:0007067 mitosis 166 13 0.09 
GO:0008630 DNA damage response. signal transduction resulting in induction of apoptosis 15 3 0.09 
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Distal 
(Linear) 
GO:0051260 protein homooligomerization 70 7 <0.01 
GO:0006953 acute-phase response 21 3 0.03 
GO:0016042 lipid catabolic process 69 5 0.03 
GO:0043085 positive regulation of catalytic activity 25 3 0.03 
GO:0006099 tricarboxylic acid cycle 16 2 0.05 
GO:0006520 cellular amino acid metabolic process 16 2 0.05 
GO:0006644 phospholipid metabolic process 17 2 0.05 
GO:0007200 
activation of phospholipase C activity by G-protein coupled 
receptor protein signaling pathway coupled to IP3 second 
messenger 
17 2 0.05 
GO:0008654 phospholipid biosynthetic process 37 3 0.05 
GO:0033344 cholesterol efflux 17 2 0.05 
GO:0042157 lipoprotein metabolic process 16 2 0.05 
GO:0045859 regulation of protein kinase activity 16 2 0.05 
GO:0051262 protein tetramerization 17 2 0.05 
GO:0051402 neuron apoptosis 16 2 0.05 
GO:0060271 cilium morphogenesis 16 2 0.05 
GO:0006869 lipid transport 43 3 0.06 
GO:0006958 complement activation. classical pathway 20 2 0.06 
GO:0008202 steroid metabolic process 41 3 0.06 
GO:0030307 positive regulation of cell growth 44 3 0.06 
GO:0006888 ER to Golgi vesicle-mediated transport 22 2 0.06 
GO:0009725 response to hormone stimulus 22 2 0.06 
GO:0006749 glutathione metabolic process 24 2 0.08 
GO:0016049 cell growth 24 2 0.08 
GO:0007224 smoothened signaling pathway 25 2 0.08 
GO:0008203 cholesterol metabolic process 50 3 0.08 
GO:0045785 positive regulation of cell adhesion 25 2 0.08 
Distal 
(Exponential) 
GO:0000910 cytokinesis 31 4 <0.01 
GO:0001824 blastocyst development 16 2 0.01 
GO:0043967 histone H4 acetylation 15 2 0.01 
GO:0019882 antigen processing and presentation 18 2 0.02 
GO:0030218 erythrocyte differentiation 24 2 0.03 
GO:0032313 regulation of Rab GTPase activity 27 2 0.03 
GO:0032851 positive regulation of Rab GTPase activity 28 2 0.03 
GO:0043154 negative regulation of caspase activity 36 2 0.06 
 
Table 3.5: Over-represented Gene Ontology Biological Process (GOBP) terms associated to 
differentially expressed genes in the three intestinal sections. Genes are classified as linear, logarithmic or 
exponential, according to the best (i.e., with the smallest adjusted p-value) response type describing their 
expression pattern. For each significant GOBP term (described by Gene set name and Gene set term) we 
summarize number of genes corresponding to the process (Set size), number of genes found with our analysis 
(Observed hits) and adjusted p-value. Universe size: proximal = 14,952; middle = 14,933; distal = 14,925.  
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Sections and responses GOBP Proximal significant genes 
Middle significant 
genes Distal significant genes 
Prox – Mid – Dist (all 
linear) 
GO:0006953: acute-
phase response 
UP: Saa3, Serpina1b 
 
DOWN: Reg3b, Reg3g, 
Stat3 
UP: Serpina1b 
 
DOWN: Reg3b, Reg3g,  
Saa2, Stat3, Sigirr 
UP: Serpina1b 
 
DOWN: Saa1, Saa2 
Prox – Mid 
(all linear) 
GO:0006629: lipid 
metabolic process 
UP: Acadl, Acadvl, 
Acads, Apoc2, Cpt2, 
Crat, Ldlr, Acer1, 
Acot2, Acot4, Acaa1b, 
Slc27a2, Acot1, Plcxd1, 
Ech1, Acaa2, Gde1, 
Hacl1, Pnpla8, Abhd5, 
Adipor2, Arv1, Crot, 
Acsl3, Echs1, Hadha 
 
 
 
 
 
DOWN: Plcb3, Daglb, 
Scap, Npc1l1, Apob, 
Asah2, Serinc1 
UP: Tecr, Hdlbp, Acadl, 
Acadvl, Acox1, Cpt1a, 
Cpt2, Crat, Fdxr, Gpx1, 
Hsd17b4, Lipa, Acer1, 
Acot4, Mttp, Pck1, 
Soat2, Acaa1b, Slc27a2, 
Slc27a4, Acot1, 
Hsd17b6, Acsl5, Ech1, 
Echdc2, Acaa2, Gde1, 
Hacl1, Lpin2, Lpin3, 
Pnpla8, Adipor2, 
Acot12, Gpcpd1, Acsl3, 
Acox2, Echs1, Hadha 
 
DOWN: Pafah1b2, 
Ppard, Daglb, Gdpd5, 
Napepld, Asah2, Plb1, 
Plce1 
 
GO:0006631: fatty acid 
metabolic process 
UP: Acadl, Acadvl, 
Acads, Apoa2, Cd36, 
Cpt2, Crat, Prkar2b, 
Acaa1b, Slc27a2, Ech1, 
Acaa2, Pnpla8, Abhd5, 
Adipor2, Crot, Acsl3, 
Echs1, Hadha 
 
UP: Acadl, Acadvl, 
Acox1, Cd36, Cpt1a, 
Cpt2, Crat, Faah, 
Fabp2, Hsd17b4, Lipa, 
Acaa1b, Slc27a2, 
Slc27a4, Mecr, Acsl5, 
Ech1, Echdc2, Acaa2, 
Lpin2, Lpin3, Pnpla8, 
Adipor2, Acot12, Acsl3, 
Acox2, Echs1, Hadha 
 
GO:0006635: fatty acid 
beta-oxidation 
UP: Acadvl, Eci1, 
Slc25a17, Eci2, Acaa2, 
Decr1, Bdh2, Echs1, 
Hadha 
 
UP: Acadvl, Acox1, 
Hsd17b4, Pex5, 
Slc25a17, Eci2, Acaa2, 
Bdh2, Acox2, Echs1, 
Hadha 
 
GO:0006637: acyl-CoA 
metabolic process 
UP: Hmgcl, Acot8, 
Acot2, Acot4, Acot1, 
Oxsm 
 
DOWN: Ces1d 
UP: Hmgcl, Acot8, 
Acot4, Acot1, Oxsm, 
Acot12 
 
DOWN:  
 
GO:0007040: lysosome 
organization 
UP: Cln8 
 
DOWN: Abca1, Tpp1, 
Hexa, Cln6 
UP: Acp2, Fam160a2 
 
DOWN: Tpp1, Hexa, 
Hexb, Ppt1 
 
GO:0015031: protein 
transport 
UP: Kdelr3, Bet1, 
Nacad, Rab1, Rab6, 
Mcfd2, Sec22b, Sec23a, 
Timm17b, Vps45, 
Atg4d, Rabep1, Rab9, 
Vps29, Apba3, Cope, 
Xpo7, Sar1b, Gpr89, 
Yif1a, Golt1a, Snx4, 
Pex13, Senp2, Snx7 
 
 
 
 
 
 
 
DOWN: Sft2d2, Gdi1, 
Cog1, Myo1c, Rab12, 
Vps33b, Rab8b, 
Scamp2, Gga3, Agap1, 
Copg2, Nup210, 
Sec61a2, Rab37, Rab32, 
Kdelr1, Ap2b1, Gga2, 
Chmp4b, Rrbp1 
UP: Chmp7, Kdelr3, 
Sec13, Vps4a, Ap1m1, 
Arf4, Bet1, Pex5, 
Sec22b, Sec23a, Stam, 
Arcn1, Timm17a, 
Timm17b, Cox18, 
Bcap31, Eif5a, Serp1, 
Timm13, Ipo8, Uevld, 
Copg, Pex14, Copz1, 
Gosr2, Apba3, Rab2a, 
Cope, Tomm6, Sar1b, 
Kdelr2, Derl1, Yif1a, 
Golt1a, Sec62, Dopey2, 
Tmem48, Fam160a2, 
Senp2, Sil1 
 
DOWN: Arrb1, Ap3d1, 
Gdi1, Mtm1, Ppt1, 
Rab17, Rab19, Rab33b, 
Rab3ip, Rufy1, Vps33b, 
Rab8b, Sec61a2, Rab37, 
Tomm40l, Duoxa2, 
Rab32, Rab27b, Rrbp1, 
Cog8 
 
GO:0022900: electron 
transport chain 
UP: Ndufb11, Etfb, Etfa, 
Ndufa4, Ndufs8, Ndufs6, 
Cyb561d2, Ndufa7, 
Cyb5b, Uqcrfs1, Etfdh 
UP: Etfb, Etfa, Fdxr, 
Ndufs8, Ndufs2, Ndufb6, 
Ndufs6, Cyb561d2, 
Ndufs5, Ndufa9, Cyb5b, 
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DOWN: Cmah, Cyb561, 
Cyba 
Uqcrfs1, Etfdh, Ndufa5 
 
DOWN: Cyb561, Frrs1, 
Enox2, Cyb561d1 
GO:0055085: 
transmembrane 
transport 
UP: Slc30a9, Aqp7, 
Aqp8, Cacna1d, Slc6a3, 
Sfxn1, Slc22a1, 
Slc23a1, Slc25a17, 
Slc6a2, Mfsd6l, 
Timm17b, Slc6a20b, 
Slc4a11, Gpr172b, 
Xpo7, Slc16a13, Abcb6, 
Senp2, Mfsd2a 
 
 
 
 
 
 
DOWN: Abca1, Atp8a1, 
Slc7a1, Itpr3, Myo1c, 
Slc12a7, Slc19a1, 
Slc2a2, Mfsd4, Slc36a1, 
Slc7a9, Atp2a3, Slc4a4, 
Nup210, Abcb10, 
Sec61a2, Cacna1h, 
Slc30a7, Slc39a8, 
Slc29a3, Hvcn1, Rrbp1 
UP: Slc25a45, Slc30a9, 
Slc35b1, Sec13, Aqp3, 
Aqp7, Abcc2, Slc6a3, 
Slc26a3, Sfxn1, Slc1a3, 
Slc22a1, Slc23a1, 
Slc25a17, Slc7a7, 
Mfsd7c, Timm17a, 
Timm17b, Catsper1, 
Slc6a20b, Slc16a12, 
Mfsd7a, Eif5a, Serp1, 
Timm13, Gpr172b, 
Pex14, Slc47a1, Sec62, 
Slc16a13, Slc39a11, 
Slc39a5, Tmem48, 
Abcb6, Abcb8, Senp2, 
Sil1 
DOWN: Slc26a2, 
Kcnu1, Slc24a6, Slc1a1, 
Slc2a2, Slc5a1, Spns2, 
Trpm6, Slc5a9, Slc17a5, 
Slc7a9, Atp9b, Sec61a2, 
Tomm40l, Hiatl1, 
Mfsd1, Spns1, Hvcn1, 
Rrbp1, Slc4a10 
 
Prox – Mid  
(linear - logarithmic) 
GO:0042632: 
cholesterol homeostasis 
UP: Apoa2, Ldlr, 
Nr1h3, Pla2g10, Npc2 
 
DOWN: Abca1, Npc1, 
Npc1l1, Apob, Abcg5, 
Abcg8 
UP: Apoa4, Cav1, 
Pla2g10 
 
 
DOWN: Cyp7a1 
 
Prox – Mid 
(linear - exponential) 
GO:0030301: 
cholesterol transport 
UP: Apoa2, Cd36, Ldlr, 
Npc2 
 
DOWN: Abca1, Npc1l1, 
Apob 
UP:  
 
 
DOWN: Abca1, Abcg1, 
Scarb1, Stard3 
 
Mid – Dist  
(all linear) 
GO:0006520: cellular 
amino acid metabolic 
process 
 
UP: Cth, Acy1, Ddc, 
Got1 
 
DOWN: Ccbl2 
UP: Cth 
 
DOWN: Tat 
GO:0016042: lipid 
catabolic process  
UP: Lipa, Pla2g2c, 
Nceh1, Pnpla8, Ddhd2 
 
DOWN: Ddhd1, 
Pafah1b2, Pla2g2a, 
Pld2, Ppt1, Daglb, 
Plb1, Plbd1, Plce1 
UP: Apoc2 
 
 
DOWN: Pla2g2a, 
Daglb, Pla2g2f, Plce1 
GO:0051262: protein 
tetramerization  
UP: Me1, Pex5, Txnrd1 
 
DOWN: Igf1r, Sbf2 
UP: Me1 
 
DOWN: Sbf2 
Mid – Dist 
(linear - exponential) 
GO:0043154: negative 
regulation of caspase 
activity 
 
UP: Prdx3, Birc5, Gpx1, 
Igf1, Por 
 
DOWN: Arrb1, Bcl2l1, 
Naip1, Igbp1, Usp47 
UP: Birc5 
 
 
DOWN: Igbp1 
Mid – Dist 
(logarithmic - linear) 
GO:0006644: 
phospholipid metabolic 
process 
 UP: Pla2g2d, Pla2g10, Pla2g12a, Ppap2b 
DOWN: Pla2g2a, 
Pla2g2f 
GO:0006749: 
glutathione metabolic 
process 
 
UP: Gpx3, Gstm1, 
Gstm3, Gstk1 
 
DOWN:  
UP: Cth, Hagh 
 
 
DOWN:  
GO:0045859: regulation 
of protein kinase 
activity 
 
UP: Prkar2b, Mtor 
 
DOWN: Tsc1, Akap13 
UP: Ect2 
 
DOWN: Plce1 
 
Table 3.6: Over-represented Gene Ontology Biological Process (GOBP) terms that can be found in 
various intestinal sections. For each GOBP term we specify up- and down-regulated genes (adjusted p-
value < 0.1; most of the results of gene set enrichment analysis fall well below this threshold - see Table 3.5).
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Section and 
responses GO ID GOBP 
Proximal Middle Distal 
Set 
size 
Hi
ts 
Adjusted 
p-value 
Set 
size 
Hi
ts 
Adjusted 
p-value 
Set 
size 
Hi
ts 
Adjusted 
p-value 
Prox – Mid – 
Dist 
(all linear) 
 
GO:00
06749 
glutathione metabolic 
process 24 5 0.01 24 6 0.01 24 2 0.04 
GO:00
06888 
ER to Golgi vesicle-
mediated transport 22 4 0.05 22 5 0.02 22 2 0.03 
Prox – Mid – 
Dist 
(lm – log -
lm) 
 
GO:00
06749 
glutathione metabolic 
process 24 5 0.01 24 4 <0.01 24 2 0.04 
GO:00
42632 
cholesterol 
homeostasis 33 5 0.06 33 3 0.04 33 2 0.08 
Prox – Mid 
(lm - lm) 
 
GO:00
06629 lipid metabolic process 184 26 <0.01 183 38 <0.01 
 
GO:00
06631 
fatty acid metabolic 
process 68 19 <0.01 67 28 <0.01 
GO:00
06635 
fatty acid beta-
oxidation 21 9 <0.01 21 11 <0.01 
GO:00
06637 
acyl-CoA metabolic 
process 19 6 <0.01 19 6 <0.01 
GO:00
06695 
cholesterol 
biosynthetic process 18 5 <0.01 18 4 0.04 
GO:00
08610 
lipid biosynthetic 
process 81 10 0.01 81 11 0.02 
GO:00
16192 
vesicle-mediated 
transport 134 13 0.03 134 19 <0.01 
GO:00
22900 
electron transport 
chain 69 11 <0.01 69 14 <0.01 
GO:00
45454 cell redox homeostasis 47 6 0.07 47 9 <0.01 
GO:00
51289 
protein 
homotetramerization 38 7 <0.01 38 6 0.07 
Prox – Mid 
(lm - log) 
 
GO:00
22900 
electron transport 
chain 69 11 <0.01 69 5 0.03 
Prox – Mid 
(log - lm) 
 
GO:00
06631 
fatty acid metabolic 
process 68 6 0.07 67 28 <0.01 
Mid – Dist 
(log - lm) 
 
GO:00
33344 cholesterol efflux 
 
17 2 0.04 17 2 0.02 
GO:00
42325 
regulation of 
phosphorylation 34 3 0.04 34 2 0.08 
 
Table 3.7: Over-represented Gene Ontology Biological Process (GOBP) terms completely up-regulated 
and found in various intestinal sections. For each GOBP term we summarize: the total number of genes in 
the microarray (gene set size, labelled as Set size), the count of genes extracted with our analysis (observed 
hits, labelled as Hits), and the adjusted p-values. Intestine sections: Prox = proximal; Mid = middle; Dist = 
distal. Response types: lm = linear; log = logarithm; exp = exponential. 
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Section and responses GOBP Proximal significant genes 
Middle significant 
genes Distal significant genes 
Prox – Mid – Dist 
(all linear) 
GO:0006749: 
glutathione metabolic 
process 
Cth, Glo1, Hagh, Gstz1, 
Idh1 
Cth, G6pdx, Ggt1, 
Hagh, Gpx1, Gstz1 Cth, Hagh 
GO:0006888: ER to 
Golgi vesicle-mediated 
transport 
Bet1, Rab1, Sec22b, 
Sec23a 
Sec13, Bet1, Sec22b, 
Sec23a, Lmf1 Sec22b, Lman1 
Prox – Mid – Dist 
(linear – logarithmic - 
linear) 
GO:0006749: 
glutathione metabolic 
process 
Cth, Glo1, Hagh, Gstz1, 
Idh1 
Gpx3, Gstm1, Gstm3, 
Gstk1 Cth, Hagh 
GO:0042632: 
cholesterol homeostasis 
Apoa2, Ldlr, Nr1h3, 
Pla2g10, Npc2 Apoa4, Cav1, Pla2g10 Apoa4, Mttp 
Prox – Mid 
(all linear) 
GO:0006629: lipid 
metabolic process 
Acadl, Acadvl, Acads, 
Apoc2, Cpt2, Crat, Ldlr, 
Acer1, Acot2, Acot4, 
Acaa1b, Slc27a2, Acot1, 
Plcxd1, Ech1, Acaa2, 
Gde1, Hacl1, Pnpla8, 
Abhd5, Adipor2, Arv1, 
Crot, Acsl3, Echs1, 
Hadha 
Tecr, Hdlbp, Acadl, 
Acadvl, Acox1, Cpt1a, 
Cpt2, Crat, Fdxr, Gpx1, 
Hsd17b4, Lipa, Acer1, 
Acot4, Mttp, Pck1, 
Soat2, Acaa1b, Slc27a2, 
Slc27a4, Acot1, 
Hsd17b6, Acsl5, Ech1, 
Echdc2, Acaa2, Gde1, 
Hacl1, Lpin2, Lpin3, 
Pnpla8, Adipor2, 
Acot12, Gpcpd1, Acsl3, 
Acox2, Echs1, Hadha 
 
GO:0006631: fatty acid 
metabolic process 
Acadl, Acadvl, Acads, 
Apoa2, Cd36, Cpt2, 
Crat, Prkar2b, Acaa1b, 
Slc27a2, Ech1, Acaa2, 
Pnpla8, Abhd5, 
Adipor2, Crot, Acsl3, 
Echs1, Hadha 
Acadl, Acadvl, Acox1, 
Cd36, Cpt1a, Cpt2, 
Crat, Faah, Fabp2, 
Hsd17b4, Lipa, Acaa1b, 
Slc27a2, Slc27a4, Mecr, 
Acsl5, Ech1, Echdc2, 
Acaa2, Lpin2, Lpin3, 
Pnpla8, Adipor2, 
Acot12, Acsl3, Acox2, 
Echs1, Hadha 
 
GO:0006635: fatty acid 
beta-oxidation 
Acadvl, Eci1, Slc25a17, 
Eci2, Acaa2, Decr1, 
Bdh2, Echs1, Hadha 
Acadvl, Acox1, 
Hsd17b4, Pex5, 
Slc25a17, Eci2, Acaa2, 
Bdh2, Acox2, Echs1, 
Hadha 
 
GO:0006637: acyl-CoA 
metabolic process 
Hmgcl, Acot8, Acot2, 
Acot4, Acot1, Oxsm 
Hmgcl, Acot8, Acot4, 
Acot1, Oxsm, Acot12  
GO:0006695: 
cholesterol biosynthetic 
process 
Ebp, Hmgcs2, Nsdhl, 
Pmvk, Tm7sf2 
Ebp, G6pdx, Hmgcs2, 
Tm7sf2  
GO:0008610: lipid 
biosynthetic process 
Hsd17b11, Ebp, H2-
Ke6, Hmgcs2, Hsd17b2, 
Nsdhl, Acss2, Pmvk, 
Oxsm, Tm7sf2 
Tecr, Hsd17b11, Ebp, 
Hmgcs2, Mecr, 
Hsd17b12, Acss2, 
Ptplad2, Oxsm, Tm7sf2, 
Lass2 
 
GO:0016192: vesicle-
mediated transport 
Kdelr3, Bet1, Rab1, 
Rab6, Mcfd2, Sec22b, 
Sec23a, Vps45, Cope, 
Sar1b, Ap4b1, Yif1a, 
Golt1a 
Kdelr3, Sec13, Vps4a, 
Ap1m1, Arf4, Bet1, 
Sec22b, Sec23a, Arcn1, 
Bcap31, Copg, Copz1, 
Gosr2, Rab2a, Cope, 
Sar1b, Kdelr2, Yif1a, 
Golt1a 
 
GO:0022900: electron 
transport chain 
Ndufb11, Etfb, Etfa, 
Ndufa4, Ndufs8, Ndufs6, 
Cyb561d2, Ndufa7, 
Cyb5b, Uqcrfs1, Etfdh 
Etfb, Etfa, Fdxr, Ndufs8, 
Ndufs2, Ndufb6, Ndufs6, 
Cyb561d2, Ndufs5, 
Ndufa9, Cyb5b, 
Uqcrfs1, Etfdh, Ndufa5 
 
GO:0045454: cell redox 
homeostasis 
1810046J19Rik, Ddit3, 
Txnrd2, 
2810407C02Rik, 
Txndc15, Glrx5 
1810046J19Rik, Gpx1, 
Txnrd1, 
2810407C02Rik, 
Txndc15, Pdia6, Pdia5, 
Glrx5, Erp44 
 
GO:0051289: protein 
homotetramerization 
Acacb, Cth, Acadl, 
Acads, Aldoc, Dhps, 
Decr1 
Cth, Acadl, Aldh1a1, 
Aldoc, Ide, Cda  
Prox – Mid 
(linear - logarithmic) 
GO:0022900: electron 
transport chain 
Ndufb11, Etfb, Etfa, 
Ndufa4, Ndufs8, Ndufs6, 
Cyb561d2, Ndufa7, 
Cyb5b, Uqcrfs1, Etfdh 
Txn2, Ndufb9, Ndufc1, 
Ndufa7, Steap2  
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Prox- Mid 
(logarithmic - linear) 
GO:0006631: fatty acid 
metabolic process 
Fabp2, Hsd17b4, 
Slc27a4, Acsl5, Acot12, 
Acox2 
Acadl, Acadvl, Acox1, 
Cd36, Cpt1a, Cpt2, 
Crat, Faah, Fabp2, 
Hsd17b4, Lipa, Acaa1b, 
Slc27a2, Slc27a4, Mecr, 
Acsl5, Ech1, Echdc2, 
Acaa2, Lpin2, Lpin3, 
Pnpla8, Adipor2, 
Acot12, Acsl3, Acox2, 
Echs1, Hadha 
 
Mid – Dist 
(logarithmic - linear) 
GO:0033344: 
cholesterol efflux  Apoa4, Cav1 Apoa4, Apoc2 
GO:0042325: regulation 
of phosphorylation  Pik3r3, Srpx2, Rptor Pik3r3, Rptor 
 
Table 3.8: Over-represented Gene Ontology Biological Process (GOBP) terms that include up-
regulated genes only. Such GOBP terms can be found in various intestinal sections; lists of (up-regulated) 
differentially expressed genes associated to each GOBP term are summarized (adjusted p-value < 0.1). 
 
Section and 
responses GO ID GOBP 
Proximal Middle Distal 
Set 
size 
Hi
ts 
Adjusted 
p-value 
Set 
size 
Hi
ts 
Adjusted 
p-value 
Set 
size 
Hi
ts 
Adjusted 
p-value 
Prox – Mid – 
Dist 
(all linear) 
GO:00
45785 
positive regulation of 
cell adhesion 26 4 0.05 26 5 0.08 25 2 0.03 
Prox – Mid – 
Dist 
(lm – exp - 
lm) 
GO:00
03333 
amino acid 
transmembrane 
transport 
39 5 0.05 39 3 0.09 39 2 0.07 
Prox – Mid 
(lm - lm) 
GO:00
07040 
lysosome 
organization 18 4 0.02 18 4 0.08 
 
GO:00
09615 response to virus 59 7 0.03 59 9 0.07 
GO:00
30335 
positive regulation of 
cell migration 83 10 0.01 83 10 0.08 
Prox – Mid 
(lm - exp) 
GO:00
07243 
intracellular protein 
kinase cascade 56 7 0.03 56 6 0.01 
GO:00
09615 response to virus 59 7 0.03 59 5 0.04 
GO:00
30301 cholesterol transport 15 3 0.05 15 4 <0.01 
GO:00
33344 cholesterol efflux 17 4 0.01 17 3 0.03 
GO:00
42632 
cholesterol 
homeostasis 33 6 0.01 33 3 0.07 
GO:00
46777 
protein 
autophosphorylation 91 9 0.04 90 5 0.09 
GO:00
71300 
cellular response to 
retinoic acid 17 5 <0.01 17 3 0.03 
Prox – Mid 
(log - lm) 
GO:00
09615 response to virus 59 6 0.04 59 9 0.07 
Prox – Mid 
(log - log) 
GO:00
43029 T cell homeostasis 15 3 0.03 15 2 0.08 
Prox – Mid 
(log - exp) 
GO:00
09615 response to virus 59 6 0.04 59 5 0.04 
GO:00
16358 dendrite development 18 4 0.01 20 2 0.09 
Mid - Dist 
(lm - lm) 
GO:00
06953 acute-phase response 
 
22 5 0.07 21 2 0.02 
GO:00
16042 
lipid catabolic 
process 69 9 0.08 69 4 0.02 
 
Table 3.9: Over-represented Gene Ontology Biological Process (GOBP) terms with down-regulated 
genes only. Data refer to GOBP terms that can be found in various intestinal sections. For each GOBP term 
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we indicate: total number of genes in the microarray (gene set size, labelled as Set size), count of genes 
extracted with our analysis (observed hits, labelled as Hits), and adjusted p-values. Intestine sections: Prox = 
proximal; Mid = middle; Dist = distal. Response types: lm = linear; log = logarithm; exp = exponential. 
 
Section and responses GOBP Proximal significant genes 
Middle significant 
genes Distal significant genes 
Prox – Mid – Dist 
(all linear) 
GO:0045785: positive 
regulation of cell 
adhesion 
Fgf1, Cx3cl1, Tgm2, 
Vegfa 
Fgf1, Itgav, Pld2, 
Cx3cl1, Tgm2 Saa1, Tgm2 
Prox – Mid – Dist 
(linear – exponential - 
linear) 
GO:0003333: amino 
acid transmembrane 
transport 
Slc7a1, Slc1a5, 
Slc36a1, Slc7a9, 
Serinc1 
Slco4a1, Slc3a2, 
Slc36a1 Slc1a1, Slc7a9 
Prox – Mid 
(all linear) 
GO:0007040: lysosome 
organization 
Abca1, Tpp1, Hexa, 
Cln6 Tpp1, Hexa, Hexb, Ppt1  
GO:0009615: response 
to virus 
Pml, Mst1r, Mavs, 
Ddx58, Oas1b, 
Unc93b1, Ifih1 
Bcl2l1, Ifit1, Ddx58, 
Rnasel, Trim56, Irf7, 
Zbp1, Ifih1, Zc3hav1 
 
GO:0030335: positive 
regulation of cell 
migration 
Acp5, Adam10, 
Adam17, Bmp2, Fgf1, 
Igf1r, Ptk2b, Cx3cl1, 
Vegfa, Zfp703 
Adam10, Bmp2, Fgf1, 
Igf1r, Itgav, Pik3r1, 
Pld2, Ptk2b, Cx3cl1, 
Zfp703 
 
Prox – Mid 
(linear - exponential) 
GO:0007243: 
intracellular protein 
kinase cascade 
Socs3, Fgf1, Smpd2, 
Wnk1, Rps6ka4, Tnik, 
Dapk1 
Socs3, Jak2, Mknk1, 
Slc9a1, Ick, Tnik  
GO:0009615: response 
to virus 
Pml, Mst1r, Mavs, 
Ddx58, Oas1b, 
Unc93b1, Ifih1 
Mx1, Mx2, Pml, Mst1r, 
Mavs  
GO:0030301: 
cholesterol transport Abca1, Npc1l1, Apob 
Abca1, Abcg1, Scarb1, 
Stard3  
GO:0033344: 
cholesterol efflux 
Abca1, Npc1, Abcg5, 
Abcg8 Abca1, Abcg1, Scarb1  
GO:0042632: 
cholesterol homeostasis 
Abca1, Npc1, Npc1l1, 
Apob, Abcg5, Abcg8 Abca1, Abcg1, Scarb1  
GO:0046777: protein 
autophosphorylation 
Clk2, Igf1r, Uhmk1, 
Lyn, Pak2, Wnk1, 
Map3k1, Taok3, Tnik 
Jak2, Lyn, Pak1, Pim3, 
Tnik  
GO:0071300: cellular 
response to retinoic acid 
Abca1, Lyn, Ptk2b, 
Ptk6, Mll5 Abca1, Lyn, Rxrb  
Prox –Mid 
(logarithmic - linear) 
GO:0009615: response 
to virus 
Ifit1, Rnasel, Trim56, 
Irf7, Zbp1, Polr3f 
Bcl2l1, Ifit1, Ddx58, 
Rnasel, Trim56, Irf7, 
Zbp1, Ifih1, Zc3hav1 
 
Prox – Mid 
(all logarithmic) 
GO:0043029: T cell 
homeostasis Bcl2l11, Fas, Stat5b Bcl2l11, Gimap5  
Prox – Mid 
(logarithmic - 
exponential) 
GO:0009615: response 
to virus 
Ifit1, Rnasel, Trim56, 
Irf7, Zbp1, Polr3f 
Mx1, Mx2, Pml, Mst1r, 
Mavs  
GO:0016358: dendrite 
development 
Mecp2, Pak1, Reln, 
Abi2 Pak1, Ss18l1  
Mid – Dist 
(all linear) 
 
GO:0006953: acute-
phase response 
 
Reg3b, Reg3g, Saa2, 
Stat3, Sigirr Saa1, Saa2 
GO:0016042: lipid 
catabolic process 
Ddhd1, Pafah1b2, 
Pla2g2a, Pld2, Ppt1, 
Daglb, Plb1, Plbd1, 
Plce1 
Pla2g2a, Daglb, 
Pla2g2f, Plce1 
 
Table 3.10: Over-represented down-regulated Gene Ontology Biological Process (GOBP) terms that 
can be found in various intestinal sections. For each term we specify the associated differentially expressed 
genes (adjusted p-value < 0.1). 
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3.4 Discussion 
Excessive saturated fat intake leads to metabolic disorders (Balwierz et al. 2009; Cheung & 
Mao 2012; Desmarchelier et al. 2012; Walley et al. 2006; Zhang et al. 2009). Especially in 
the small intestine, studies have shown connections to altered lipid metabolic functions or 
illustrated its role in the development of obesity and diabetes (Kondo et al. 2006; de Wit et 
al. 2008). However, it is quite rare to find analyses on intestinal section-specific response 
to dietary fat. Differences in the absorption capabilities of intestine sections are caused by 
changes in gene expression (Chen et al. 2001; Simon et al. 2011). de Wit and colleagues 
analyzed the transcriptomic variation between dietary groups (e.g., 20% vs. 10%, 45% vs. 
10% calories from fat), specific to three sections of small intestine of mice (de Wit et al. 
2011). In their experiment, mice were fed diets that differed in dietary fat and carbohydrate 
content; the respective diets contained 10%, 20%, 30% or 45% kcal fat, which was termed 
as fat intake (within the field of nutrition it is generally accepted to refer to macronutrient 
content of the diets as percentage of calories derived from fat). Our goal was to re-analyze 
their data to assess linear and nonlinear transcriptomic response to fat intake by modeling 
gene expression as a function of fat intake %. The percentage of calories derived from fat 
intake represented the independent variable, even though such percentage might have been 
different from the relative amount of calories from fat that was effectively sensed by 
enterocytes. Moreover, the absorption capacity of enterocytes could be modulated by 
dietary fat (but in our study the type of fat that varied was always palm oil; i.e., C16:0).  
3.4.1 Gene- and section-specific transcriptomic response to dietary fat intake 
We investigated whether the transcriptomic response type was related to specific intestine 
sections (thus being potentially triggered by fat availability along the longitudinal axis), or 
uniquely associated to specific genes and biological processes (and preserved in all 
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intestine sections, without any change along the longitudinal axis). Due to progressive 
absorption along the intestine, we expected higher amount of fat to be available in the 
proximal section and a progressive decrease towards the distal section. Furthermore, it can 
be the case that the quantity of dietary fat exceeds the absorption capacity of the proximal 
section, and thus “overflows” to the middle and distal sections. Moreover, the middle 
section has greater absorptive area than proximal and distal sections, and is known to be 
highly affected by the dietary fat (de Wit et al. 2008). Our results corroborate previous 
findings, confirming that the highest number of differentially expressed genes is in the 
middle section of small intestine (the proximal part has a relevant metabolic role, while the 
middle and distal sections are mainly dedicated to fat absorption and transportation 
processes). However, two new and clear patterns emerged from our analysis: (I) most of 
the genes characterized by a significant relationship between expression levels and dietary 
fat intake exhibited linear responses (i.e., their activity was not overloaded, even at high fat 
concentration), and the prevalence of linear relationships was persistent along the whole 
small intestine; (II) the relevance of nonlinear relationships linking fat intake to gene 
expression levels was section-specific and reflected the progressive reduction of fat 
availability (due to intestinal absorption) along the longitudinal axis of the small intestine 
(i.e., the relative importance of logarithmic responses, which can be associated with 
overload mechanisms, decreased from proximal to distal section, while the relative 
importance of exponential responses increased when moving towards the distal part). The 
relevance of quadratic and cubic response types was marginal both in absolute and relative 
terms, in all sections. Throughout the small-intestine, we observed biological processes 
that responded to fat intake in a single section, and other processes with either unaltered 
(e.g., acute-phase response is linear in all three sections; Table 3.4) or varying responses 
across the sections (e.g., cholesterol transport changes from linear response in the proximal 
   
 Discussion 
 
79 
 
section, with both up- and down-regulated genes, to exponential response in the middle 
section, with down-regulated genes only; Table 3.6).  
(1) Gene-specific acute-phase response to fat. When analyzing differentially expressed 
genes, we observed that over-representation of APR was linked to fat intake through a 
linear relationship in all three intestinal sections (Table 3.4). Increasing dietary fat intake 
caused intestinal inflammatory transcriptomic response and led to linear increase in APR. 
This response does not show a univocal pattern and is associated to both up- and down-
regulated genes (e.g., Serpina1b is up-regulated; Reg3b and Reg3g are down-regulated). 
Serine protease inhibitor (Serpina1b) was found to be differentially expressed and up-
regulated in all three sections. Some studies have shown that the presence of 
lipopolysaccharide (LPS) in the small intestine stimulates pro-inflammatory mediators that 
are activators of insulin resistance (Cani et al. 2007; Ding et al. 2010) (Cani et al. 2007; 
Ding et al. 2010). The resultant inflammatory reaction causes APR and its prolonged 
activation is seen with increased plasma levels of small, low-density lipoproteins (LDLs; 
Khovidhunkit et al. 2000, 2003). Moreover, during inflammation plasma triglyceride and 
very low-density lipoprotein (VLDL) levels rise, while high-density lipoprotein (HDL) 
level declines (Khovidhunkit et al. 2000). In the present study, Reg3g and Reg3b are down-
regulated both in proximal and middle small intestine. The protein encoded by these genes 
(REG3G and REG3B) belong to the family of C-type lectins and are secreted by epithelial 
cells and Paneth cells. Their expression is reduced in the small intestine of mice fed 
alcohol compared with control mice, and the effect is more pronounced in the proximal 
part (Hartmann et al. 2013). REG3G and REG3B play a protective role against gram-
positive and gram-negative bacteria, respectively (Abreu 2010; van Ampting et al. 2012). 
REG3G is essential for maintaining a zone that physically separates the luminal bacteria 
from the small intestinal epithelial surface (Schnabl 2013). Dysregulation of a 
microorganism-induced program of epithelial cell homeostasis and repair can result in 
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chronic inflammatory responses, and is associated with the development of colon cancer 
(Abreu 2010; Khovidhunkit et al. 2000). Down-regulation of Reg3g and Reg3b is likely to 
result in increased bacterial colonization of the intestinal epithelial surface, with 
consequent induction of inflammation. The oncogenic transcription factor Stat3 is down-
regulated in both the proximal and the middle section, and the same pattern holds in middle 
and distal sections for Saa2, a member of the family of APR proteins that is usually up-
regulated during infection, tissue damage or inflammation disease (Ivanov et al. 2009).  
(2) Section-specific cholesterol processing through the intestinal length. A complex 
scenario characterizes cholesterol, with a prevalence of up- and down-regulation for what 
concerns cholesterol homeostasis and transport, respectively (Tables 3.5 – 3.10). In the 
middle section, cholesterol homeostasis was overloaded (i.e., logarithmic response), while 
cholesterol transport was particularly impaired in presence of highest levels of fat intake 
(i.e., exponential response). In the middle section, we observed the up-regulated, 
logarithmic response in the expression of cholesterol homeostasis genes (i.e., Apoa4, Cav1 
and Pla2g10), except for what concerns Cyp7a1 (down-regulated, logarithmic). In 
different parts of the small intestine, we found down-regulation of ABC transporters: 
Abca1 in proximal as well as in the middle section, Abcg1 in middle section, and Abcg5 
and Abcg8 in the proximal section (Table 3.6).These genes displayed fat-responsive 
expression pattern and are involved in cholesterol transport and cholesterol efflux. They 
are characterized by a change in the response pattern from proximal (linear response) to 
middle (exponential response) section. These data suggest that high fat concentrations 
available in the proximal small intestine down-regulate ABC transporters involved in 
cholesterol efflux (Abca1, Abcg5 and Abcg8; Tables 3.6, 3.8 and 3.10). The linear response 
of these down-regulated genes stands for relevant effects also in presence of low fat 
intakes. The negative exponential response observed in the middle section for Abca1 and 
Abcg1 illustrates how only the highest level of fat intake results in the sharp impairment of 
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cholesterol absorption. This is in line with the fact that the middle section is characterized 
by a higher uptake capacity than the proximal section. Sections that are downstream the 
proximal small intestine (which consists of the duodenum plus the proximal jejunum) are 
exposed to smaller amounts of fat and less pronounced effects (except for the case of 
highest fat content in the diet; i.e., 45 E%). The highest fat concentration is the only one 
that triggered a strong change, leading to the down-regulation of two ABC transporters in 
the middle section.  
(3) Section-specific negative regulation of caspase activity. The negative regulation of 
caspase activity shows a transition from linear response in the middle section to 
exponential response in the distal part. This process does not present a univocal response 
pattern and includes both up- and down-regulated genes. In the middle and distal sections, 
there was up-regulation of the gene Birc5 (baculoviral IAP repeat-containing 5, also 
known as survivin). Birc5 is bifunctional, plays a key role in inhibition of apoptosis and 
regulation of mitosis, and is essential for cell division (Blanc-Brude et al. 2007; Chiou et 
al. 2003; Fukuda & Pelus 2006). Birc5 is mostly linked with carcinogenesis; during early 
atherogenesis, it shows elevated expression in inflamed macrophage-rich areas (Blanc-
Brude et al. 2007). Linear and positive transcriptomic response of genes Prdx3 (that 
encodes the protein thioredoxin-dependent peroxide reductase, mitochondrial) and Gpx1 
(that encodes the enzyme glutathione peroxidase 1) was confined to the middle, small 
intestine. Bellafante et al. (2014) have shown that PGC-1E overexpression in enterocytes 
enhances antioxidant enzymes such as Sod2, Gpx4, Prdx3, Prdx5, Txn2 and Sirt3. Up-
regulation of these enzymes has an antiapoptotic role both in normal mucosa and 
protumorigenic conditions, and causes a greater increase in the length of the villi of the 
small intestine. Chu et al. (2004) have observed that the targeted disruption of Gpx1 and 
Gpx2 harms two glutathione peroxidase (GPX) isoenzymes. GPX isoenzymes reduce 
hydroperoxidases in intestinal epithelium and their impairment increases the sensitivity of 
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ileum and colon to bacteria-associated inflammation and cancer. Our results show linear, 
up-regulation of Prdx3 and Gpx1 in the middle section of small intestine; this can activate 
antioxidant processes that are relevant for bacteria-associated inflammation, cancer-
promoting conditions and tumor progression. Our result suggests that these biological 
processes are not overloaded in the middle and distal sections, possibly due to the 
absorption that contributes, in a progressive way, to reduce the amount of fat in the small 
intestine lumen. The linear, positive responses found in the middle part illustrate the 
relevance of antiapoptotic processes, even in presence of low fat intake. The exponential, 
positive response identified in the distal section (specific to Birc5) is descriptive of an 
outstanding activation, only for most extreme values of fat intake. 
(4) Transcriptomic response in small intestine: a comparative analysis with other 
metabolic organs. Our study aimed at identifying changes in differentially expressed 
genes in three small intestine sections as a response to dietary fat intake. Kondo et al. 
(2006) analyzed differential gene expression among multiple metabolic organs, including 
small intestine. They showed that some lipid metabolism-related genes (i.e., Mod1, 
Cyp4a10, Hmgcs2, Acot1, Acot2, Pdk4, Acaa1b, Cpt1, Fabp1, and Acadl) were 
significantly up-regulated in the intestine of both A/J (obesity-resistant) and C57BL/6J 
(obesity-prone) mice fed with high fat diet. They observed that in the liver of A/J mice, 
high fat feeding significantly decreased the expression of Mod1 and Cyp4a10. Also, the 
expression of Mod1, Hmgcs2, Acot2 and Pdk4 was not increased during high fat feeding in 
the muscle and white adipose tissue. We found that: (I) Fabp1 was up-regulated and 
linearly responsive in all the three sections of the small intestine; (II) Hmgcs2, Acot1, 
Acaa1b and Acadl were linearly responsive and up-regulated in the proximal and middle 
sections; (III) in the proximal and middle sections, the expression of Pdk4 was up-
regulated and displayed a logarithmic response; (IV) Acot2 was up-regulated and linearly 
responsive in the proximal section only. Al-Dwairi et al. (2014) reported that during diet-
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induced obesity, ME1 over-expression in small intestine promoted the expression of 
hepatic genes associated with lipogenesis, cholesterol synthesis and cholesterol uptake. 
This suggests gatekeeper functionality of the small intestine, with changes in the 
expression of ME1 that influence metabolic processes in the liver. In our study, the gene 
Me1 was up-regulated and logarithmically responsive in the proximal section, while the 
up-regulation was associated with linear response in the middle and distal sections. 
Moreover, we found that processes related to cholesterol homeostasis were particularly 
active in the middle small intestine and only highest fat intake impaired cholesterol 
transport and efflux (with a key role played by the down-regulation of ATP binding 
cassette transporters). In the small intestine, de Wit et al. reported that high fat modulates 
the expression of secreted proteins such as Il18, Fgf15, Mif, Igfbp3 and Angptl4 (de Wit et 
al. 2008). They suggested that these signaling molecules might have metabolic effects in 
liver, muscle and adipose tissue that underlie the development of the metabolic syndrome. 
In our study, the gene expression of Il18 was down-regulated (changing from logarithmic 
response in the proximal to linear response in the middle section), while Igfbp3 was 
linearly up-regulated in the middle section only.  
3.5 Conclusions 
Our approach to modelling nonlinear transcriptomic signatures in the small intestine 
revealed that - for a range of biological processes including cholesterol transport and 
homeostasis - there exists a 'tipping point' for fat intake, beyond which the relationship 
between fat intake and gene expression either weakens (logarithmic curves) or strengthens 
(exponential curves). For example, the shift from linear to exponential response observed 
for down-regulated ABC transporters (from the proximal to the middle section; see Table 
3.11) is representative of the intense absorption capability of the middle section (i.e., only 
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extreme levels of fat intake down-regulate ABC transporters, while no effect is detected for 
fat intake ≤ 30E%). 
 
Section Response Genes  GOBP 
Proximal Linear 
Cd36 Cholesterol transport 
Abcg5; Abcg8  Cholesterol efflux Cholesterol homeostasis 
Middle Exponential Abcg1 Cholesterol transport 
Proximal - Middle Linear - Logarithm Pla2g10 Cholesterol homeostasis 
Proximal - Middle Linear - Exponential Abca1 Cholesterol transport 
Middle - Distal Linear - Exponential Birc5 Negative regulation of caspase activity 
Proximal - Middle - Distal Linear - Linear - Linear Serpina1b Acute-phase response 
 
Table 3.11: Fat-responsive differentially expressed genes and the associated Gene Ontology Biological 
Process (GOBP) terms. Red colored genes: up-regulated; yellow colored genes: down-regulated. For each 
gene, site of expression (i.e., Section) and response type/trend (i.e., Response) are shown. These eight genes 
are the most representative for acute-phase response (and inflammatory processes, in all three intestine 
sections), cholesterol-related processes (i.e., cholesterol homeostasis, transport and efflux: in proximal and 
middle section) and negative regulation of caspase (in middle and distal section). 
 
Our results highlight the relevance of nonlinear analysis for modelling more precisely the 
effects of diet on molecular activity in the small intestine. The observation of increasing 
relative importance of exponential responses and decreasing relative importance of 
logarithmic responses from the proximal to distal section is in agreement with the 
hypothesis that when the absorptive capacity of the intestinal epithelia is overloaded, the 
remaining fat will overflow to more distal sections (i.e., section-specific behavior). 
Although most of the genes related to inflammatory processes preserved their linear 
expression pattern along the whole small intestine (i.e., gene-specific behavior; e.g., see 
Serpina1b and Cd36), fat intake regulated in a section-specific fashion the transcriptomic 
response of Birc5 (Table 3.11). The regionalized behavior of Birc5 suggests that 
antiapoptotic mechanisms are particularly relevant in the middle section of small intestine 
and can represent an adaptation to counteract the lipotoxic effect of high fat diets on 
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intestinal cells (Desmarchelier et al. 2012; Gniuli et al. 2008). Future studies should assess 
whether the nonlinear patterns observed here are influenced by other factors (e.g., 
microbiome composition), and study the relevance of nonlinear responses in other tissues 
and clinically relevant markers.  
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Chapter 4  
High fat perturbed pathways along 
the gut axis of C57BL/6J mice 
4.1 Introduction 
Dietary fat is an energy rich nutrient. Approximately 95% of dietary lipids in human diet 
are triacylglycerols that primarily contain long-chain fatty acids (with carbon number 16 or 
above), while the remaining are phospholipids (4.5%) and sterols (Niot et al. 2009). Fatty 
acids are essential components of the cell membrane, influence the transport activity across 
cell membranes (i.e., by influencing receptor and channel function), and modulate gene 
expression (Duplus et al. 2000). However, chronic fat overconsumption has been shown to 
increase the risk of a wide range of diseases including metabolic disorders. Even though 
the activity of the small intestine is crucial for fat absorption and digestion, its role is often 
underappreciated in the study of nutritional health and diseases (Niot et al. 2009). 
The small intestine is a continuously proliferating epithelium with complex geographic 
differences in gene expression (Figure 1.1a). This is due to the fact that the structure of the 
intestinal epithelium differs along the cephalocaudal (duodenum to ileum) and crypt 
(undifferentiated) to villus (differentiated) axes (Gordon 1989). Peculiar differences in 
gene expression characterize each of the three small intestine axes (Figure 1.1b). Thus, the 
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number of expressed genes (or level of expression) is affected both by the epithelial cell 
lineage and by the location with respect to the three axes (Dusing et al. 2000; Gordon 
1989). Murine small intestine shows adaptable cell proliferation and gene regulation in 
response to the dietary fat content (Niot et al. 2009). Such lipid-mediated intestinal 
adaptation is double edged with positive effects during food scarcity, whereas the risks and 
the progression of metabolic related diseases are maximized during food surplus (Figure 
1.1d).  
Considering the intricate architecture of the small intestine, we hypothesized three kinds of 
transcriptomic response to low- and high-fat diet intervention in mice. We characterized 
the differentially expressed genes intro linear and nonlinear (i.e., logarithmic and 
quadratic) response, as a function of the interaction between diet and 10 sections of the 
small intestine. Since dietary fat is both an important metabolic fuel and an integral part of 
the cell membrane, we examined diet-responsive metabolic and transport processes that 
were enriched from the proximal to the distal section of small intestine. After having 
identified the lists of significantly over-represented biological processes, we assessed the 
predominance of specific transcriptomic responses (i.e., either linear or nonlinear 
functions) with respect to either metabolic or transport processes. Since our main interest 
was related to the investigation of regional differences, we checked whether the 10 sections 
of small intestine were commonly affected by the fat content (i.e., showing gene-specific 
responses) or displayed peculiar transcriptomic patterns (i.e., section-specific responses). 
4.2 Materials and methods  
4.2.1 Microarray data 
We analyzed microarray transcriptomic data from the intestinal mucosa of C57BL/6J male 
mice in 10 sections. The mice were fed with three kinds of diet for two weeks: high fat 
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(HF), low fat (LF) and chow (see Table 2.2 for dietary composition). The data contained 
21,266 genes and 120 arrays (n = 4 per site, but 4 arrays were removed during the phases 
of data preprocessing and quality assessment, and therefore we analyzed 116 arrays). The 
Affymetrix mouse array used for this study is mogene11stmmentrezgprobe. 
4.2.2 Data pre-processing 
We used affyPLM (Bolstad 2004) library in R (Gentleman et al. 2004; R Core Team 2015) 
for data preprocessing and quality assessment. Background correction was performed 
using RMA (Robust Multichip Average; see Irizarry et al. 2003), whereas data 
normalization was achieved by using the quantile (Bolstad 2001) and UPC (Universal 
Probability of expression Codes) function of the SCAN.UPC library (Piccolo et al. 2013). 
Non-specific filtering of the genes whose intensity was above 0.50 (which corresponded to 
UPC output values ranging from 0 to 1) in at least four arrays were chosen for further 
analysis (i.e., differential gene expression analysis) with the genefilter library (Gentleman 
et al. 2012). 
4.2.3 Differential gene expression analysis 
To find differentially expressed genes (DEG) through the small intestine while using the 
resolution of 10 sections, we have modelled gene expression as a function of the 
interaction between diet and site (using the limma library; see Smyth 2005).The 
independent variable diet was considered as a categorical parameter (i.e., HF, LF, and 
Chow). For modelling the geographical location along the longitudinal axis of small 
intestine (from the proximal to the distal section) we assigned continuous numerical values 
from 1 to 10 to the independent variable called site. We fitted linear and nonlinear (i.e., 
logarithmic and quadratic) responses to model gene expression as a function of: (1) the 
level of fat intake; and (2) the small intestine section.  
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Figure 4.1 illustrates three theoretical examples (i.e., for the linear, logarithmic and 
quadratic response types) where the expression of an up-regulated gene is described either 
with linear or nonlinear response, as a function of the intestinal sections. We used 
Benjamini and Hochberg’s false discovery rate (1995) for multiple test correction and the 
significance threshold was 0.1(adjusted p-value = 0.1). After having found which genes 
responded in a significant way to linear and nonlinear response types (i.e., linear, 
logarithmic and quadratic), we obtained diet responsive DEG by applying contrast tests. 
Contrast tests have been carried out between: (1) HF vs. LF; (2) LF vs. Chow. When a 
significant DEG was associated with more than one response, we selected the response 
with the lowest adjusted p-value.  
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Figure 4.1: Theoretical response types. (a) The linear response portrays gradual increase in expression 
from the proximal to the distal section. (b) The logarithmic response represents a saturation behavior that is 
particularly pronounced along the most downstream sections. (c) The quadratic response describes major 
contribution of the proximal and distal sections in terms of gene expression. The response types are 
illustrated for three hypothetical, up-regulated genes. 
4.2.4 Weighted co-expression network analysis 
We performed hierarchical clustering by using the mean expression value of the 1,650 
DEG in the 30 samples (i.e., 10 samples per dietary interventions). This served to check 
associations (and similarities) in gene expression across samples collected from the ten 
intestinal sections. Using the WGCNA (Weighted correlation network analysis; see 
Langfelder & Horvath 2008) library we defined clusters (i.e., modules) of highly correlated 
DEG and investigated their relation with the 10 intestinal sections (i.e., to see whether 
these modules responded in a coherent way along the longitudinal axis of small intestine). 
Then, gene set enrichment test was carried out to detect over-represented Gene Ontology, 
Biological Processes in each module separately. 
4.2.5 Gene set enrichment test 
We performed Gene Ontology Biological Process (GOBP) enrichment test to functionally 
annotate each of the modules that were significantly correlated with the small intestine 
longitudinal axis (we selected the modules that displayed a correlation ≥ 0.85 with the 10 
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sections; p-value threshold = 0.1); gene set enrichment was tested using the gage library 
(Generally Applicable Gene-set Enrichment; see Luo et al. 2009). Three kinds of analysis 
were performed per module by: (1) ignoring the diet effect (abbreviated as ND that stands 
for non-diet); (2) focusing on HF responsive processes (HF vs. LF); (3) studying LF 
responsive processes (LF vs. Chow). For each analysis, three lists of over-represented 
GOBP terms were obtained, according to the direction of regulation of DEG: (1) processes 
composed of up-regulated genes only; (2) processes including down-regulated genes only; 
(3) processes that were enriched in genes regulated in both directions (i.e., both up- and 
down-regulation). Within each module, GOBP that displayed two regulatory directions 
were classified by giving preference to the lowest q-value. Then unique GOBP terms 
described by specific regulatory directions were obtained. To reduce the complexity, each 
GOBP output was clustered based on the pairwise GO-term similarity using the GOSim 
library (Fröhlich et al. 2007). Since we aimed at finding dietary-fat perturbed biological 
functions along the gut axis, we focused our subsequent analysis on clusters that were 
relevant to metabolism and transport processes only. 
4.2.6 KEGG disease pathway enrichment test 
Using gage library (Luo et al. 2009), KEGG (Kyoto Encyclopedia of Genes and Genomes) 
disease pathway enrichment tests were performed for the modules that presented 
significant correlation with the ten intestinal sections. Three kinds of analysis were 
performed: (1) ND; (2) HF vs. LF; and (3) LF vs. Chow. For each analysis, outputs were 
classified in three groups of KEGG disease pathways that differ in regulatory direction of 
the DEG: (1) pathways with up-regulated genes only; (2) pathways with down-regulated 
genes only; and, (3) pathways consisting of both up- and down-regulated genes.  
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4.2.7  Dominant response-type and intestinal section 
For the significant GOBP terms found in each cluster (i.e., each cluster was characterized 
separately for transport and metabolic processes), we considered the response with the 
highest value of gene count as the dominant. The section (i.e., within the first to the tenth 
section) that has the number of differentially expressed genes (i.e., associated to a specific 
GOBP term) either highest (termed as Max Site) or lowest (termed as Min Site) was 
considered as being actively or passively responsive to diet, respectively.  
4.3  Results  
4.3.1 Diet responsive DEG 
After data pre-processing and quality assessment we obtained a set of 9,432 
transcriptionally active genes. We found 1,650 diet responsive DEG. The final count of 
total DEG (as well as the count of DEG for each response type) in the HF vs. LF contrast 
was considerably higher than in the LF vs. Chow contrast. The majority of the HF 
responsive DEG belonged to the logarithmic response (Figure 4.2).  
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Figure 4.2: Up- and down-regulated DEG. We obtained diet responsive DEG and response types using the 
limma library (adjusted p-value = 0.1). Red and green bars represent up- and down-regulated counts of DEG, 
respectively. For each pair of bars, the x-axis label is written with the following format: experimental diet, 
control diet and response type. Diets: lf = LF; hf = HF; response types: lin = linear; log = logarithmic; quad = 
quadratic. 
4.3.2 Significant modules 
The hierarchical clustering of the 30 samples was defined by relying on the mean 
expression value of 1,650 DEG in 10 samples per dietary intervention. Such clustering 
suggested high similarities in the site 1 of the small intestine in case of Chow and LF diet 
while a different behavior was found in presence of HF diet. However, site 1 showed 
higher similarities among each of the three dietary interventions than what could be 
observed with the more downstream parts (Figure 4.3). Section 2 through 6 in HF was 
more similar to section 2 to 4 in LF and Chow. Section 7 through 9 in HF and LF differed 
slightly from Chow.  
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Figure 4.3: Hierarchical clustering of transcriptomic data of ten samples per dietary intervention. Ten 
samples are considered for each diet: high-fat – HFD; low-fat – LFD; and chow. Each sample is labelled as 
intestinal section number followed by diet type. For example, sample collected from first section of the 
intestine with the intervention of HFD was labelled as, “i1_hfd”. The relationships between diet and ten 
samples were further illustrated with heat maps (i.e., for ten sections – Ten_Sections; and for dietary 
interventions – Three_Diets) below the dendrogram.  
 
As implemented in the WGCNA library (Langfelder & Horvath 2008), the Pearson 
correlation between eigengene values of each module and the ten intestinal sections (i.e., 
continuous numerical value ranging from 1 through 10) was calculated, including the 
corresponding p-values. The threshold for correlation is > 0.7. Since the correlation values 
of modules blue, brown and green were larger than 0.8 (and associated p-values 
significant), they were considered as highly correlated (Figure 4.4). The three significant 
modules were: (1) blue, which was positively correlated (i.e., 0.89) with the longitudinal 
axis of small intestine; (2) brown, which was negatively correlated (i.e., -0.91) with the 10 
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intestinal sections; (3) green, which showed a negative correlation (i.e., -0.92) along the 
small intestine. The majority of the genes were HF-responsive and HF vs. LF contrast had 
the highest count of DEG in comparison with LF vs. Chow (Table 4.1). The highest 
number of DEG in both the blue and the green module showed logarithmic response as a 
function of the small intestine site whereas the brown module had the highest number of 
genes responding in a linear way (Figure 4.5). 
 
 
Figure 4.4: Associations between module eigengene and ten intestinal sections. The vertical axis 
represents eigengene profile of each module (i.e., ME for module eigengene followed by the color code of 
each module; e.g., MEblue – color cording is used to name the modules but has no biological meaning). The 
color in each cell corresponds to the correlation (i.e., between module eigengene and the ten intestinal 
sections); color legend is on the right side. The correlation (upper value) and p-value (bottom value within 
parenthesis) between module eigengene and the ten intestinal sections are displayed within each cell.  
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Figure 4.5 Genes that respond significantly to diet and ten intestinal sections. Using weighted co-
expression network analysis, three main modules were identified: (1) the green module contains genes 
involved in metabolic and transport processes that are modulated by HF, with a prevalence of logarithmic 
responses; (2) the brown module includes a predominant group of DEGs that respond in a linear way to HF; 
(3) logarithmic responsive DEGs not enriched with any biological process related to dietary fat are in the 
blue module. For this illustration, the network was constructed using the protein interactions from Biogrid 
(Stark et al. 2011). First, the giant component (i.e., the connected sub-network that includes the largest 
number of proteins) was extracted and used as a scaffold to show the genes identified with weighted co-
expression network analysis. Second, topological communities were found using the "spinglass.community" 
function from the R package igraph (Csardi & Nepusz 2006). Third, the topological community most 
significantly enriched with genes from the green, brown and blue modules (i.e., modules that were previously 
characterized with weighted co-expression network analysis) was visualized and nodes color coded according 
to the color of the module (i.e., blue, brown and green). 
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Contrasts Response Green Brown Blue 
HF vs. LF 
Linear 
Quadratic 
Logarithmic 
250 
29 
262 
85 
5 
66 
33 
0 
147 
LF vs. Chow 
Linear 
Quadratic 
Logarithmic 
31 
7 
0 
27 
1 
2 
3 
0 
1 
                     Total 579 186 184 
 
Table 4.1: DEG counts per module. We reported the counts of DEG concerning three modules (Green, 
Brown, and Blue); they refer to genes responsive to HF (HF vs. LF) and LF (LF vs. Chow) diets. Modules 
were extracted using the WGCNA library. Red colored numbers represent the highest counts in each column. 
4.3.3 Enriched GOBP 
The number of enriched GOBP terms differed considerably among the three modules 
(Table 4.2). The green module had the most diet-responsive GOBP terms and was 
followed by the brown, whereas the majority of GOBP terms in the blue module belonged 
to ND (i.e., non-diet) processes. 
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Analysis Regulation Green Brown Blue 
ND 
Up 
Down 
Both 
- 
142 
160 
- 
27 
28 
- 
11 
24 
HF vs. LF 
Up 
Down 
Both 
11 
187 
58 
5 
8 
11 
- 
- 
- 
LF vs. Chow 
Up 
Down 
Both 
120 
8 
35 
3 
- 
14 
- 
10 
- 
 
Table 4.2: Count of significant GOBP terms per module. The enrichment test was performed using the 
gage library and refers to three modules (Green, Brown, and Blue). Three analyses (ND - non-diet, HF 
responsive, and LF responsive) were conducted to find diet-responsive and diet-independent GOBP terms. 
Three outputs were obtained from each analysis: Up – up-regulated processes; Down – down-regulated 
processes; and Both – processes that show regulatory patterns involving both up- and down-regulated genes. 
 
We analyzed GOBP terms in clusters based on their pairwise GO-term similarity (i.e., the 
enriched GOBP terms were categorized into clusters). One of our goals was to find dietary-
fat perturbed biological processes along the gut axis. Therefore, we considered only GOBP 
clusters that consisted of metabolic and transport processes (separately for the green the 
brown modules; see Table 4.3). Our main focus was on the green module as it contained 
the highest number of diet-responsive GOBP terms and DEG (Table 4.3). Moreover, the 
green module was the one with the most significant and strongest correlation with the ten 
sections of the small intestine (Figure 4.4).  
Results 
 
99 
 
Modules Analysis Regulation 
Count 
Clusters Transport processes DEG Clusters 
Metabolic 
Processes DEG 
Green 
HF  
vs.  
LF 
Up 1 2 35 1 8 63 
Down 3 6 40 12 46 165 
Both 2 3 69 7 13 82 
LF  
vs.  
Chow 
Up 2 4 40 8 26 226 
Down 1 1 35 1 4 26 
Both 1 2 70 3 9 65 
Brown 
 
HF  
vs.  
LF 
Up - - - 3 5 45 
Down - - - 2 6 78 
Both 1 5 25 1 3 17 
LF  
vs.  
Chow 
Up 1 3 11 - - - 
Down - - - - - - 
Both 1 3 19 2 6 49 
 
Table 4.3 Count of significant GOBP terms and the corresponding DEG per module. Within each 
module (i.e., Green and Brown), per analysis group (for example, HF vs. LF), clusters of GOBP terms 
representing transport and metabolic processes were considered. The count of GOBP terms were reported 
separately for up- and down-regulated processes. 
 
In case of HF diet, the green module showed over-representation of processes related to 
lipid metabolism and transport (Table 4.4). Other processes that are not related to lipid 
metabolism were down-regulated (Table 4.4). The response of the green module to LF was 
the opposite if compared to the response in presence of HF diet: we observed up-regulation 
of various processes related to carbohydrate metabolism (Table 4.4) and under-
representation of lipid metabolism and transport processes (Table 4.4).   
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Diet 
Clus 
ID 
Type Regulation GOBP Qval ICval count Response:count 
HF 1 TP Up 
GO:0016192 vesicle-mediated 
transport 
<0.01 4.51 35 
Hf-lin:13; Hf-log:15; 
Lf-lin:6; Lf-quad:1 
GO:0006897 endocytosis 0.06 5.38 14 
Hf-lin:7; Hf-log:6; 
Lf-quad:1 
HF 2 MP Up 
GO:0044242 cellular lipid catabolic 
process 
0.01 6.62 12 
Hf-lin:6; Hf-log:5; 
Hf-quad:1 
GO:0006631 fatty acid metabolic 
process 
0.01 5.41 27 
Hf-lin:11; Hf-log:12; 
Hf-quad:2; Lf-lin:2 
GO:0006644 phospholipid 
metabolic process 
0.01 5.86 14 Hf-lin:5; Hf-log:9 
GO:0016042 lipid catabolic process 0.01 5.97 14 
Hf-lin:6; Hf-log:7; 
Hf-quad:1 
GO:0045834 positive regulation of 
lipid metabolic process 
0.03 6.91 10 
Hf-lin:7; Hf-log:1; 
Hf-quad:1; Lf-lin:1 
GO:0046486 glycerolipid metabolic 
process 
0.03 5.89 15 Hf-lin:8; Hf-log:7 
GO:0032787 monocarboxylic acid 
metabolic process 
0.06 5.17 32 
Hf-lin:12; Hf-log:15; 
Hf-quad:2; Lf-lin:3 
GO:0046434 organophosphate 
catabolic process 
0.07 8.99 24 
Hf-lin:10; Hf-log:11; 
Hf-quad:2; Lf-lin:1 
HF 
48 
TP Down 
GO:0055085 transmembrane 
transport 
0.02 3.98 31 
Hf-lin:13; Hf-log:15; 
Hf-quad:3 
GO:0034220 ion transmembrane 
transport 
0.03 4.50 15 
Hf-lin:3, Hf-log:9; 
Hf-quad:3 
49 
GO:0006812 cation transport 0.03 4.24 17 
Hf-lin:3; Hf-log:10; 
Hf-quad:3; Lf-lin:1 
GO:0006811 ion transport 0.03 3.56 30 
Hf-lin9; Hf-log16; 
Hf-quad:4; Lf-lin:1 
GO:0030001 metal ion transport 0.03 4.46 11 
Hf-lin:3; Hf-log:5; 
Hf-quad:3 
61 
GO:0043269 regulation of ion 
transport 
0.03 5.41 10 
Hf-lin2; Hf-log:5; 
Hf-quad:2; Lf-lin:1 
HF 11 MP Down 
GO:0010557 positive regulation of 
macromolecule biosynthetic process 
<0.01 4.04 32 
Hf-lin20; Hf-log:8; 
Hf-quad:3; Lf-lin:1 
GO:0010628 positive regulation of 
gene expression 
0.01 4.11 27 
Hf-lin:15; Hf-log:8; 
Hf-quad:3; Lf-lin:1 
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GO:0010604 positive regulation of 
macromolecule metabolic process 
0.01 3.68 54 
Hf-lin:30; Hf-log:18; 
Hf-quad:3; Lf-lin:3 
GO:0045944 positive regulation of 
transcription from RNA polymerase 
II promoter 
0.01 4.71 22 
Hf-lin:12; Hf-log:6; 
Hf-quad:3; Lf-lin:1 
20 
GO:0045935 positive regulation of 
nucleobase-containing compound 
metabolic process 
<0.01 4.08 32 
Hf-lin:18; Hf-log:10; 
Hf-quad3; Lf-lin:1 
GO:0045893 positive regulation of 
transcription, DNA-dependent 
0.01 4.19 27 
Hf-lin:15; Hf-log:8; 
Hf-quad:3; Lf-lin:1 
GO:0051254 positive regulation of 
RNA metabolic process 
0.01 4.17 28 
Hf-lin16; Hf-log:8; 
Hf-quad:3; Lf-lin:1 
GO:0051173 positive regulation of 
nitrogen compound metabolic 
process 
0.01 4.06 34 
Hf-lin:18; Hf-log:11; 
Hf-quad:3; Lf-lin:2 
25 
GO:0005996 monosaccharide 
metabolic process 
<0.01 5.64 23 
Hf-lin:8; Hf-log:11; 
Hf-quad:2; Lf-lin:2 
GO:0019318 hexose metabolic 
process 
0.01 5.85 22 
Hf-lin8; Hf-log:11; 
Hf-quad:2; Lf-lin:1 
GO:0006006 glucose metabolic 
process 
0.01 6.08 18 
Hf-lin:6; Hf-log:10; 
Hf-quad:1; Lf-lin:1 
GO:0044262 cellular carbohydrate 
metabolic process 
0.07 5.05 16 
Hf-lin:7; Hf-log:6; 
Hf-quad:1; Lf-lin:2 
29 
GO:0010605 negative regulation of 
macromolecule metabolic process 
0.01 4.12 36 
Hf-lin:21; Hf-log:12; 
Hf-quad:2; Lf-lin:1 
GO:0031324 negative regulation of 
cellular metabolic process 
0.01 4.16 39 
Hf-lin:22; Hf-log:13; 
Hf-quad:3; Lf-lin:1 
GO:0010629 negative regulation of 
gene expression 
0.05 4.39 23 
Hf-lin:14; Hf-log:7; 
Hf-quad:2 
GO:2000113 negative regulation of 
cellular macromolecule biosynthetic 
process 
0.05 4.45 23 
Hf-lin:13; Hf-log:8; 
Hf-quad:2 
GO:0010558 negative regulation of 
macromolecule biosynthetic process 
0.06 4.41 26 
Hf-lin:15; Hf-log:9; 
Hf-quad:2 
GO:0031327 negative regulation of 
cellular biosynthetic process 
0.1 4.37 27 
Hf-lin15; Hf-log:9; 
Hf-quad:3 
30 
GO:0031399 regulation of protein 
modification process 
0.01 4.42 40 
Hf-lin:21; Hf-log:15; 
Hf-quad:1; Lf-lin:3 
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GO:0051246 regulation of protein 
metabolic process 
0.04 3.99 48 
Hf-lin:26; Hf-log:18; 
Hf-quad:1; Lf-lin:3 
GO:0051247 positive regulation of 
protein metabolic process 
0.05 5.02 30 
Hf-lin:17; Hf-log:10; 
lf_chow_lin3 
GO:0031401 positive regulation of 
protein modification process 
0.06 5.48 28 
Hf-lin:15; Hf-log:10; 
Lf-lin:3 
GO:0032268 regulation of cellular 
protein metabolic process 
0.06 4.17 46 
Hf-lin:25; Hf-log:17; 
Hf-quad:1; Lf-lin3 
GO:0032270 positive regulation of 
cellular protein metabolic process 
0.08 5.25 29 
Hf-lin:16; Hf-log:10; 
Lf-lin:3 
33 
GO:0005975 carbohydrate 
metabolic process 
0.01 4.69 39 
Hf-lin:12; Hf-log:22; 
Hf-quad:2; Lf-lin:3 
GO:0016051 carbohydrate 
biosynthetic process 
0.05 6.38 10 
Hf-lin:4; Hf-log:5; 
Lf-lin:1 
36 
GO:0060255 regulation of 
macromolecule metabolic process 
0.01 2.56 101 
Hf-lin:57; Hf-log:37; 
Hf-quad:3; Lf-lin:4 
GO:0006355 regulation of 
transcription. DNA-dependent 
0.02 3.04 61 
Hf-lin:36; Hf-log:21; 
Hf-quad:3; Lf-lin:1 
GO:0010556 regulation of 
macromolecule biosynthetic process 
0.03 2.93 73 
Hf-lin:43; Hf-log:26; 
Hf-quad:3; Lf-lin:1 
GO:2000112 regulation of cellular 
macromolecule biosynthetic process 
0.04 2.97 69 
Hf-lin:41; Hf-log:24; 
Hf-quad:3; Lf-lin:1 
GO:0010468 regulation of gene 
expression 
0.05 2.86 71 
Hf-lin:42; Hf-log:25; 
Hf-quad:3; Lf-lin:1 
45 
GO:0051252 regulation of RNA 
metabolic process 
0.02 3.01 61 
Hf-lin:36; Hf-log:21; 
Hf-quad:3; Lf-lin:1 
GO:0006351 transcription, DNA-
dependent 
0.02 2.72 62 
Hf-lin:37; Hf-log:21; 
Hf-quad:3; Lf-lin:1 
GO:0032774 RNA biosynthetic 
process 
0.02 2.72 62 
Hf-lin:37; Hf-log:21; 
Hf-quad:3; Lf-lin:1 
GO:0019219 regulation of 
nucleobase-containing compound 
metabolic process 
0.07 2.86 71 
Hf-lin:42; Hf-log:24; 
Hf-quad:3; Lf-lin:2 
70 
GO:0045934 negative regulation of 
nucleobase-containing compound 
metabolic process 
0.05 4.45 23 
Hf-lin:14; Hf-log:7; 
Hf-quad:2 
GO:0051172 negative regulation of 
nitrogen compound metabolic 
0.05 4.44 23 
Hf-lin:14; Hf-log:7; 
Hf-quad:2 
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process 
GO:0051253 negative regulation of 
RNA metabolic process 
0.07 4.51 22 
Hf-lin:13; Hf-log:7; 
Hf-quad:2 
GO:0045892 negative regulation of 
transcription, DNA-dependent 
0.07 4.56 21 
Hf-lin:12; Hf-log:7; 
Hf-quad:2 
GO:0000122 negative regulation of 
transcription from RNA polymerase 
II promoter 
0.09 5.17 12 
Hf-lin:6; Hf-log:4; 
Hf-quad:2 
71 
GO:0001933 negative regulation of 
protein phosphorylation 
0.05 7.24 10 
Hf-lin:5; Hf-log:4; 
Hf-quad:1 
GO:0010563 negative regulation of 
phosphorus metabolic process 
0.05 6.79 10 
Hf-lin:5; Hf-log:4; 
Hf-quad:1 
GO:0042326 negative regulation of 
phosphorylation 
0.05 6.83 10 
Hf-lin:5; Hf-log:4; 
Hf-quad:1 
GO:0045936 negative regulation of 
phosphate metabolic process 
0.05 6.79 10 
Hf-lin:5; Hf-log:4; 
Hf-quad:1 
38 
GO:0044723 single-organism 
carbohydrate metabolic process 
0.01 NA 30 
Hf-lin:10; Hf-log:16; 
Hf-quad:2; Lf-lin:2 
73 
GO:1901135 carbohydrate 
derivative metabolic process 
0.07 NA 45 
Hf-lin:15; Hf-log:24; 
Hf-quad:3; Lf-lin:2; 
Lf-quad:1 
HF 
10 
TP Both 
GO:0006869 lipid transport <0.01 5.87 10 
Hf-lin:7; Hf-log:2; 
Hf-quad:1 
GO:0010876 lipid localization 0.02 5.70 12 
Hf-lin:8; Hf-log:3; 
Hf-quad:1 
14 
GO:0071702 organic substance 
transport 
0.03 4.70 68 
Hf-lin:33; Hf-log:23; 
Hf-quad:3; Lf-lin:7; 
Lf-quad:2 
HF 
1 
MP Both 
GO:0008202 steroid metabolic 
process 
<0.01 5.46 10 
Hf-lin:4; Hf-log:4; 
Hf-quad:1; Lf-lin:1 
GO:0044255 cellular lipid 
metabolic process 
<0.01 4.50 45 
Hf-lin:17; Hf-log:22; 
Hf-quad:3; Lf-lin:3 
GO:0006629 lipid metabolic 
process 
<0.01 3.92 54 
Hf-lin:19; Hf-log:27; 
Hf-quad:4; Lf-lin:4 
GO:0008610 lipid biosynthetic 
process 
0.03 4.89 33 
Hf-lin:15; Hf-log:14; 
Hf-quad:2; Lf-lin:2 
4 
GO:0044283 small molecule 
biosynthetic process 
<0.01 4.65 30 
Hf-lin:13; Hf-log:12; 
Hf-quad:2; Lf-lin:3 
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GO:0006633 fatty acid biosynthetic 
process 
0.08 6.32 12 
Hf-lin:5; Hf-log:5; 
Hf-quad:1; lf-lin:1 
6 
GO:0006066 alcohol metabolic 
process 
<0.01 4.91 19 
Hf-lin:9; Hf-log:7; 
Hf-quad:1; lf-lin:2 
8 
GO:0010565 regulation of cellular 
ketone metabolic process 
<0.01 7.14 11 
Hf-lin:7; Hf-log:2; 
Hf-quad:1; lf-lin:1 
GO:0042180 cellular ketone 
metabolic process 
<0.01 4.39 11 
Hf-lin:7; Hf-log:2; 
Hf-quad:1; lf-lin:1 
9 
GO:0019216 regulation of lipid 
metabolic process 
<0.01 6.11 15 
Hf-lin:8; Hf-log:4; 
Hf-quad:2; lf-lin:1 
GO:0046890 regulation of lipid 
biosynthetic process 
<0.01 6.94 12 
Hf-lin:7; Hf-log:2; 
Hf-quad:2; lf-lin:1 
29 GO:0033993 response to lipid 0.1 8.22 18 
Hf-lin:11; Hf-log:5; 
Hf-quad:1; lf-quad:1 
2 
GO:1901615 organic hydroxy 
compound metabolic process 
<0.01 NA 23 
Hf-lin:11; Hf-log:7; 
Hf-quad:1; lf-lin:4 
LF 
29 
TP UP 
GO:0055085 transmembrane 
transport 
0.01 3.98 31 
Hf-lin:13; Hf-log:15; 
Hf-quad:3 
35 
GO:0006812 cation transport 0.04 4.24 17 
Hf-lin:3; Hf-log:10; 
Hf-quad:3; lf-lin:1 
GO:0006811 ion transport 0.06 3.56 30 
Hf-lin:9; Hf-log:16; 
Hf-quad:4; lf-lin:1 
GO:0043269 regulation of ion 
transport 
0.09 5.41 10 
Hf-lin:2; Hf-log:5; 
Hf-quad:2; lf-lin:1 
LF 
1 
MP UP 
GO:0005975 carbohydrate 
metabolic process 
<0.01 4.69 39 
Hf-lin:12; Hf-log:22; 
Hf-quad:2; lf-lin:3 
GO:0016051 carbohydrate 
biosynthetic process 
<0.01 6.38 10 
Hf-lin:4; Hf-log:5; 
lf-lin:1 
GO:0046390 ribose phosphate 
biosynthetic process 
0.07 9.95 12 
Hf-lin:2; Hf-log:9; 
Hf-quad:1 
2 
GO:0005996 monosaccharide 
metabolic process 
<0.01 5.65 23 
Hf-lin:8; Hf-log:11; 
Hf-quad:2; lf-lin:2 
GO:0019318 hexose metabolic 
process 
<0.01 5.85 22 
Hf-lin:8; Hf-log::11; 
Hf-quad:2; Lf-lin:1 
GO:0006006 glucose metabolic 
process 
<0.01 6.08 18 
Hf-lin:6; Hf-log:10; 
Hf-quad:1; Lf-lin:1 
GO:0044262 cellular carbohydrate 
metabolic process 
<0.01 5.05 16 
Hf-lin:7; Hf-log:6; 
Hf-quad:1; Lf-lin:2 
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GO:0016052 carbohydrate catabolic 
process 
0.01 6.59 12 
Hf-lin:3; Hf-log:7; 
Hf-quad:1; Lf-lin:1 
GO:0019320 hexose catabolic 
process 
0.01 7.10 12 
Hf-lin:3; Hf-log:7; 
Hf-quad:1; Lf-lin:1 
GO:0046365 monosaccharide 
catabolic process 
0.01 7.08 12 
Hf-lin:3; Hf-log:7; 
Hf-quad:1; Lf-lin:1 
21 
GO:0016311 dephosphorylation <0.01 5.31 20 
Hf-lin:9; Hf-log:8; 
Hf-quad:1; Lf-lin:1; 
Lf-quad:1 
GO:0006468 protein 
phosphorylation 
0.02 3.95 46 
Hf-lin:23; Hf-log:17; 
Hf-quad:2; Lf-lin:4 
GO:0016310 phosphorylation 0.02 3.56 70 
Hf-lin:31; Hf-log:31; 
Hf-quad:2; Lf-lin:6 
GO:0006793 phosphorus metabolic 
process 
0.09 3.40 125 
Hf-lin:51; Hf-log:59; 
Hf-quad:6; Lf-lin:8; 
Lf-quad:1 
32 
GO:0031324 negative regulation of 
cellular metabolic process 
0.03 4.16 39 
Hf-lin:22; Hf-log:13; 
Hf-quad:3; Lf-lin:1 
GO:0010605 negative regulation of 
macromolecule metabolic process 
0.04 4.11 36 
Hf-lin:21; Hf-log:12; 
Hf-quad:2; Lf-lin:1 
GO:0009892 negative regulation of 
metabolic process 
0.06 4.02 43 
Hf-lin:24; Hf-log:15; 
Hf-quad:3; Lf-lin:1 
34 
GO:0019222 regulation of 
metabolic process 
0.04 2.32 127 
Hf-lin:65; Hf-log:47; 
Hf-quad:6; Lf-lin:7; 
Lf-quad:2 
GO:0006357 regulation of 
transcription from RNA polymerase 
II promoter 
0.1 4.06 30 
Hf-lin:17; Hf-log:9; 
Hf-quad:3; Lf-lin:1 
40 
GO:0045944 positive regulation of 
transcription from RNA polymerase 
II promoter 
0.07 4.71 22 
Hf-lin:12; Hf-log:6; 
Hf-quad:3; Lf-lin:1 
GO:0051173 positive regulation of 
nitrogen compound metabolic 
process 
0.09 4.06 34 
Hf-lin:18; Hf-log:11; 
Hf-quad:3; Lf-lin:2 
GO:0051254 positive regulation of 
RNA metabolic process 
0.09 4.17 28 
Hf-lin:16; Hf-log:8; 
Hf-quad:3; Lf-lin:1 
GO:0010628 positive regulation of 
gene expression 
0.09 4.11 27 
Hf-lin:15; Hf-log:8; 
Hf-quad:3; Lf-lin:1 
Results 
 
106 
 
GO:0045893 positive regulation of 
transcription. DNA-dependent 
0.09 4.20 27 
Hf-lin:15; Hf-log:8; 
Hf-quad:3; Lf-lin:1 
43 
GO:0006520 cellular amino acid 
metabolic process 
0.09 5.21 20 
Hf-lin:10; Hf-log:6; 
Hf-quad:2; Lf-lin:2 
4 
GO:0044723 single-organism 
carbohydrate metabolic process 
<0.01 NA 30 
Hf-lin:10; Hf-log:16; 
Hf-quad:2; Lf-lin:2 
LF 3 TP Down 
GO:0016192 vesicle-mediated 
transport 
0.01 4.51 35 
Hf-lin:13; Hf-log:15; 
Lf-lin:6; Lf-quad:1 
LF 2 MP Down 
GO:0044242 cellular lipid catabolic 
process 
0.01 6.62 12 
Hf-lin:6; Hf-log:5; 
Hf-quad:1 
GO:0006644 phospholipid 
metabolic process 
0.01 5.86 14 Hf-lin:5; Hf-log:9 
GO:0016042 lipid catabolic process 0.01 5.97 14 
Hf-lin:6; Hf-log:7; 
Hf-quad:1 
GO:0030258 lipid modification 0.06 6.62 10 
Hf-lin:6; Hf-log:3; 
Hf-quad:1 
LF 6 TP Both 
GO:0071702 organic substance 
transport 
0.02 4.70 68 
Hf-lin:33; Hf-log:23; 
Hf-quad:3; Lf-lin:7; 
2Lf-quad: 
GO:0032940 secretion by cell 0.08 4.83 18 
Hf-lin:8; Hf-log:8; 
Lf-lin:2 
LF 
2 
MP Both 
GO:0008202 steroid metabolic 
process 
0.01 5.46 10 
Hf-lin:4; Hf-log:4; 
Hf-quad:1; Lf-lin:1 
GO:0044255 cellular lipid 
metabolic process 
0.09 4.50 45 
Hf-lin:17; Hf-log:22; 
Hf-quad:3; Lf-lin:3 
3 
GO:0010565 regulation of cellular 
ketone metabolic process 
0.01 7.14 11 
Hf-lin:7; Hf-log:2; 
Hf-quad:1; Lf-lin:1 
GO:0042180 cellular ketone 
metabolic process 
0.01 4.39 11 
Hf-lin:7; Hf-log:2; 
Hf-quad:1; Lf-lin:1 
GO:0006066 alcohol metabolic 
process 
0.03 4.91 19 
Hf-lin:9; Hf-log:7; 
Hf-quad:1; Lf-lin:2 
GO:0044283 small molecule 
biosynthetic process 
0.04 4.65 30 
Hf-lin:13; Hf-log:12; 
Hf-quad:2; Lf-lin:3 
1 
GO:1901615 organic hydroxy 
compound metabolic process 
<0.01 NA 23 
Hf-lin:11; Hf-log:7; 
Hf-quad:1; Lf-lin:4 
GO:1901617 organic hydroxy 
compound biosynthetic process 
<0.01 NA 11 
Hf-lin:5; Hf-log:3; 
Hf-quad:1; Lf-lin:2 
GO:0044711 single-organism 0,04 NA 30 Hf-lin:13; Hf-log:12; 
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biosynthetic process Hf-quad:2; Lf-lin:3 
 
Table 4.4: Diet responsive GOBP terms. Two types of diet are considered: HF and LF. GOBP terms can be 
either up- or down-regulated (Regulation), and be associated to linear, logarithmic or quadratic response 
types. GOBP terms refer to either metabolic (MP) or transport processes (TP). Results were obtained using 
the gage library. GOBP terms with the same cluster ID (ClusID) belong to the same cluster (this was based 
on GO term similarity, measured using the GOSim library). For each GOBP term, the results include: the 
multiple test correction computed using the Benjamini and Hochberg false discovery rate (Qval); the 
information content value (ICval) that was calculated for each GO term using GOSim; the number of DEGs 
(count); the response specific count of the DEGs and the corresponding response name for each count of 
responses (Response:count). For example (in the first row), GO:0016192 vesicle-mediated transport 
contained 35 DEG (count), out of which 13 (Response:count) were HF and linear responsive (Hf- lin); the 
dominant response (in red color) represents the response with the highest gene count; e.g., in the first column, 
15 (Response:count) out of 35 (count) genes were HF and logarithmic responsive (Hf-log). 
4.3.4 KEGG disease pathways 
Among the three modules, only one HF (i.e., HF vs. LF) responsive disease pathway was 
enriched. The over-represented term was pathways in cancer (mmu05200); it consists of 
genes that are both up- and down-regulated and was found in the green module (Table 4.5). 
Disease KEGG pathway p.geomean stat.mean p.val q.val set.size genes 
mmu05200: Pathways in 
cancer 
0.16 1.04 <0.01 <0.01 12 
Adcy6, Bcl2, 
Bcl2l1, Bmp2, 
Csf2ra, Fgf1, 
Fos, Lamb3, 
Slc2a1, Sufu, 
Map2k2, Mtor 
 
Table 4.5 HF responsive KEGG disease pathway in the green module. The statistical results include: 
geometric mean of the individual p-values (p.geomean); mean of gene-set directional changes (stat.mean); 
global p-value (p.val); multiple test correction using Benjamini and Hochberg false discovery rate (q.val); the 
number of DEG (set.size). More details on statistics used in the columns are available in Luo et al. (2009). 
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4.3.5 Dominant response types 
To associate either linear or nonlinear functions to all significantly over-represented 
biological processes, we considered as dominant the responses with the highest gene count 
per GOBP in each cluster (Table 4.4). Logarithmic and linear responses were the most 
dominant (Tables 4.4 and 4.6). Logarithmic response was characteristic of transport 
processes whereas linear response was mainly associated to metabolic processes. 
 
Modules Analysis Regulation 
Clusters 
Transport Processes Metabolic Processes 
Response 
Max 
Site 
Min 
Site 
Response 
Max 
Site 
Min 
Site 
Green 
HF Vs. LF 
Up 
Lin (1) 
Log (1) 
2 1 Lin (3) 
Log (5) 
10 1 
Down 
Log (6) 5 1 Lin (39) 
Log (7) 
1 1 
Both 
Lin (3) 5 1 Lin (11) 
Log (2) 
10 1 
LF Vs. Chow 
Up 
Log (4) 9 1 Lin (15) 
Log (11) 
9 1 
Down 
Log (1) 1, 9 2, 3, 
7 
Lin (2) 
Log (2) 
1 10, 9 
Both 
Lin (2) 9 3 Lin (8) 
Log (1) 
9 9 
 
Table 4.6 Dominant response types and intestinal sections. For each significant GOBP term, the response 
type with the highest gene count was defined as dominant. The Max site is the one where the highest number 
of differentially expressed genes associated to a specific GOBP term was found, while the Min site is the 
section where the lowest number of differentially expressed genes (for a given GOBP term) was observed. 
4.3.6 Dominant intestinal sections 
Within the first to the tenth section: site with the highest number of differentially expressed 
genes associated to a specific GOBP term was considered as actively responsive to diet, 
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which was called as Max site; and, the site with the lowest number of differentially 
expressed genes (for a given GOBP term) as being passively responsive to diet, which was 
termed as Min site (Table 4.6).With HF diet, sections 1-2, 5 and 10 were the most active. 
Sections 2 and 5 had the highest number of high expression values related to transport 
activities whereas sections 1 and 10 had the highest counts of high expression values 
specific to metabolic processes. With LF diet, sections 1-3, 7 and 9-10 were the most 
active. Sections 1 and 9 had the highest activity for both transport and metabolic processes. 
4.4 Discussion 
Over-consumption of energy dense fatty food combined with a sedentary and inactive 
lifestyle has evidenced a predisposition to chronic diseases (Cheung & Mao 2012; 
Desmarchelier et al. 2012; Walley et al. 2006). Studies have shown the importance of the 
gut in the maintenance of fat homeostasis and energy balance, with this regulation that is 
impaired in obesity and diabetes (Cheung & Mao 2012; Walley et al. 2006). The lipid 
sensing mechanism of small intestine is one of the first metabolic defenses against nutrient 
excess and contributes to maintain energy and metabolic balance (Wang et al. 2008). 
However, excessive fat intake is suggested to induce a delayed onset of satiety and 
promotes high fat diet hyperphagia (Little et al. 2007). The small intestine plays a key role 
in both absorption and digestion of dietary fat. Along the longitudinal axis, the small 
intestine shows regionalized differences in the absorptive capabilities and in the expression 
of genes encoding metabolic enzymes (Dusing et al. 2000; Gordon 1989). In consideration 
of the role of fatty acids as a metabolic fuel and as an integral part of the cell membrane 
(Gordon 1989; Niot et al. 2009), our main goals were: (1) to identify which metabolic and 
transport processes were fat-responsive; (2) to understand whether the prevalence of over-
expressed metabolic and transport processes was unevenly distributed from the proximal to 
the distal small intestine. Our broadest objective was investigating which intestinal sections 
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displayed similar response patterns and whether they were commonly affected by the fat 
content. The regionalized behavior of the small intestine was modelled by proposing 
characteristic response patterns (either linear or nonlinear - i.e., logarithmic or quadratic) 
of diet sensitive biological processes to take into account how varying levels of fat could 
affect gene expression. Contrast statistical analysis between HF and LF showed significant 
impact of HF on the differential gene expression in small intestine. Irrespective of the 
response type, approximately 93% of the DEGs were HF responsive whereas about 6.9% 
responded to LF (Table 4.7). Taking into account the response of each DEG, a remarkable 
43% was up-regulated and showed logarithmic response to HF (Table 4.7). This confirms 
high influence of HF within the intestinal milieu and suggests that excess fat in the lumen 
can be associated to a saturated response in terms of gene expression intensity. Excessive 
amounts of fat that reach the middle and the distal parts of small intestine can exceed the 
organ capacity. Such behavior describes a saturation response, which could set upper limits 
to digestion and absorption.  
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Test Response Regulation DEG count Relative % Total % 
HF vs. LF 
Linear 
Up 267 16.18 
93.08 
Down 298 18.06 
Quadratic 
Up 36 2.18 
Down 14 0.84 
Logarithmic 
Up 709 42.97 
Down 212 12.85 
LF vs. Chow 
Linear 
Up 43 2.61 
6.91 
Down 51 3.09 
Quadratic 
Up 8 0.48 
Down 9 0.55 
Logarithmic 
Up 1 0.06 
Down 2 0.12 
 
Table 4.7: Response specific DEG counts. Using the limma library we obtained diet and response specific 
DEGs along the longitudinal axis of murine small intestine (adjusted p-value = 0.1). We summarized the 
relative percentage of DEGs counts per response types. 
 
The proximal small intestine is vital for nutrient digestion and absorption. During acute 
lipid intake, the upper intestinal lipid sensing mechanism suppresses glucose production 
(i.e., by the activation of intestine-brain axis) to negatively regulate food intake and 
maintain energy balance (Wang et al. 2008). Conversely, increased levels of carbohydrate 
intake suppress lipid metabolism but increase carbohydrate metabolism (Jeukendrup 2003). 
We observed an inverse relation between numerous biological processes that responded to 
either HF or LF along the longitudinal axis of the small intestine (Table 4.8). Both lipid 
metabolism and transport related processes were highly represented in HF while being 
repressed in LF. Processes related to carbohydrate metabolism and ion transport were up-
regulated in LF and down-regulated in HF. The intestinal feedback varied considerably 
between HF and LF. In response to HF, we observed the prevalence of metabolic activities 
in the upper proximal and lower distal sections, whereas upper proximal and middle 
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sections had the highest number of transport activities. In LF diet, the upper proximal and 
lower distal sections were particularly active in both transport and metabolic processes. 
The proximal intestine was always particularly active, even with low levels of fat intake, 
while the most downstream sections were more sensitive to dietary fat. Linear and 
logarithmic response types were the most dominant in both metabolic and transport 
processes. The logarithmic response was more characteristic for the transport processes 
while the linear response was mainly associated to metabolic processes (Table 4.6). 
BP Rel GOBP 
HF LF 
pgmean smean p.val q.val ssize pgmean smean p.val q.val ssize 
MP 
HFup 
vs. 
LFdown 
GO:0044242 
cellular lipid 
catabolic process 
0.09 1.28 <0.01 0.01 12 0.08 -1.35 <0.01 0.01 12 
GO:0006644 
phospholipid 
metabolic process 
0.11 1.22 <0.01 0.01 14 0.10 -1.27 <0.01 0.01 14 
GO:0016042 lipid 
catabolic process 0.10 1.19 <0.01 0.01 14 0.10 -1.22 <0.01 0.01 14 
HFdown 
vs. 
LFup 
GO:0010628 
positive regulation 
of gene expression 
0.11 -1.07 <0.01 0.01 27 0.23 0.66 0.02 0.09 27 
GO:0045944 
positive regulation 
of transcription 
from RNA 
polymerase II 
promoter 
0.12 -1.02 <0.01 0.01 22 0.21 0.71 0.01 0.07 22 
GO:0045893 
positive regulation 
of transcription, 
DNA-dependent 
0.11 -1.07 <0.01 0.01 27 0.23 0.66 0.02 0.09 27 
GO:0051254 
positive regulation 
of RNA metabolic 
process 
0.11 -1.07 <0.01 0.01 28 0.22 0.67 0.02 0.09 28 
GO:0051173 
positive regulation 
of nitrogen 
compound 
metabolic process 
0.11 -1.03 <0.01 0.01 34 0.23 0.67 0.02 0.09 34 
GO:0005996 
monosaccharide 
metabolic process 
0.11 -1.11 <0.01 <0.01 23 0.08 1.41 <0.01 <0.01 23 
GO:0019318 
hexose metabolic 
process 
0.11 -1.09 <0.01 0.01 22 0.09 1.35 <0.01 <0.01 22 
GO:0006006 
glucose metabolic 
process 
0.14 -0.99 <0.01 0.01 18 0.12 1.16 <0.01 <0.01 18 
GO:0044262 
cellular 
carbohydrate 
metabolic process 
0.24 -0.65 0.02 0.07 16 0.13 1.15 <0.01 <0.01 16 
GO:0010605 
negative 
regulation of 
macromolecule 
metabolic process 
0.10 -1.02 <0.01 0.01 36 0.20 0.80 0.01 0.04 36 
GO:0031324 
negative 
regulation of 
cellular metabolic 
0.12 -0.94 <0.01 0.01 39 0.19 0.83 <0.01 0.03 39 
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process 
GO:0005975 
carbohydrate 
metabolic process 
0.11 -1.00 <0.01 0.01 39 0.06 1.48 <0.01 <0.01 39 
GO:0016051 
carbohydrate 
biosynthetic 
process 
0.23 -0.71 0.01 0.05 10 0.09 1.38 <0.01 <0.01 10 
GO:0044723 
single-organism 
carbohydrate 
metabolic process 
0.13 -0.97 <0.01 0.01 30 0.08 1.40 <0.01 <0.01 30 
HFboth 
vs. 
LFboth 
GO:0008202 
steroid metabolic 
process 
0.05 1.70 <0.01 <0.01 10 0.10 1.23 <0.01 0.01 10 
GO:0044255 
cellular lipid 
metabolic process 
0.07 1.42 <0.01 <0.01 45 0.22 0.75 0.01 0.09 45 
GO:0044283 
small molecule 
biosynthetic 
process 
0.07 1.40 <0.01 <0.01 30 0.13 0.96 <0.01 0.04 30 
GO:0006066 
alcohol metabolic 
process 
0.07 1.39 <0.01 <0.01 19 0.15 1.02 <0.01 0.02 19 
GO:0010565 
regulation of 
cellular ketone 
metabolic process 
0.10 1.31 <0.01 <0.01 11 0.13 1.17 <0.01 0.01 11 
GO:0042180 
cellular ketone 
metabolic process 
0.10 1.31 <0.01 <0.01 11 0.13 1.17 <0.01 0.01 11 
GO:1901615 
organic hydroxy 
compound 
metabolic process 
0.05 1.60 <0.01 <0.01 23 0.07 1.50 <0.01 <0.01 23 
TP 
Hfup 
vs. 
LFdown 
GO:0016192 
vesicle-mediated 
transport 
0.04 1.69 <0.01 <0.01 35 0.06 -1.23 <0.01 0.01 35 
HFdown 
vs. 
LFup 
GO:0055085 
transmembrane 
transport 
0.16 -0.83 <0.01 0.02 31 0.16 0.96 <0.01 0.01 31 
GO:0006812 
cation transport 0.19 -0.83 <0.01 0.03 17 0.19 0.80 0.01 0.04 17 
GO:0006811 ion 
transport 0.18 -0.82 <0.01 0.03 30 0.19 0.76 0.01 0.06 30 
GO:0043269 
regulation of ion 
transport 
0.19 -0.79 0.01 0.03 10 0.22 0.68 0.02 0.09 10 
Hfboth 
vs. 
LFboth 
GO:0071702 
organic substance 
transport 
0.14 0.95 <0.01 0.03 68 0.13 1.06 <0.01 0.02 68 
 
Table 4.8 GOBP terms in HF and LF. Each row represents a particular biological process (BP), either 
metabolic (MP) or transport (TP). Often, such processes were characterized by an inverse relationship 
between HF and LF. The nature of each relation is in column “Rel”. For example, the first row of column 
“Rel” represents three metabolic GOBP terms that were up-regulated in HF and down-regulated in LF. The 
statistical results include: geometric mean of the individual p-values (pgmean); mean of gene-set directional 
changes (smean); global p-value (p.val); multiple test correction using Benjamini and Hochberg false 
discovery rate (q.val); the number of DEGs (ssize). More details on statistics used in the columns are 
available in (Luo et al. 2009). The statistical results are reported for both HF (HF vs. LF) and LF (LF vs. 
Chow).  
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4.5 Conclusions 
HF western style diet showed high impact on the differential gene expression in the small 
intestine of C57BL/6J mice. Increased HF intake repressed carbohydrate metabolism and 
led to over-expressing genes involved in lipid metabolism. The middle and the distal 
sections were particularly sensitive to fat content while the proximal section was proactive 
irrespective of the diet. The transport processes responded to increased levels of fat content 
with a saturated logarithmic response. In both HF and LF there was high metabolic activity 
in the upper proximal and in the lower distal small intestine although the enriched 
pathways showed opposite trends of regulation (i.e., lipid metabolic processes were up-
regulated on a high-fat diet but the same processes were down-regulated on a LF diet). 
Such responses could be due to the lipid-mediated small intestine adaptation (i.e., 
increased levels of fat triggers higher absorption) and lead to chronic metabolic disorders.  
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Chapter 5  
Conclusions 
Nonlinear modelling can be used as an investigative tool to describe different types of 
physiological responses triggered by external (i.e., environmental) stimuli. This approach 
is particularly suitable to characterize the genetic mechanisms of expression involved in 
the regulation of biological processes as fat absorption and digestion in response to various 
dietary habits or to microbiota activity (i.e., with the term microbiota we indicate the 
ecological community of microorganisms of our body). In molecular nutrition, the small 
intestine plays a key role in the absorption and digestion of food, but its relevance has 
often been overlooked. The small-intestine consists of a large surface area that functions as 
the main portal for nutrient absorption, with physiological differences from the proximal to 
the distal section. The small intestine is colonized by a large and heterogeneous community 
of microorganisms (i.e., the microbiota that includes both beneficial and harmful 
populations) and performs the simultaneous functions of (1) nutrient absorption and (2) 
barrier against the entry of harmful antigens (such as pathogenic bacteria or allergens). 
Breaches in the small intestinal boundary disturb the intestinal homeostasis and excess 
high-fat intake compromises intestinal barrier sealing functions by down-regulating tight 
junction proteins (i.e., ZO-1 and occludin; see Cani et al. 2008). This triggers inflammatory 
damages until reaching extra-intestinal sites (e.g., the liver - Carding et al. 2015; Fasano & 
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Shea-Donohue 2005; see Figure 1.1). Such a complex interplay between physiological and 
environmental reactions (e.g., the relationships that link the diet to the activity of the 
luminal antigens) can be studied with nonlinear modelling. Also the modulation of gene 
expression mechanisms driven by fat availability can be studied effectively by using 
nonlinear models that mimic the consequences of fat overload (e.g., the saturation of 
dietary fat absorption in response to excessive amounts of fat intake can be described by 
modelling gene expression as a logarithmic function of different levels of fat intake). 
5.1 Nonlinear regulation of fat intake 
The importance of studying nonlinear responses to dietary fat intake in the small intestine 
is justified by evident morphological and physiological differences that characterize its 
longitudinal axis (DeSesso & Jacobson 2001). Also, the small intestine is capable of 
accommodating excess fat with increased absorption and this response is coordinated at the 
level of gene expression. Dietary fat mediated up-regulation of genes (i.e, FATP4, I-FABP 
or L-FABP) facilitates intestinal fatty acid uptake (Niot et al. 2009; Petit et al. 2007). This 
activity can be measured using nonlinear logarithmic or exponential functions that depict 
saturation or proactive absorption responses to fat intake, respectively. The approach based 
on nonlinear patterns perfectly matches the need of modelling the regionalized responses 
of small intestine to the intake of dietary fat gradients (i.e., by considering the modulations 
that involve absorptive and transport processes).  
5.1.1 Consequences of fat intake on the transcriptomic response along the 
longitudinal axis of small intestine 
The Chapter 3 of this thesis investigated the linear and nonlinear gene expression 
responses to dietary fat doses (i.e., 10%, 20%, 30% or 45% of kcal from fat) along the 
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longitudinal axis of the small intestine. The linear gene expression represents a constant 
raise in response to increasing fat intake. The logarithmic response illustrates the presence 
of overload mechanisms. The exponential response stands for enhanced gene expression 
behavior as a consequence of highest levels of fat intake. The quadratic response measures 
parabolic functions that are typical for enzyme kinetics. The cubic response refers to an 
oscillating behavior that can be associated to circadian rhythms. The study of Chapter 3 
aimed at analyzing the presence of either gene-specific or section-specific responses to fat 
doses. A gene-specific response explains expression of genes exhibiting a constant pattern 
in each of the three intestinal sections. For example, we found that Serpina1b was up-
regulated and linearly responsive to fat doses in the whole small intestine (Table 3.11). 
Section-specific responses characterize those genes that modulate their behavior depending 
on the intestine sections where the differential expression occurs. For example, Abca1 
changed from being linearly responsive in the proximal to be exponentially responsive in 
the middle section (always down-regulated). The main reasons that motivate the 
application of this novel approach are: (1) to provide dynamic understanding of the 
influence of dietary fat on intestinal lipid metabolism; (2) to understand which factors lead 
to fat mediated adaptations of intestinal lipid metabolism thus triggering the development 
of metabolic disorders (e.g., obesity). 
We found that an increased intake of high-fat diets exerts significant impact on the 
differential gene expression patterns of the small intestine (Tables 3.2 and 4.7). The middle 
section is known to be the most responsive to fat intake (de Wit et al. 2011) and this was 
corroborated by the findings of our analysis. By studying both linear and nonlinear 
responsive genes, we showed that the middle section of the small intestine contained the 
highest number of differentially expressed genes. Conversely, the lowest number of 
differentially expressed genes was found in the distal section (Table 3.2). As illustrated by 
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the study of Chapter 4, the intake of a high-fat diet mainly resulted in the over-expression 
of processes related to metabolism and transport of lipid, while there was down-regulation 
of carbohydrate metabolism. Such pattern suggests that an adaptation mechanism is at play 
in the small intestine and can result in enhanced levels of fat absorption; this mechanism is 
likely to be driven by fat availability (Petit et al. 2007). The whole small intestine 
displayed the prevalence of linear gene expression responses as a function of increasing 
levels of dietary fat doses (Table 3.2 and Figure 3.3). The availability of highest amounts 
of fat in the proximal section stimulated the highest relative importance of saturated 
logarithmic responses (Table 3.2 and Figure 3.3). The overflow of (decreasing amounts of) 
excess fat into the distal region resulted in the highest relative importance of unsaturated, 
exponential responses (Table 3.2 and Figure 3.3). Along the intestinal axis, logarithmic and 
linear responses were the most representative in case of transport and metabolic processes, 
respectively (Table 4.6). In each of the three sections of the small intestine, there was gene-
specific linear response of processes related to inflammatory reaction (Table 3.11). 
Processes related to cholesterol transport and efflux exhibited section-specific responses. 
In the middle section, there was inhibition (with negative, exponential response) of 
cholesterol transport and efflux processes in response to the intake of highest amounts of 
fat. The distal section showed an enhanced expression (with positive, exponential 
response) in terms of negative regulation of caspase activity (i.e., Birc5; see Table 3.11). 
This suggests that the small intestine activated some measures to counterbalance the excess 
lipid overflow into the distal section (Desmarchelier et al. 2012). In this way the intestine 
is able to cope by means of apoptosis the lipotoxic effect stimulated by excess fat 
(Desmarchelier et al. 2012). However, disease enrichment analysis suggested a significant 
over-representation of pathways related to cancer (Table 4.5). 
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5.2 Applicability beyond intestinal system 
This thesis introduced the use of linear and nonlinear modelling to describe the changes of 
gene expression in response to dietary fat intake. Therefore, the novelties of the approach 
implemented in the Chapter 3 and 4 consist in: (1) describing the carrying capacity of each 
section of the small intestine in response to a gradient of dietary fat intake; (2) providing a 
dynamic characterization of the expression pattern of the genes, where each response 
pattern explains a unique state of gene expression to varying levels of fat intake; (3) 
illustrating the presence of gene- and section-specific responses to fat intake along the 
longitudinal axis of the small intestine. Thus, our study draws a map concerning the 
carrying capacity of genes and intestinal sections to different doses of dietary fat (i.e., 
using linear and nonlinear modelling, fat intake was studied as a continuous predictor of 
gene expression). As potential future applications, we suggest that this approach can be 
promising to investigate the differences in the efficacy of various treatments (e.g., a 
particular drug can be more effective in a group of individuals only and its consequences 
can be measured by the fact it determines unsaturated or saturated gene expression 
response patterns) or to model individual-level responses to increased levels of nutrients 
(e.g., in the case of fat intake it can be used to investigate for which reasons some 
individuals are more resistant to weight gain than others). These studies (i.e., based on the 
differences among individuals) could serve to identify peculiar response types in specific 
genes as potential biomarkers. Such biomarkers could model continuous responses (i.e., 
gene expression) as a function of external, environmental factors (e.g., various drug doses 
or different concentrations of micronutrients) and serve to examine: (1) differences in 
response patterns among individuals; (2) spatial or temporal trends in the responses within 
different regions of the organs (e.g., in this thesis we have illustrated that the small 
intestine displays regionalized functions). 
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5.3 Outlook 
The investigation of the diet-mediated physiological and pathological changes represents 
the key for better understanding the onset of metabolic disorders. Previous studies have 
demonstrated high-fat mediated long term effects such as chronic inflammation, weight 
gain and obese phenotype (Cani et al. 2007; Garrett et al. 2010; de Wit et al. 2011), 
showing the high individual-level variability that characterizes these responses (e.g., 
individualized response to weight gain; see Speakman et al. 2011). In my work, the 
transcriptomic response was modelled as a function of dietary fat doses, and DEGs 
displayed regionalized expression along the longitudinal axis of small intestine. A possible 
extension of the study could be based on (1) investigating individualized responses to 
treatments, and (2) identifying specific biomarkers that are robust to individual-level 
variability. Also epigenetics could be taken into account to consider how high-fat diets 
influence the methylation state of genes (Amaral et al. 2014; Milagro et al. 2009). 
The large surface area of intestine is a hotbed for both beneficial and harmful pathogens 
(O’Hara & Shanahan 2006; Shen et al. 2013). Influence of diet on the composition of gut 
microbiota has been widely documented, with western-style high-fat diets that reduce 
bacterial diversity and lead to dysbiosis (Bäckhed et al. 2004; Bäckhed et al. 2007). This 
triggers the development of metabolic complications such as obesity, inflammatory bowel 
disease and diabetes (Clemente et al. 2012; Shen et al. 2013), suggesting that gene 
expression can be influenced by various external factors (e.g., diet, microbiome and their 
interactions). Thus, gene expression in intestine depends on: (1) cell types (i.e., 
enteroendocrine vs. absorptive cells), (2) location (i.e., the crypt-villus axis), and (3) 
luminal factors (e.g., diet and microbiota). This thesis takes into account the role of diet on 
gene expression and could be integrated by new, multi-factorial experiments to consider 
the interactions between diet and microbiota. 
 121 
 
Bibliography 
Abreu, M.T., 2010. Toll-like receptor signalling in the intestinal epithelium: how bacterial 
recognition shapes intestinal function. Nature Reviews Immunology, 10(2), pp.131–
44. 
Al-Dwairi, A. et al., 2014. Enhanced gastrointestinal expression of cytosolic malic enzyme 
(ME1) induces intestinal and liver lipogenic gene expression and intestinal cell 
proliferation in mice. PloS One, 9(11), p.e113058. 
Altmann, S.W. et al., 2004. Niemann-Pick C1 Like 1 protein is critical for intestinal 
cholesterol absorption. Science, 303(5661), pp.1201–4. 
Amaral, C.L. et al., 2014. DNA Methylation Changes Induced by a High-Fat Diet and Fish 
Oil Supplementation in the Skeletal Muscle of Mice. Journal of Nutrigenetics and 
Nutrigenomics, 7(4-6), pp.314–26. 
van Ampting, M.T.J. et al., 2012. Intestinally secreted C-type lectin Reg3b attenuates 
salmonellosis but not listeriosis in mice. Infection and Immunity, 80(3), pp.1115–20. 
Bäckhed, F. et al., 2007. Mechanisms underlying the resistance to diet-induced obesity in 
germ-free mice. Proceedings of the National Academy of Sciences, 104(3), pp.979–
84. 
Bäckhed, F. et al., 2004. The gut microbiota as an environmental factor that regulates fat 
storage. Proceedings of the National Academy of Sciences of the United States of 
America, 101(44), pp.15718–23. 
Balwierz, A. et al., 2009. Angiogenesis in the New Zealand obese mouse model fed with 
high fat diet. Lipids in Health and Disease, 8(1), p.13. 
Balzan, S. et al., 2007. Bacterial translocation: overview of mechanisms and clinical 
impact. Journal of Gastroenterology and Hepatology, 22(4), pp.464–71. 
Bellafante, E. et al., 2014. PGC-1β promotes enterocyte lifespan and tumorigenesis in the 
intestine. Proceedings of the National Academy of Sciences of the United States of 
America, 111(42), pp.E4523–31. 
Benjamini, Y. & Hochberg, Y., 1995. Controlling the false discovery rate: a practical and 
powerful approach to multiple testing. Journal of the Royal Statistical Society. Series 
Outlook 
 
122 
 
B (Methodological), 57(1), pp.289–300. 
Berge, K.E. et al., 2000. Accumulation of dietary cholesterol in sitosterolemia caused by 
mutations in adjacent ABC transporters. Science, 290(5497), pp.1771–5. 
Blanc-Brude, O.P. et al., 2007. IAP survivin regulates atherosclerotic macrophage survival. 
Arteriosclerosis, thrombosis, and vascular biology, 27(4), pp.901–7. 
Bloks, V.W. et al., 2004. Down-regulation of hepatic and intestinal Abcg5 and Abcg8 
expression associated with altered sterol fluxes in rats with streptozotocin-induced 
diabetes. Diabetologia, 47(1), pp.104–12. 
Bolstad, B., 2001. Probe level quantile normalization of high density oligonucleotide array 
data. Unpublished manuscript. 
Bolstad, B.M. et al., 2003. A comparison of normalization methods for high density 
oligonucleotide array data based on variance and bias. Bioinformatics, 19(2), pp.185–
93. 
Bolstad, B.M., 2004. Low-level Analysis of High-density Oligonucleotide Array Data: 
Background, Normalization and Summarization. UNIVERSITY OF CALIFORNIA, 
BERKELEY. 
Borgström, B., 1977. Digestion and absorption of lipids. International Review of 
Physiology, 12, pp.305–23. 
Bourgon, R., Gentleman, R. & Huber, W., 2010. Independent filtering increases detection 
power for high-throughput experiments. Proceedings of the National Academy of 
Sciences of the United States of America, 107(21), pp.9546–51. 
Brettschneider, J. et al., 2008. Quality assessment for short oligonucleotide microarray 
data. Technometrics, 50(3). 
Brun, P. et al., 2007. Increased intestinal permeability in obese mice: new evidence in the 
pathogenesis of nonalcoholic steatohepatitis. American Journal of Physiology-
Gastrointestinal and Liver Physiology, 292(2), pp.G518–25. 
Buhman, K.K. et al., 2000. Resistance to diet-induced hypercholesterolemia and gallstone 
formation in ACAT2-deficient mice. Nature Medicine, 6(12), pp.1341–7. 
Buts, J.P. et al., 1990. Refeeding after starvation in the rat: comparative effects of lipids, 
proteins and carbohydrates on jejunal and ileal mucosal adaptation. European Journal 
of Clinical Investigation, 20(4), pp.441–52. 
Cani, P.D. et al., 2008. Changes in gut microbiota control metabolic endotoxemia-induced 
inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes, 57(6), 
pp.1470–81. 
Cani, P.D. et al., 2007. Metabolic endotoxemia initiates obesity and insulin resistance. 
Diabetes, 56(7), pp.1761–72. 
Outlook 
 
123 
 
Carding, S. et al., 2015. Dysbiosis of the gut microbiota in disease. Microbial Ecology in 
Health and Disease, 26, p.26191. 
Chen, M. et al., 2001. Gut expression and regulation of FAT/CD36: possible role in fatty 
acid transport in rat enterocytes. American Journal of Physiology-Endocrinology and 
Metabolism, 281(5), pp.E916–23. 
Cheung, W.W. & Mao, P., 2012. Recent advances in obesity: genetics and beyond. ISRN 
Endocrinology, 2012, p.536905. 
Chiou, S.-K. et al., 2003. Survivin expression in the stomach: implications for mucosal 
integrity and protection. Biochemical and Biophysical Research Communications, 
305(2), pp.374–379. 
Chu, F.-F. et al., 2004. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and 
Gpx2 genes. Cancer Research, 64(3), pp.962–8. 
Clark, S.B. & Tercyak, A.M., 1984. Reduced cholesterol transmucosal transport in rats 
with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic 
function. Journal of Lipid Research, 25(2), pp.148–59. 
Clemente, J.C. et al., 2012. The impact of the gut microbiota on human health: An 
integrative view. Cell, 148(6), pp.1258–1270. 
Csardi, G. & Nepusz, T., 2006. The igraph software package for complex network 
research. InterJournal, Complex Systems, 1695(5), pp.1–9. 
Daves, M.H. et al., 2011. Meta-analysis of multiple microarray datasets reveals a common 
gene signature of metastasis in solid tumors. BMC Medical Genomics, 4(1), p.56. 
Dawson, K., Rodriguez, R.L. & Malyj, W., 2005. Sample phenotype clusters in high-
density oligonucleotide microarray data sets are revealed using Isomap, a nonlinear 
algorithm. BMC Bioinformatics, 6, p.195. 
Delzenne, N.M. & Cani, P.D., 2011. Interaction between obesity and the gut microbiota: 
relevance in nutrition. Annual Review of Nutrition, 31, pp.15–31. 
DeSesso, J.M. & Jacobson, C.F., 2001. Anatomical and physiological parameters affecting 
gastrointestinal absorption in humans and rats. Food and Chemical Toxicology, 39(3), 
pp.209–28. 
Desmarchelier, C. et al., 2012. C57Bl/6 N mice on a western diet display reduced intestinal 
and hepatic cholesterol levels despite a plasma hypercholesterolemia. BMC 
Genomics, 13(1), p.84. 
Desvergne, B., Michalik, L. & Wahli, W., 2006. Transcriptional regulation of metabolism. 
Physiological Reviews, 86(2), pp.465–514. 
Ding, S. et al., 2010. High-fat diet: bacteria interactions promote intestinal inflammation 
which precedes and correlates with obesity and insulin resistance in mouse. PloS One, 
Outlook 
 
124 
 
5(8), p.e12191. 
Ding, S. & Lund, P.K., 2011. Role of intestinal inflammation as an early event in obesity 
and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care, 
14(4), pp.328–33. 
Dobbs, R. et al., 2014. Overcoming obesity : An initial economic analysis, 
Drover, V.A. et al., 2005. CD36 deficiency impairs intestinal lipid secretion and clearance 
of chylomicrons from the blood. Journal of Clinical Investigation, 115(5), pp.1290–7. 
Dunel-Erb, S. et al., 2001. Restoration of the jejunal mucosa in rats refed after prolonged 
fasting. Comparative Biochemistry and Physiology Part A: Molecular & Integrative 
Physiology, 129(4), pp.933–47. 
Duplus, E., Glorian, M. & Forest, C., 2000. Fatty acid regulation of gene transcription. 
Journal of Biological Chemistry, 275(40), pp.30749–52. 
Dusing, M.R. et al., 2000. A duodenum-specific enhancer regulates expression along three 
axes in the small intestine. American Journal of Physiology-Gastrointestinal and 
Liver Physiology, 279(5), pp.G1080–93. 
Eckburg, P.B. et al., 2005. Diversity of the human intestinal microbial flora. Science, 
308(5728), pp.1635–8. 
Everard, A. et al., 2013. Cross-talk between Akkermansia muciniphila and intestinal 
epithelium controls diet-induced obesity. Proceedings of the National Academy of 
Sciences, 110(22), pp.9066–71. 
Everard, A. et al., 2011. Responses of gut microbiota and glucose and lipid metabolism to 
prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes, 60(11), 
pp.2775–86. 
Fasano, A. et al., 2000. Zonulin, a newly discovered modulator of intestinal permeability, 
and its expression in coeliac disease. The Lancet, 355(9214), pp.1518–9. 
Fasano, A. & Shea-Donohue, T., 2005. Mechanisms of disease: the role of intestinal 
barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nature 
Clinical Practice Gastroenterology & Hepatology, 2(9), pp.416–22. 
De Filippo, C. et al., 2010. Impact of diet in shaping gut microbiota revealed by a 
comparative study in children from Europe and rural Africa. Proceedings of the 
National Academy of Sciences, 107(33), pp.14691–6. 
Fleissner, C.K. et al., 2010. Absence of intestinal microbiota does not protect mice from 
diet-induced obesity. British Journal of Nutrition, 104(6), pp.919–29. 
Fröhlich, H. et al., 2007. GOSim--an R-package for computation of information theoretic 
GO similarities between terms and gene products. BMC Bioinformatics, 8, p.166. 
Fukuda, S. & Pelus, L.M., 2006. Survivin, a cancer target with an emerging role in normal 
Outlook 
 
125 
 
adult tissues. Molecular Cancer Therapeutics, 5(5), pp.1087–98. 
Garrett, W.S., Gordon, J.I. & Glimcher, L.H., 2010. Homeostasis and Inflammation in the 
Intestine. Cell, 140(6), pp.859–870. 
Gentleman, R. et al., 2012. genefilter: Methods for filtering genes from microarray 
experiments. R package version 1.36.0. 
Gentleman, R.C. et al., 2004. Bioconductor: open software development for computational 
biology and bioinformatics. Genome Biology, 5(10), p.R80. 
George, M.D. et al., 2008. In vivo gene expression profiling of human intestinal epithelial 
cells: analysis by laser microdissection of formalin fixed tissues. BMC Genomics, 9, 
p.209. 
Georgiadi, A. & Kersten, S., 2012. Mechanisms of gene regulation by fatty acids. 
Advances in Nutrition: An International Review Journal, 3(2), pp.127–34. 
Gniuli, D. et al., 2008. High saturated-fat diet induces apoptosis in rat enterocytes and 
blunts GIP and insulin-secretive response to oral glucose load. International Journal 
of Obesity, 32(5), pp.871–4. 
Goncalves, A. et al., 2015. Fat-soluble vitamin intestinal absorption: absorption sites in the 
intestine and interactions for absorption. Food Chemistry, 172, pp.155–60. 
Gordon, J.I., 1989. Intestinal epithelial differentiation: new insights from chimeric and 
transgenic mice. The Journal of Cell Biology, 108(4), pp.1187–94. 
Greenwalt, D.E., Scheck, S.H. & Rhinehart-Jones, T., 1995. Heart CD36 expression is 
increased in murine models of diabetes and in mice fed a high fat diet. Journal of 
Clinical Investigation, 96(3), pp.1382–8. 
Harris, L.W. et al., 2009. Gene expression in the prefrontal cortex during adolescence: 
implications for the onset of schizophrenia. BMC Medical Genomics, 2, p.28. 
Hartmann, P. et al., 2013. Deficiency of intestinal mucin-2 ameliorates experimental 
alcoholic liver disease in mice. Hepatology, 58(1), pp.108–19. 
Herrmann, T. et al., 2001. Mouse fatty acid transport protein 4 (FATP4): characterization 
of the gene and functional assessment as a very long chain acyl-CoA synthetase. 
Gene, 270(1-2), pp.31–40. 
Hollander, D. & Truscott, T.C., 1976. Mechanism and site of small intestinal uptake of 
vitamin D3 in pharmacological concentrations. The American Journal of Clinical 
Nutrition, 29(9), pp.970–5. 
Hotamisligil, G.S., 2006. Inflammation and metabolic disorders. Nature, 444(7121), 
pp.860–7. 
Institute of Medicine, 2005. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, 
Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients), 
Outlook 
 
126 
 
Washington, D.C.: National Academies Press. 
Iqbal, J. & Hussain, M.M., 2009. Intestinal lipid absorption. American Journal of 
Physiology-Endocrinology and Metabolism, 296(6), pp.E1183–94. 
Irizarry, R. a. et al., 2003. Summaries of Affymetrix GeneChip probe level data. Nucleic 
Acids Research, 31(4), p.15e–15. 
Ivanov, I.I. et al., 2009. Induction of intestinal Th17 cells by segmented filamentous 
bacteria. Cell, 139(3), pp.485–98. 
Janssen, S. & Depoortere, I., 2013. Nutrient sensing in the gut: new roads to therapeutics? 
Trends in Endocrinology and Metabolism, 24(2), pp.92–100. 
Jeukendrup, A.E., 2003. Modulation of carbohydrate and fat utilization by diet, exercise 
and environment. Biochemical Society Transactions, 31(Pt 6), pp.1270–3. 
Kaminsky, L.S. & Zhang, Q.-Y., 2003. The small intestine as a xenobiotic-metabolizing 
organ. Drug Metabolism and Disposition, 31(12), pp.1520–5. 
Kaufman, L. & Rousseeuw, P.J., 1990. Finding Groups in Data: An Introduction to 
Cluster Analysis, New York: John Wiley & Sons, Inc. 
Khaodhiar, L., McCowen, K.C. & Blackburn, G.L., 1999. Obesity and its comorbid 
conditions. Clinical Cornerstone, 2(3), pp.17–31. 
Khovidhunkit, W. et al., 2003. Endotoxin down-regulates ABCG5 and ABCG8 in mouse 
liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. 
Journal of Lipid Research, 44(9), pp.1728–36. 
Khovidhunkit, W. et al., 2000. Infection and inflammation-induced proatherogenic changes 
of lipoproteins. The Journal of Infectious Diseases, 181 Suppl, pp.S462–72. 
Knights, D., Lassen, K.G. & Xavier, R.J., 2013. Advances in inflammatory bowel disease 
pathogenesis: linking host genetics and the microbiome. Gut, 62(10), pp.1505–10. 
Kondo, H. et al., 2006. Differential regulation of intestinal lipid metabolism-related genes 
in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. American Journal of 
Physiology-Endocrinology And Metabolism, 291(5), pp.E1092–9. 
Kroll, K.M., Barkema, G.T. & Carlon, E., 2008. Modeling background intensity in DNA 
microarrays. arXiv preprint arXiv:0712.3494, 77(6), p.061915. 
de La Serre, C.B. et al., 2010. Propensity to high-fat diet-induced obesity in rats is 
associated with changes in the gut microbiota and gut inflammation. American 
Journal of Physiology-Gastrointestinal and Liver Physiology, 299(2), pp.G440–8. 
Langfelder, P. & Horvath, S., 2008. WGCNA: an R package for weighted correlation 
network analysis. BMC Bioinformatics, 9, p.559. 
de Lartigue, G., de La Serre, C.B. & Raybould, H.E., 2011. Vagal afferent neurons in high 
Outlook 
 
127 
 
fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin. 
Physiology & Behavior, 105(1), pp.100–5. 
Ley, R.E. et al., 2006. Microbial ecology: human gut microbes associated with obesity. 
Nature, 444(7122), pp.1022–3. 
Lim, S.S. et al., 2012. A comparative risk assessment of burden of disease and injury 
attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a 
systematic analysis for the Global Burden of Disease Study 2010. The Lancet, 
380(9859), pp.2224–60. 
Lipshutz, R.J. et al., 1999. High density synthetic oligonucleotide arrays. Nature Genetics, 
21(1 Suppl), pp.20–4. 
Little, T.J., Horowitz, M. & Feinle-Bisset, C., 2007. Modulation by high-fat diets of 
gastrointestinal function and hormones associated with the regulation of energy 
intake: implications for the pathophysiology of obesity. The American Journal of 
Clinical Nutrition, 86(3), pp.531–41. 
Lombardo, D., Fauvel, J. & Guy, O., 1980. Studies on the substrate specificity of a 
carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, 
glycerides and phospholipids. Biochimica et Biophysica Acta (BBA)-Enzymology, 
611(1), pp.136–46. 
Lozupone, C. a et al., 2012. Diversity, stability and resilience of the human gut microbiota. 
Nature, 489(7415), pp.220–30. 
Luo, W. et al., 2009. GAGE: generally applicable gene set enrichment for pathway 
analysis. BMC Bioinformatics, 10, p.161. 
Mansbach, C.M. & Dowell, R., 2000. Effect of increasing lipid loads on the ability of the 
endoplasmic reticulum to transport lipid to the Golgi. Journal of Lipid Research, 
41(4), pp.605–12. 
Mansbach, C.M. & Nevin, P., 1998. Intracellular movement of triacylglycerols in the 
intestine. Journal of Lipid Research, 39(5), pp.963–8. 
Martin, F.-P.J. et al., 2007. A top-down systems biology view of microbiome-mammalian 
metabolic interactions in a mouse model. Molecular Systems Biology, 3(112), p.112. 
McCall, M.N., Bolstad, B.M. & Irizarry, R.A., 2010. Frozen robust multiarray analysis 
(fRMA). Biostatistics, 11(2), pp.242–53. 
Meresse, B., Malamut, G. & Cerf-Bensussan, N., 2012. Celiac disease: an immunological 
jigsaw. Immunity, 36(6), pp.907–19. 
Milagro, F.I. et al., 2009. High fat diet-induced obesity modifies the methylation pattern of 
leptin promoter in rats. Journal of Physiology and Biochemistry, 65(1), pp.1–9. 
Mowat, A.M., 2003. Anatomical basis of tolerance and immunity to intestinal antigens. 
Outlook 
 
128 
 
Nature Reviews Immunology, 3(4), pp.331–41. 
Mowat, A.M. & Agace, W.W., 2014. Regional specialization within the intestinal immune 
system. Nature Reviews Immunology, 14(10), pp.667–85. 
Murphy, D., 2002. Gene expression studies using microarrays: principles, problems, and 
prospects. Advances in Physiology Education, 26(1-4), pp.256–70. 
Nassir, F. et al., 2007. CD36 is important for fatty acid and cholesterol uptake by the 
proximal but not distal intestine. Journal of Bological Chemistry, 282(27), pp.19493–
501. 
Nassir, F. & Abumrad, N., 2009. CD36 and Intestinal Fatty Acid Absorption. Immunology‚ 
Endocrine & Metabolic Agents in Medicinal Chemistry, 9(1), pp.3–10. 
Newman, L., Haryono, R. & Keast, R., 2013. Functionality of fatty acid chemoreception: a 
potential factor in the development of obesity? Nutrients, 5(4), pp.1287–300. 
Ng, M. et al., 2014. Global, regional, and national prevalence of overweight and obesity in 
children and adults during 1980-2013: a systematic analysis for the Global Burden of 
Disease Study 2013. The Lancet, 384. 
Nicholson, J.K. et al., 2004. The challenges of modeling mammalian biocomplexity. 
Nature Biotechnology, 22(10), pp.1268–74. 
Niot, I. et al., 2009. Intestinal absorption of long-chain fatty acids: evidence and 
uncertainties. Progress in Lipid Research, 48(2), pp.101–15. 
O’Hara, A.M. & Shanahan, F., 2006. The gut flora as a forgotten organ. EMBO reports, 
7(7), pp.688–93. 
Ockner, R.K. et al., 1972. A binding protein for fatty acids in cytosol of intestinal mucosa, 
liver, myocardium, and other tissues. Science, 177(4043), pp.56–8. 
Ockner, R.K. & Manning, J.A., 1974. Fatty acid-binding protein in small intestine. 
Identification, isolation, and evidence for its role in cellular fatty acid transport. 
Journal of Clinical Investigation, 54(2), pp.326–38. 
Pácha, J., 2000. Development of intestinal transport function in mammals. Physiological 
Reviews, 80(4), pp.1633–67. 
Parks, B.W. et al., 2013. Genetic control of obesity and gut microbiota composition in 
response to high-fat, high-sucrose diet in mice. Cell Metabolism, 17(1), pp.141–152. 
Peterson, L.W. & Artis, D., 2014. Intestinal epithelial cells: regulators of barrier function 
and immune homeostasis. Nature Reviews Immunology, 14(3), pp.141–53. 
Petit, V. et al., 2007. Chronic high-fat diet affects intestinal fat absorption and postprandial 
triglyceride levels in the mouse. Journal of Lipid Research, 48(2), pp.278–87. 
Phan, C.T. & Tso, P., 2001. Intestinal lipid absorption and transport. Frontiers in 
Outlook 
 
129 
 
Bioscience: a Journal and Virtual Library, 6, pp.D299–319. 
Piccolo, S.R. et al., 2013. A single-sample microarray normalization method to facilitate 
personalized-medicine workflows. Genomics, 100(6), pp.337–344. 
Pocai, A. et al., 2006. Restoration of hypothalamic lipid sensing normalizes energy and 
glucose homeostasis in overfed rats. Journal of Clinical Investigation, 116(4), 
pp.1081–91. 
Poirier, H. et al., 1996. Localization and Regulation of the Putative Membrane Fatty-Acid 
Transporter (FAT) in the Small Intestine. European Journal of Biochemistry, 238(2), 
pp.368–373. 
Qin, J. et al., 2010. A human gut microbial gene catalogue established by metagenomic 
sequencing. Nature, 464(7285), pp.59–65. 
R Core Team, 2015. R: A language and environment for statistical computing. R 
Foundation for Statistical Computing, Vienna, Austria. 
Raymond, F. et al., 2010. Comparative gene expression profiling between human cultured 
myotubes and skeletal muscle tissue. BMC Genomics, 11, p.125. 
Schnabl, B., 2013. Linking intestinal homeostasis and liver disease. Current Opinion in 
Gastroenterology, 29(3), pp.264–70. 
Schulthess, G. et al., 1994. Absorption of monoacylglycerols by small intestinal brush 
border membrane. Biochemistry, 33(15), pp.4500–8. 
Schwenk, R.W. et al., 2010. Fatty acid transport across the cell membrane: regulation by 
fatty acid transporters. Prostaglandins, Leukotrienes and Essential Fatty Acids 
(PLEFA), 82(4-6), pp.149–54. 
Serino, M. et al., 2009. Intestinal microflora and metabolic diseases. Diabetes & 
Metabolism, 35(4), pp.262–72. 
Shaw-Smith, C.J. & Walters, J.R., 1997. Regional expression of intestinal genes for 
nutrient absorption. Gut, 40(1), pp.5–8. 
Shen, J., Obin, M.S. & Zhao, L., 2013. The gut microbiota, obesity and insulin resistance. 
Molecular Aspects of Medicine, 34(1), pp.39–58. 
Shi, H. et al., 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. 
Journal of Clinical Investigation, 116(11), pp.3015–25. 
Shim, J. et al., 2009. Fatty acid transport protein 4 is dispensable for intestinal lipid 
absorption in mice. Journal of Lipid Research, 50(3), pp.491–500. 
Simon, T. et al., 2011. Impact of murine intestinal apolipoprotein A-IV expression on 
regional lipid absorption, gene expression, and growth. Journal of Lipid Research, 
52(11), pp.1984–94. 
Outlook 
 
130 
 
Smyth, G.K., 2005. Limma : Linear Models for Microarray Data. In R. Gentleman et al., 
eds. Bioinformatics and Computational Biology Solutions using R and Bioconductor. 
Springer New York, pp. 397–420. 
Speakman, J.R. et al., 2011. Set points, settling points and some alternative models: 
theoretical options to understand how genes and environments combine to regulate 
body adiposity. Disease Models & Mechanisms, 4(6), pp.733–45. 
Stahl, A. et al., 1999. Identification of the major intestinal fatty acid transport protein. 
Molecular Cell, 4(3), pp.299–308. 
Stark, C. et al., 2011. The BioGRID Interaction Database: 2011 update. Nucleic Acids 
Research, 39(Database issue), pp.D698–704. 
Stenman, L.K., Holma, R. & Korpela, R., 2012. High-fat-induced intestinal permeability 
dysfunction associated with altered fecal bile acids. World Journal of 
Gastroenterology: WJG, 18(9), pp.923–9. 
Stevens, A. et al., 2013. Human growth is associated with distinct patterns of gene 
expression in evolutionarily conserved networks. BMC Genomics, 14(1), p.547. 
Suzuki, T. & Hara, H., 2010. Dietary fat and bile juice, but not obesity, are responsible for 
the increase in small intestinal permeability induced through the suppression of tight 
junction protein expression in LETO and OLETF rats. Nutrition & Metabolism, 7, 
p.19. 
Thomas, K.E. et al., 2006. Gliadin Stimulation of Murine Macrophage Inflammatory Gene 
Expression and Intestinal Permeability Are MyD88-Dependent: Role of the Innate 
Immune Response in Celiac Disease. The Journal of Immunology, 176(4), pp.2512–
2521. 
Thomson, A.B. et al., 1986. Dietary fat selectively alters transport properties of rat 
jejunum. Journal of Clinical Investigation, 77(1), pp.279–88. 
Turnbaugh, P.J. et al., 2009. A core gut microbiome in obese and lean twins. Nature, 
457(7228), pp.480–484. 
Turnbaugh, P.J. et al., 2008. Diet-induced obesity is linked to marked but reversible 
alterations in the mouse distal gut microbiome. Cell Host & Microbe, 3(4), pp.213–
23. 
Turner, J.R., 2009. Intestinal mucosal barrier function in health and disease. Nature 
Reviews Immunology, 9(11), pp.799–809. 
Vaishnava, S. et al., 2008. Paneth cells directly sense gut commensals and maintain 
homeostasis at the intestinal host-microbial interface. Proceedings of the National 
Academy of Sciences, 105(52), pp.20858–63. 
Vassileva, G. et al., 2000. The intestinal fatty acid binding protein is not essential for 
dietary fat absorption in mice. The FASEB Journal, 14(13), pp.2040–6. 
Outlook 
 
131 
 
Velagapudi, V.R. et al., 2010. The gut microbiota modulates host energy and lipid 
metabolism in mice. Journal of Lipid Research, 51(5), pp.1101–1112. 
Walley, A.J., Blakemore, A.I.F. & Froguel, P., 2006. Genetics of obesity and the 
prediction of risk for health. Human Molecular Genetics, 15(2), pp.R124–30. 
Wang, P.Y.T. et al., 2008. Upper intestinal lipids trigger a gut-brain-liver axis to regulate 
glucose production. Nature, 452(7190), pp.1012–6. 
Wang, T.Y. et al., 2013. New insights into the molecular mechanism of intestinal fatty acid 
absorption. European Journal of Clinical Investigation, 43(11), pp.1203–23. 
Wang, X. et al., 2011. HTSanalyzeR: an R/Bioconductor package for integrated network 
analysis of high-throughput screens. Bioinformatics, 27(6), pp.879–80. 
Werner, A., Kuipers, F. & Verkade, H.J., 2000. Fat Absorption and Lipid Metabolism in 
Cholestasis. In Madame Curie Bioscience Database [Internet]. Austin (TX): Landes 
Bioscience. 
Westergaard, H. & Dietschy, J.M., 1974. Delineation of the dimensions and permeability 
characteristics of the two major diffusion barriers to passive mucosal uptake in the 
rabbit intestine. Journal of Clinical Investigation, 54(3), p.718. 
Westergaard, H. & Dietschy, J.M., 1976. The mechanism whereby bile acid micelles 
increase the rate of fatty acid and cholesterol uptake into the intestinal mucosal cell. 
Journal of Clinical Investigation, 58(1), pp.97–108. 
de Wit, N.J. et al., 2008. The role of the small intestine in the development of dietary fat-
induced obesity and insulin resistance in C57BL/6J mice. BMC Medical Genomics, 
1(1), p.14. 
de Wit, N.J.W. et al., 2011. Dose-dependent effects of dietary fat on development of 
obesity in relation to intestinal differential gene expression in C57BL/6J mice. PLoS 
One, 6(4), p.e19145. 
Wright, S.D. et al., 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and 
LPS binding protein. Science, 249(4975), pp.1431–3. 
Wu, J. et al., 2012. gcrma: Background Adjustment Using Sequence Information. R 
package version 2.26.0. 
Wu, J., Irizarry, R. & Gentry, J.M.J., 2007. gcrma: Background Adjustment Using 
Sequence Information. R package version. 
Yatsunenko, T. et al., 2012. Human gut microbiome viewed across age and geography. 
Nature, 486(7402), pp.222–7. 
Yu, L. et al., 2002. Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in 
biliary cholesterol secretion. Proceedings of the National Academy of Sciences, 
99(25), pp.16237–42. 
Outlook 
 
132 
 
Zhang, H. et al., 2009. Human gut microbiota in obesity and after gastric bypass. 
Proceedings of the National Academy of Sciences, 106(7), pp.2365–70. 
Zhong, Y. et al., 2015. Barley malt increases hindgut and portal butyric acid, modulates 
gene expression of gut tight junction proteins and Toll-like receptors in rats fed high-
fat diets, but high advanced glycation end-products partially attenuate the effects. 
Food & Function, 6(9), pp.3165–76. 
Zoetendal, E.G., Akkermans, A.D. & De Vos, W.M., 1998. Temperature gradient gel 
electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and 
host-specific communities of active bacteria. Applied and Environmental 
Microbiology, 64(10), pp.3854–9. 
 
